Ĺ‹ß‚ĚŠw‰ď”­•\i”˛ˆj

2026

6) ‘ž“cŠyl, ‘q‰iŒ’Žj, Žü–h‘ĺŽ÷, ‹g“cšˆť, “ż“c“VŹ, Š|’JGş. V‹K‚Ş‚ńО×–EƒXƒtƒFƒƒCƒhŒ`Ź‘jŠQÜƒXƒgƒŒƒvƒgƒXƒtƒFƒŠƒ“A‚Ě‘S‡Ź. “ú–{–ňŠw‰ď‘ć146”N‰ďi‘ĺăj, ‘ĺă, 3ŒŽ, 2026.@@
5) z–K”šl, ‘q‰iŒ’Žj, ŸÇ–ě‡‘ž, ŕ“c•Ž, Š|’JGş. R‹ŰÜƒcƒƒZƒiƒ~ƒhC‚ĚŽŔ‘H“I‡ŹŒo˜H‚ĚŒŸ“˘‚¨‚ć‚э\‘˘ŠˆŤ‘ŠŠÖŒ¤‹†. “ú–{–ňŠw‰ď‘ć146”N‰ďi‘ĺăj, ‘ĺă, 3ŒŽ, 2026.@@
4) Š™“ŕ “™, “n i, ‹´Œł ˝, Îě˜aŽ÷, ŒF–{‘ěĆ, Š|’JGş, ŽsŁ_Žu. ActVA-ORF—ly‘f‚É‚ć‚éƒAƒŠ[ƒ‹ƒJƒbƒvƒŠƒ“ƒO”˝‰ž‚đ‰î‚ľ‚˝ƒiƒtƒgƒLƒmƒ“‰ť‡•¨‚Ě“ń—ʉť. “ú–{–ňŠw‰ď‘ć146”N‰ďi‘ĺăj, ‘ĺă, 3ŒŽ, 2026.@@
3) ź“c仍ç, ’r“c‘ńŒd, Ž™‹Ę ŠJ, Š|’JGş. ‚Ş‚ńО×–EƒXƒtƒFƒƒCƒhŒ`Ź‘jŠQŠˆŤ‚đ—L‚ˇ‚éPKS-NRPSƒnƒCƒuƒŠƒbƒh“V‘R‰ť‡•¨‚Ě”­ŒŠ‚ƍě—p‹@˜‰đÍ. “ú–{–ňŠw‰ď‘ć146”N‰ďi‘ĺăj, ‘ĺă, 3ŒŽ, 2026.@@
2) ŽR“c‘אŹ, œAŁP‹v, ‰şŠÔŽuŽm, ’r“c–ž‰Ä—˘, ěŁ‹M”Ž, ’Ň ˆ¤, —F‰iČŽO, ‘q‰iŒ’Žj, Š|’JGş, ”öč ˝. ‚Š´“xƒ‰ƒxƒ‹‰ťÜD-FDLDA‚đ—p‚˘‚˝ˆŔ’蓯ˆĘ‘Ě•WŽŻ—U“ą‘̉ť–@‚É‚ć‚éƒAƒ‹ƒcƒnƒCƒ}[•aŠłŽŇŒŒ´’†‚ĚD/L-Ser‚ĆD/L-Pro‚Ě’č—Ę•ŞÍ. ‘ć17‰ńJBFƒVƒ“ƒ|ƒWƒEƒ€, •şŒÉ, 3ŒŽ, 2026. (*JBF: Japan Bioanalysis Forum)
1) Kakeya, H. (TBA). Asian Chemical Biology Initiative (ACBI) 2026 Chiang Mai Meeting, Chiang Mai, Thailand, Jan. 2026. (invited)

2025

47) Š|’JGş. “V‘R•¨‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚É‚¨‚Ż‚éhƒ‚ƒmƒgƒŠhŒ¤‹†‚Ě‘çŒí–Ą. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ďEŽYŠw˜AŒgˆĎˆő‰ď2025”N“x‘ć3‰ń’č—áˆĎˆő‰ď, ‘ĺă, 12ŒŽ, 2025.iľ‘ҍu‰‰j
46) Kakeya, H. On-gel combined-culture screening and discovery of new microbial metabolites of actinomycetes for drug discovery. PACIFICHEM 2025, Hawaii, USA, Dec. 2025. [Natural Products in the 'Omics Era' (#ORG018)] (invited)
45) Kakeya, H. Natural products-inspired chemical biology: Development of highly sensitive labeling reagents for amino acids, short peptide fragments, and scarce natural products. PACIFICHEM 2025, Hawaii, USA, Dec. 2025. [Recent Advances in Chemical Biology - in Memory of Koji Nakanishi, the Pioneer in Natural Product Chemistry on the Occasion of his 100 Year Birthday (#ORG024)] (invited)
44) Zhang, L., Pan, Y., Hattori, A., Uekusa, H., Suzuki, T., Dohmae, N., Hirano, Y., Kakeya, H. Discovery of lysine-reactive metabolites as covalent asparagine synthetase inhibitors from Stachybotrys sp. PACIFICHEM 2025, Hawaii, USA, Dec. 2025. [Bio-active Molecular Design Interwoven by AI Technology, Chemical Biology and Organic Synthesis (#ORG004)]
43) Mimura, A., Ikeda, H., Shibasaki, M., Suo, T., Hashimoto, J., Shin-ya, K., Imoto, M., Kakeya, H. Isolation, structural determination, and biological activity of novel cancer stem cell inhibiots streptospherins A-F. The 11th Japan-Korea Chemical Biology Symposium. Chungbuk, Korea, Dec. 2025.
42) Ikeda, H., Imoto, M., Kakeya, H. Establishment of a new screening strategy targeting cancer stem cells (CSCs) and development of the CSC inhibitors. The 11th Japan-Korea Chemical Biology Symposium. Chungbuk, Korea, Dec. 2025.
41) Yanagisawa, K., Kaneko, K., Ikeda, H., Iwata, S., Muranaka, A., Koshino, H., Nagao, N., Watari, S., Nishimura, S., Shinzato, N., Onaka, H., Kakeya, H. Discovery of actinoquinonal A and its congeners from the combined-culture of Streptomyces sp. and their production profile. The 11th Japan-Korea Chemical Biology Symposium. Chungbuk, Korea, Dec. 2025.
40) ŕ“c•Ž, ‘q‰iŒ’Žj, ’ç—˝‘ž˜Y, Š|’JGş. V‹KR^‹ŰÜƒAƒ€ƒtƒBƒI[ƒ‹‚ĚŽű‘Š“I‘S‡Ź. ‘ć42‰ńƒƒfƒBƒVƒiƒ‹ƒPƒ~ƒXƒgƒŠ[ƒVƒ“ƒ|ƒWƒEƒ€, “ż“‡, 11ŒŽ, 2025.
39) ź‰Ş‘ń˜N, ă–ě‘sŒĺ, ‚č—ş•, H—tGŽ÷, ŹŒ`Œö—ş, •ž•” –ž, —L’n–@l, Š|’JGş, ŽRč ť, Îŕ_ ‘×, ‘ĺ–ě_Í, ˆäŠŃW•ă. ‰ÂŽ‹Œő‰ž“šŤŒőG”}‚đ—p‚˘‚˝diaryltetrazole‚É‚ć‚鐜‘Ě•ŞŽq‚Ěƒ‰ƒxƒ‹‰ť”˝‰ž‚ĚŠJ”­. ‘ć42‰ńƒƒfƒBƒVƒiƒ‹ƒPƒ~ƒXƒgƒŠ[ƒVƒ“ƒ|ƒWƒEƒ€, “ż“‡, 11ŒŽ, 2025.
38) ”öč ˝, ŽR“c‘אŹ, œAŁP‹v, ’r“c–ž‰Ä—˘, ěŁ‹M”Ž, ’Ň ˆ¤, —F‰iČŽO, ‘q‰iŒ’Žj, Š|’JGş. ‚Š´“x—U“ą‘̉ťŽŽ–ňD-FDLDA‚đ—p‚˘‚˝ADŠłŽŇŒŒ´’†‚ĚD/L-ƒZƒŠƒ“‚ĆD/L-ƒvƒƒŠƒ“‚Ě’č—Ę•ŞÍ. “ú–{ƒAƒ~ƒmŽ_Šw‰ď‘ć19‰ńŠwp‘ĺ‰ď, ˆ¤’m, 11ŒŽ, 2025.
37) ź‰Ş‘ń˜N, ă–ě‘sŒĺ, ‚úą—ş•, H—tGŽ÷, •űŒö—ş, •ž•” –ž, —L’n–@l, Š|’JGş, ŽRč ť, Îŕ_ ‘×, ‘ĺ–ě_Í, ˆäŠŃW•ă. ‰ÂŽ‹Œő‰ž“šŤŒőG”}‚đ—p‚˘‚˝ƒeƒgƒ‰ƒ][ƒ‹‚ĆƒJƒ‹ƒ{ƒ“Ž_‚ĚƒJƒbƒvƒŠƒ“ƒO”˝‰ž‚É‚ć‚鐜‘Ě•ŞŽq‚Ěƒ‰ƒxƒ‹‰ť. ‘ć51‰ń”˝‰ž‚ƍ‡Ź‚̐i•ŕƒVƒ“ƒ|ƒWƒEƒ€, L“‡, 11ŒŽ, 2025.
36) Matsui, M., Ikeda, H., Sakai, K., Nishio, K., Imoto, M., Kakeya, H. Discovery of an anticancer seed targeting cancer stem cells and analysis of its mode of action. 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, MA, USA, Oct. 2025.
35) Kakeya, H., Abe, T., Horisawa, Y., Kikuchi, O., Ozawa-Umezawa, H., Kishimoto, A., Katsuura, Y., Imaizumi, A., Hashimoto, T., Shirakawa, K., Takaori-Kondo, A., Yusa, K., Asakura, T., Kanai, M. Development of an innovative anticancer drug TBP1901, an injectable prodrug of curcumin, for the treatment of multiple myeloma. 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, MA, USA, Oct. 2025.
34) ŽR“c‘אŹ, œAŁP‹v, ‰şŠÔŽuŽm, ’r“c–ž‰Ä—˘, ‘q‰iŒ’Žj, Š|’JGş, ”öč ˝. ‚Š´“xƒLƒ‰ƒ‹ƒ‰ƒxƒ‹‰ťÜD-FDLDA‚đ—p‚˘‚˝”­yH•i‚Ć”­yˆů—ż’†‚ĚD/L-ƒAƒ~ƒmŽ_‚Ě’č—Ę•ŞÍ. ‘ć19‰ńƒƒ^ƒ{ƒ[ƒ€ƒVƒ“ƒ|ƒWƒEƒ€, _ŒË, 10ŒŽ, 2025. @
33) ”öč˝, ŽR“c‘אŹ, œAŁP‹v, ‰şŠÔŽuŽm, ’r“c–ž‰Ä—˘, ěŁ‹M”Ž, ’Ň ˆ¤, —F‰iČŽO, ‘q‰iŒ’Žj, Š|’JGş. ‚Š´“xƒLƒ‰ƒ‹ƒ‰ƒxƒ‹‰ťÜD-FDLDA‚đ—p‚˘‚˝“ŻˆĘ‘Ě•WŽŻ—U“ą‘̉ť–@‚É‚ć‚錌´’†‚ĚD/L-ƒZƒŠƒ“‚ĆD/L-ƒvƒƒŠƒ“‚Ě’č—Ę•ŞÍ. ‘ć19‰ńƒƒ^ƒ{ƒ[ƒ€ƒVƒ“ƒ|ƒWƒEƒ€, _ŒË, 10ŒŽ, 2025. @
32) “ż“c“VŹ,@‘q‰iŒ’Žj, ´…Œú•ă, Š|’JGş. ‚Ë‚ś‚ęŒ^ƒAƒ~ƒh‚đ‰î‚ľ‚˝V‹KŒĹ‘ŠƒAƒ~ƒh‰ť”˝‰ž. ‘ć75‰ń“ú–{–ňŠw‰ďŠÖźŽx•”‘‰ďE‘ĺ‰ď, ‹ž“s, 10ŒŽ, 2025.@
31) ź“c仍ç, ’r“c‘ńŒd, Ž™‹Ę@ŠJ, Š|’JGş. ‚Ş‚ńО×–EƒXƒtƒFƒƒCƒhŒ`Ź‚đ‘jŠQ‚ˇ‚éPKS-NRPSƒnƒCƒuƒŠƒbƒh“V‘R‰ť‡•¨‚Ě”­ŒŠ. ‘ć75‰ń“ú–{–ňŠw‰ďŠÖźŽx•”‘‰ďE‘ĺ‰ď, ‹ž“s, 10ŒŽ, 2025.@
30) ’r“c‘ńŒd, ŽÄčŽçO, ŽO‘ş •Ň, Žü–h‘ĺŽ÷, ‘q‰iŒ’Žj, ‹´–{ˆşŽq, V‰Ćˆę’j, ˆä–{łĆ, Š|’JGş. V‹K‚Ş‚ńО×–E‘ƒƒtƒFƒAŒ`Ź‘jŠQÜƒXƒgƒŒƒvƒgƒXƒtƒFƒŠƒ“—ނ̊J”­‚ƍ\‘˘ŠˆŤ‘ŠŠÖŒ¤‹†. ‘ć75‰ń“ú–{–ňŠw‰ďŠÖźŽx•”‘‰ďE‘ĺ‰ď, ‹ž“s, 10ŒŽ, 2025.@
29) Furutani, Y., Yanaka, K., Kukimoto, M., Kobayashi, K., Nagamori, S., Shirouzu, M., Aizaki, H., Ochi, S., Kakeya, H., Matsuura, T. Development of an orally available JAK1 activator CDM-2020 that suppresses HBV through the induction of inteferon-stimulated genes. 2025 International HBV Meeting, Berlin, Germany, Sep. 2025.
28) ŕ“c•Ž, ‘q‰iŒ’Žj, ’ç—˝‘ž˜Y, Š|’JGş. V‹KR^‹ŰÜƒAƒ€ƒtƒBƒI[ƒ‹‚̍\‘˘’ůł‚¨‚ć‚Ń‘S‡ŹŒ¤‹†. ‘ć67‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď, ‹{é, 9ŒŽ, 2025.
27) Mimura, A., Ikeda, H., Shibasaki, M., Suo, T., Hashimoto, J., Shin-ya, K., Imoto, M., Kakeya, H. Isolation, structural determination, and biological activity of streptospherins A-F, new inhibitors targeting cancer stem cells. The 5th Research Network Salon, Medical Innovation Program, Kyoto University, Kyoto, Sep. 2025.
26) ŒĂ’J —T, ”ö’†D, •A–{–rŽq, Ź—ŃƒJƒIƒ‹, ‰iXŽűŽu, ”’…”üŽq, ‘Šč‰pŽ÷, ‰z’qŹŽ}, Š|’JGş, ź‰Y’m˜a. ’ᕪŽqJAKŠˆŤ‰ťÜCDM-2020‚ĚŠJ”­. ‘ć33‰ń“ú–{RƒEƒCƒ‹ƒX—Ă–@Šw‰ď, “Œ‹ž, 8ŒŽ, 2025.
25) “Ą–{ŘXŽq, ’r“c‘ńŒd, Ź—ѐ´, ˆä‰§Œĺ, “ü]ˆę_, Œ´“c _, Š|’JGş. ”÷ś•¨‘ăŽÓŽY•¨—R—ˆ‚Ě’áŽ_‘f—U“ąˆöŽqƒ‚ƒWƒ…ƒŒ[ƒ^[‚ĚŠJ”­Œ¤‹†. ‘ć35‰ńV–ň‘nť’k˜b‰ď, Ă‰Ş, 7ŒŽ, 2025.
24) ŽO‘ş@•Ň, ’r“c‘ńŒd, ŽÄčŽçO, Žü–h‘ĺŽ÷, ‹´–{ˆşŽq, V‰Ćˆę’j, ˆä–{łĆ, Š|’JGş. V‹K‚Ş‚ńО×–EƒXƒtƒFƒAŒ`Ź‘jŠQÜƒXƒgƒŒƒvƒgƒXƒtƒFƒŠƒ“—ނ̒P—ِ¸ťA\‘˘‰đÍA‹y‚ѐś•¨ŠˆŤ. ‘ć35‰ńV–ň‘nť’k˜b‰ď, Ă‰Ş, 7ŒŽ, 2025. [Œ¤‹†§—ăÜ]@@
23) źˆä”ü—RŠó, ’r“c‘ńŒd, âˆä˜aŽq, ź”ö˜al, ˆä–{łĆ, Š|’JGş. ‚Ş‚ńО×–EƒXƒtƒFƒAŒ`Ź‘jŠQ‚Ě”­ŒŠ‚ƍě—p‹@˜‰đÍ. ‘ć29‰ń“ú–{‚Ş‚ń•ŞŽq•W“IŽĄ—ĂŠw‰ď, ŽD–y, 7ŒŽ, 2025.@
22) ‘q‰iŒ’Žj, ŹŽR@ˆ¤, ´…Œú•ă, “ż“c“VŹ, Š|’JGş. ”ńG”}“IƒTƒXƒeƒiƒuƒ‹ƒAƒ~ƒh‰ť”˝‰ž‚ĚŠJ”­‚Ɖž—p. ‘ć126‰ń—L‹@‡ŹƒVƒ“ƒ|ƒWƒEƒ€, ‹ž“s, 6ŒŽ, 2025.@
21) ”öč˝, ’†o—F”ü, ŽR“c‘אŹ, ŠÖŒű–ƒ—I, œAŁP‹v, ěŁ‹M”Ž, ’Ň ˆ¤, ‘q‰iŒ’Žj, Š|’JGş, —F‰iČŽO, ‰şŠÔŽuŽm. PBrƒJƒ‰ƒ€‚ƍ‚Š´“x—U“ą‘̉ťŽŽ–ňL-FDVDA‚đ—p‚˘‚˝ƒVƒ“ƒOƒ‹Žld‹ÉLC-MS‚É‚ć‚éH“÷’†‚ĚƒCƒ~ƒ_ƒ][ƒ‹ƒWƒyƒvƒ`ƒh‚ĆŠÖ˜A‘ăŽÓ•¨‚Ě’č—Ę•ŞÍ. ‘ć42‰ń“ú–{”÷—ʉh—{‘fŠw‰ďŠwpW‰ď, ‹ž“s, 6ŒŽ, 2025. @
20) Keck, D., Yamada, Y., Hirose, T., Shimotsuma, M., Ikeda, A., Kawase, T., Tsuji, A., Tomonaga, S., Kuranaga, T., Kakeya, H., Ozaki, M., Quantitative analysis of D/L-Ser and D/L-Pro in serum using a highly sensitive chiral resolution labeling reagents D-FDLDA. HPLC 2025, Bruges, Belgium, Jun. 2025.@
19) ”öč˝, ŽR“c‘אŹ, œAŁP‹v, ‰şŠÔŽuŽm, ’r“c–ž‰Ä—˘, ěŁ‹M”Ž, ’Ň ˆ¤, —F‰iČŽO, ‘q‰iŒ’Žj, Š|’JGş. ‚Š´“xƒ‰ƒxƒ‹‰ťÜD-FDLDA‚đ—p‚˘‚˝ƒAƒ‹ƒcƒnƒCƒ}[•aŠłŽŇŒŒ´’†‚ĚD-Ser‚ĆD-Pro‚Ě’č—Ę–@‚ĚŠm—§. “ú–{ƒAƒ~ƒmŽ_Šw‰ď‘ć8‰ńŽYŠw˜AŒgƒVƒ“ƒ|ƒWƒEƒ€. “Œ‹ž, 6ŒŽ, 2025. @
18) Zhang, L., Pan, Y., •ž•” –ž, A‘G—T, —é–ŘŒ’—T, “°‘O ’ź, •˝–ěG“T, Š|’JGş. Stachybotrys‘ސ^‹Ű—R—ˆ‚Ě‹¤—LŒ‹‡ŤƒAƒXƒpƒ‰ƒMƒ“‡Źy‘f‘jŠQÜ‚Ě’Tő‚ĆŠJ”­Œ¤‹†. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ď@‘ć19‰ń”N‰ď, ‹ž“s, 6ŒŽ, 2025.
17) ‰Ş–{ŤŽu, X“c‘ĺ•ă, H—tGŽ÷, •ž•” –ž, —L’n–@l, Š|’JGş, ‘ĺ–ě_Í, ˆäŠŃW•ă. CD1aS‘АŤT×–E‚đ§Œä‚ˇ‚éŽ‰ŽżƒŠƒKƒ“ƒh‚Ě’TőŒ¤‹†. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ď@‘ć19‰ń”N‰ď, ‹ž“s, 6ŒŽ, 2025.
16) ’r“c‘ńŒd, “Ą–{ŘXŽq, ˆä‰§Œĺ, “ü]ˆę_, Œ´“c _, Š|’JGş. “V‘R•¨öÝ‹óŠÔ‚đŠˆ—p‚ľ‚˝’áŽ_‘f—U“ąˆöŽqƒ‚ƒWƒ…ƒŒ[ƒ^[‚ĚŠJ”­Œ¤‹†. öÝ‹óŠÔ•ŞŽqÝŒvE‘ć3‰ńŒöŠJƒVƒ“ƒ|ƒWƒEƒ€, ‰Ą•l, 5ŒŽ, 2025.@
15) ‰Ş–{ŤŽu, X“c‘ĺ•ă, H—tGŽ÷, •ž•” –ž, —L’n–@l, Š|’JGş, ‘ĺ–ě_Í, ˆäŠŃW•ă. CD1a‚É’ńŽŚ‚ł‚ę‚郊ƒKƒ“ƒh‚Ě’TőŽč–@‚ĚŠJ”­‚ƍ\‘˘ŠˆŤ‘ŠŠÖŒ¤‹†Œ¤‹†. öÝ‹óŠÔ•ŞŽqÝŒvE‘ć3‰ńŒöŠJƒVƒ“ƒ|ƒWƒEƒ€, ‰Ą•l, 5ŒŽ, 2025.
14) ”öč˝, ’†o—F”ü, ŽR“c‘אŹ, ŠÖŒű–ƒ—I, œAŁP‹v, ěŁ‹M”Ž, ’Ň ˆ¤, ‘q‰iŒ’Žj, Š|’JGş, —F‰iČŽO, ‰şŠÔŽuŽm. PBrƒJƒ‰ƒ€‚Ćƒ‰ƒxƒ‹‰ťÜL-FDLDA‚đ—p‚˘‚˝“Ž•¨Ží‚ĚˆŮ‚Č‚éH“÷’†‚ĚƒCƒ~ƒ_ƒ][ƒ‹ƒWƒyƒvƒ`ƒh‚ĆŠÖ˜A‰ť‡•¨‚Ě’č—Ę•ŞÍ–@‚ĚŠm—§. ‘ć79‰ń“ú–{‰h—{EH—ĆŠw‰ď‘ĺ‰ď, ˆ¤’m, 5ŒŽ, 2025. @
13) ŽR“c‘אŹ, ”öč ˝, œAŁP‹v, ’r“c–ž‰Ä—˘, ‘q‰iŒ’Žj,@Š|’JGş, ‰şŠÔŽuŽm. ‚Š´“x—U“ą‘̉ťŽŽ–ňD-FDLDA‚đ—p‚˘‚˝“ŻˆĘ‘Ě•WŽŻ—U“ą‘̉ť–@‚É‚ć‚鐜‘ĚƒAƒ~ƒ“‚¨‚ć‚Ń‘O‹ě‘ĚƒAƒ~ƒmŽ_‚Ě’č—Ę. ‘ć79‰ń“ú–{‰h—{EH—ĆŠw‰ď‘ĺ‰ď, ˆ¤’m, 5ŒŽ, 2025. @
12) Š|’JGş. “ú–{–ňŠw‰ďÜEŽóÜu‰‰F‘n–ň‚đŽuŒü‚ľ‚˝“V‘R•¨ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†. “ú–{–ňŠw‰ď‘ć145”N‰ďi•Ÿ‰Şj, •Ÿ‰Ş, 3ŒŽ, 2025. iŽóÜu‰‰j@
11) Š|’JGş. ƒVƒ“ƒ|ƒWƒEƒ€uƒ‚ƒmƒgƒŠƒTƒCƒGƒ“ƒX@ƒAƒbƒvƒgƒDƒfƒCƒgvFhƒ‚ƒmƒgƒŠh‚đŠî”Ő‚Ć‚ľ‚˝“V‘R•¨‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. “ú–{–ňŠw‰ď‘ć145”N‰ďi•Ÿ‰Şj, •Ÿ‰Ş, 3ŒŽ, 2025. iľ‘ҍu‰‰j@
10) ŽO‘ş@•Ň, ’r“c‘ńŒd, ŽÄčŽçO, Žü–h‘ĺŽ÷, ‹´–{ˆşŽq, V‰Ćˆę’j, ˆä–{łĆ, Š|’JGş. V‹K‚Ş‚ńО×–EƒXƒtƒFƒAŒ`Ź‘jŠQÜƒXƒgƒŒƒvƒgƒXƒtƒFƒŠƒ“A‚̐śŽYŤŒüă‚ƐV‹K—މ‘̂̔­ŒŠ. “ú–{–ňŠw‰ď‘ć145”N‰ďi•Ÿ‰Şj, •Ÿ‰Ş, 3ŒŽ, 2025.
9) úĺŕV˜aŠó, ‹ŕŽqŒŤ‰î, ’r“c‘ńŒd, Šâ“cƒ‰Ŕ, ‘ş’†ŒúĆ, ‰z–ěLá, ’ˇ”ö–ě‰f‰Ô, “n i, ź‘şTˆę, V—˘Ž–ç, ”ö’‡GN, Š|’JGş. •úü‹Ű‚Ě•Ą‡”|—{‚É‚ć‚čŽYś‚ł‚ę‚éV‹Kƒsƒ‰ƒmƒiƒtƒgƒLƒmƒ“Œn‰ť‡•¨‚Ě’P—فE\‘˘‰đÍ‚Ć‚ť‚ĚŽYś‚ÉŠÖ‚ˇ‚錤‹†. “ú–{–ňŠw‰ď‘ć145”N‰ďi•Ÿ‰Şj, •Ÿ‰Ş, 3ŒŽ, 2025. [Šwś—DG”­•\ÜiŒű“Ş”­•\‚Ě•”j]@
8) Zhang, L., Pan, Y., •ž•” –ž, A‘G—T, •˝–ěG“T, Š|’JGş. ^‹ŰStachybotrys‘Ž‚ŞśŽY‚ˇ‚éV‹K‹¤—LŒ‹‡ŤƒAƒXƒpƒ‰ƒMƒ“‡Źy‘f‘jŠQÜ‚ĚŠJ”­Œ¤‹†. “ú–{–ňŠw‰ď‘ć145”N‰ďi•Ÿ‰Şj, •Ÿ‰Ş, 3ŒŽ, 2025.
7) źˆä”ü—RŠó, ’r“c‘ńŒd, ŽÄčŽçO, âˆä˜aŽq, ź”ö˜al, ˆä–{łĆ, Š|’JGş. ‚Ş‚ńО×–EƒXƒtƒFƒAŒ`Ź‘jŠQŠˆŤ‚đ—L‚ˇ‚é•úü‹Ű‘ăŽÓŽY•¨‚Ě”­ŒŠ‚ƍě—p‹@˜‰đÍ. “ú–{–ňŠw‰ď‘ć145”N‰ďi•Ÿ‰Şj, •Ÿ‰Ş, 3ŒŽ, 2025. [Šwś—DG”­•\ÜiŒű“Ş”­•\‚Ě•”j]@@
6) ’r“c‘ńŒd, ˆä‰§Œĺ, “Ą–{ŘXŽq, Ź—ѐ´, “ü]ˆę_, Œ´“c _, Š|’JGş. ‹•ŒŒŤŽžŠłŽĄ—Âɂ¨‚Ż‚éPKCƒż/mTORCƒVƒOƒiƒ‹‚đ‰î‚ľ‚˝HIF-1ƒżŠˆŤ‰ťí—Ş. “ú–{–ňŠw‰ď‘ć145”N‰ďi•Ÿ‰Şj, •Ÿ‰Ş, 3ŒŽ, 2025.@
5) “n i, ‹´–{ ˝, Îě˜aŽ÷, ŒF–{‘ěĆ, Š|’JGş, ŽsŁ_Žu. ƒAƒNƒ`ƒmƒƒWƒ“ś‡Ź‚ÉŠÖ—^‚ˇ‚éV‹KŽ_‰ťy‘fActVA-ORF3‚ĚAlphaFold‚đ—˜—p‚ľ‚˝‹@”\‰đÍŒ¤‹†. “ú–{–ňŠw‰ď‘ć145”N‰ďi•Ÿ‰Şj, •Ÿ‰Ş, 3ŒŽ, 2025.@
4) ‰Ş–{ŤŽj, X“c‘ĺ•ă, H—tGŽ÷, •ž•” –ž —L’n–@l, Š|’JGş, ‘ĺ–ě_Í, ˆäŠŃW•ă. Ž‰ŽżRŒ´’ńŽŚƒ^ƒ“ƒpƒNŽżCD1a‚É”FŽŻ‚ł‚ę‚郊ƒ|ƒyƒvƒ`ƒhDDM-838‚̍\‘˘ŠˆŤ‘ŠŠÖŒ¤‹†. “ú–{–ňŠw‰ď‘ć145”N‰ďi•Ÿ‰Şj, •Ÿ‰Ş, 3ŒŽ, 2025.@
3) Kakeya, H. Natural product-inspired chemical biology: Development of an agrochemical seed targeting the scab-forming actinomycete. Asian Chemical Biology Initiative (ACBI) 2025 Hanoi Meeting, Hanoi, Vietnam, Jan. 2025. (invited)
2) Kakeya, H. Natural product-inspired chemical biology: Development of highly sensitive labeling reagents for amino acids, scarce natural products, and amylooid beta fragment peptides. The 5th Intenational Conference on Natural Product Discovery and Development in the Genomic Era. San Diego, CA, USA, Jan. 2025.
1) Yanagisawa, K., Kaneko, K., Ikeda, H., Iwata, S., Muranaka, A., Koshino, H., Nagao, N., Watari, S., Nishimura, S., Shinzato, N., Onaka, H., Kakeya, H. Discovery of a new pyranonaphthoquinone, actinoquinonal A: Combined-culture of Streptomyces sp. 23-50 with Tsukamurella pulmonis TP-B0596 triggers a shunt of the mevalonate pathway of Streptomyces sp. 23-50. The 5th Intenational Conference on Natural Product Discovery and Development in the Genomic Era. San Diego, CA, USA, Jan. 2025. [—DG”­•\Üiƒ|ƒXƒ^[”­•\)FThe Carol D. Litchfield Honorable Mention Student Poster Presentation]

2024

33) ”öč˝, ’†o—F”ü, ŠÖŒű–ƒ—I, œAŁP‹v, ěŁ‹M”Ž, ’Ň ˆ¤, ‘q‰iŒ’Žj, Š|’JGş, —F‰iČŽO, ‰şŠÔŽuŽm. PBrƒJƒ‰ƒ€‚Ćƒ‰ƒxƒ‹‰ťÜL-FDLDA‚đ—p‚˘‚˝H“÷’†‚ĚƒCƒ~ƒ_ƒ][ƒ‹ƒWƒyƒvƒ`ƒh‚ĆŠÖ˜A‰ť‡•¨‚Ě’č—Ę. ‘ć14‰ńVƒAƒ~ƒmŽ_•ސ͌¤‹†‰ď, “Œ‹ž, 12ŒŽ, 2024. @
32) ŽR“c‘אŹ, ”öč ˝, œAŁP‹v, ’r“c–ž‰Ä—˘, ‘q‰iŒ’Žj,@Š|’JGş, ‰şŠÔŽuŽm. ‚Š´“xƒ‰ƒxƒ‹‰ťÜD-FDLDA‚đ—p‚˘‚˝ƒr[ƒ‹’†‚̐ś‘ĚƒAƒ~ƒ“—Ţ‚¨‚ć‚ŃŠÖ˜A‰ť‡•¨‚ĚˆęÄ•ސÍ. ‘ć14‰ńVƒAƒ~ƒmŽ_•ސ͌¤‹†‰ď, “Œ‹ž, 12ŒŽ, 2024. @
31) Žü–h‘ĺŽ÷, ‘q‰iŒ’Žj, ‹g“cšˆť, ŹŽR ˆ¤, ’r“c‘ńŒd, ŽÄčŽçO, Š|’JGş. V‹K‚Ş‚ńО×–EƒXƒtƒFƒAŒ`Ź‘jŠQÜƒXƒgƒŒƒvƒgƒXƒtƒFƒŠƒ“A‚̍\‘˘Œˆ’č‹y‚Ń‘S‡ŹŒ¤‹†. ‘ć41‰ńƒƒfƒBƒVƒiƒ‹ƒPƒ~ƒXƒgƒŠ[ƒVƒ“ƒ|ƒWƒEƒ€, ‹ž“s, 11ŒŽ, 2024.
30) ‰Ş–{ŤŽu, X“c‘ĺ•ă, H—tGŽ÷, •ž•” –ž —L’n–@l, Š|’JGş, ‘ĺ–ě_Í, ˆäŠŃW•ă. CD1aS‘АŤT×–E‚đ§Œä‚ˇ‚錋Šj‹Ű—R—ˆƒŠƒ|ƒyƒvƒ`ƒhDDM-838‚̍\‘˘ŠˆŤ‘ŠŠÖŒ¤‹†. ‘ć41‰ńƒƒfƒBƒVƒiƒ‹ƒPƒ~ƒXƒgƒŠ[ƒVƒ“ƒ|ƒWƒEƒ€, ‹ž“s, 11ŒŽ, 2024.
29) Zhang, L., Pan, Y., Hattori, A., Uekusa, H., Kakeya, H.Discovery of new meroterpenoids produced by Stachybotrys ruwenzoriensis RF-6853 as asparagine synthetase inhibitors. Seoul Univ.-Kyoto Univ.-Osaka Univ. Symposium 2024 (SKO Symposium 2024). Seoul, Korea, Nov., 2024.
28) ŽR“c‘אŹ, ”öč˝, ‰şŠÔŽuŽm, ’r“c–ž‰Ä—˘, ‘q‰iŒ’Žj, Š|’JGş, œAŁP‹v. ‚Š´“xƒ‰ƒxƒ‹‰ťÜD-FDLDA‚đ—p‚˘‚˝ƒr[ƒ‹’†‚Ě•…”sƒAƒ~ƒ“—Ţ‚¨‚ć‚ŃŠÖ˜A‰ť‡•¨‚ĚˆęÄ•ސÍ. ‘ć120‰ń“ú–{H•i‰qśŠw‰ďŠwpu‰‰‰ď, ˆ¤’m, 11ŒŽ, 2024.
27) ”öč˝, ’†o—F”ü, ŠÖŒű–ƒ—I, ‰şŠÔŽuŽm, ěŁ‹M”Ž, ’Ň ˆ¤, ‘q‰iŒ’Žj, Š|’JGş, —F‰iČŽO,@œAŁP‹v. ƒ‰ƒxƒ‹‰ťÜL-FDVDA‚ĆPBrƒJƒ‰ƒ€‚đ—p‚˘‚˝“Ž•¨ŽíE‘gDE•iŽí‚ĚˆŮ‚Č‚éH“÷’†‚ĚƒCƒ~ƒ_ƒ][ƒ‹ƒWƒyƒvƒ`ƒh‚ƍ\ŹƒAƒ~ƒmŽ_Aƒ^ƒEƒŠƒ“‚Ě’č—Ę•ŞÍ. ‘ć120‰ń“ú–{H•i‰qśŠw‰ďŠwpu‰‰‰ď, ˆ¤’m, 11ŒŽ, 2024.
26) ”öč˝, ’†o—F”ü, ’r“c–ž‰Ä—˘, ‘q‰iŒ’Žj, Š|’JGş, œAŁP‹v. ‚Š´“xŒőŠw•ŞŠ„ƒ‰ƒxƒ‹‰ťÜL-FDLDA‚đ—p‚˘‚˝”­yH•iEˆů—ż’†‚ĚDL-ƒAƒ~ƒmŽ_‚Ě’č—Ę•ŞÍ–@‚ĚŠJ”­. ‘ć120‰ń“ú–{H•i‰qśŠw‰ďŠwpu‰‰‰ď, ˆ¤’m, 11ŒŽ, 2024.
25) Kakeya, H., Pan, Y., Zhang, L., Suzuki, T., Sakai, K., Hirano, Y., Ikeda, H., Hattori, A., Dohmae, N., Nishio, K. Identification and a mode of action of bisabosqual A, a novel asparaginase synthetase (ASNS) inhibitor, towards the development of molecular-targeted anticancer drug. 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. Barcelona, Spain, Oct. 2024. (EORTC, the European Organization for Research and Treatment of Cancer; NCI, the National Cancer Institute; AACR, the American Association for Cancer Research)
24) úĺŕV˜aŠó, ‹ŕŽqŒŤ‰î, ’r“c‘ńŒd, Šâ“cƒ‰Ŕ, ‘ş’†ŒúĆ, ‰z–ěLá, ’ˇ”ö–ě‰f‰Ô, “n i, ź‘şTˆę, V—˘Ž–ç, ”ö’‡GN, Š|’JGş. •úü‹Ű‚Ě•Ą‡”|—{‚Ćƒƒ^ƒ{ƒ[ƒ€‰đÍ‚É‚ć‚éV‹KR‚Ş‚ńÜƒV[ƒY‚ĚŠJ”­Œ¤‹†. ‘ć74‰ń“ú–{–ňŠw‰ďŠÖźŽx•”‘‰ďE‘ĺ‰ď, •şŒÉ, 10ŒŽ, 2024.[—DGÜiŒű“Ş”­•\‚Ě•”j]@@
23) ’r“c‘ńŒd, ěŒŠ”ü—˘, ŽÄčŽçO, ŽO‘ş •Ň, Š|’JGş. ‚Ş‚ńО×–E‚đ•W“I‚Ć‚ˇ‚é”÷ś•¨“ńŽŸ‘ăŽÓŽY•¨‚Ě”­ŒŠ‚ƍě—p‹@˜‰đÍ. ‘ć74‰ń“ú–{–ňŠw‰ďŠÖźŽx•”‘‰ďE‘ĺ‰ď, •şŒÉ, 10ŒŽ, 2024.@
22) ŹŽR ˆ¤, ‘q‰iŒ’Žj, X–{—Á‘ž, źŒł‘ńŠC, Š|’JGş. ‚Ë‚ś‚ęŒ^ƒAƒ~ƒh‚đ‰î‚ľ‚˝ƒyƒvƒ`ƒh‡Ź–@‚ĚŠJ”­‚Ć’†•ŞŽqŠÂóƒyƒvƒ`ƒh‡Ź‚ւ̉ž—p. ‘ć74‰ń“ú–{–ňŠw‰ďŠÖźŽx•”‘‰ďE‘ĺ‰ď, •şŒÉ, 10ŒŽ, 2024. [—DGÜiŒű“Ş”­•\‚Ě•”j]@
21) Ikeda, H., Iseki, S., Kobayashi, S., Irie, K., Harada, H., Kakeya, H. Upregulation of HIF-1ƒż via the PKCƒż/mTORC signaling pathway is a potential therapeutic strategy for ishemia-related diseases. The 4th network salon, Medical Innovation Program, Kyoto University, Kyoto, Sep. 2024.
20) Furutani, Y., Tanaka, K., Nagamori, S., Kobayashi, K., Aizaki, H., Ochi, S., Kakeya, H., Matsuura, T. Development of cccDNA modulators, CDMs, that specifically activate interferon-related signals and inhibit HBV replication. 2024 International HBV Meeting: Biology of the Hepatitis B and Viruses. Chicago, IL, USA, Sep. 2024@
19) ”öč˝, ’†o—F”ü, ŠÖŒű–ƒ—I, ‰şŠÔŽuŽm, ěŁ‹M”Ž, ’Ň ˆ¤, ‘q‰iŒ’Žj, Š|’JGş, —F‰iČŽO,@œAŁP‹v. ƒ‰ƒxƒ‹‰ťÜL-FDVDA‚ĆPBrƒJƒ‰ƒ€‚đ—p‚˘‚˝“Ž•¨ŽíE‘gDE•iŽí‚ĚˆŮ‚Č‚éH“÷’†‚ĚƒCƒ~ƒ_ƒ][ƒ‹ƒWƒyƒvƒ`ƒh‚ƍ\ŹƒAƒ~ƒmŽ_Aƒ^ƒEƒŠƒ“‚ĚˆęÄ•ސÍ. “ú–{ƒAƒ~ƒmŽ_Šw‰ď‘ć18‰ńŠwp‘ĺ‰ďiJSAAS2024j, é‹Ę, 9ŒŽ, 2024.
18) “ż“c“VŹ, ’r“c‘ńŒd, ‘q‰iŒ’Žj, –ĽŽč–œ—R—˘, ŕNłŒŞ, ’JŒű“§, V—˘Ž–ç, ”ö’‡GN, Š|’JGş. V‹KƒAƒmƒCƒLƒX—U“ąÜƒAƒ‚ƒLƒZƒ^ƒ~ƒhA‚Ě’P—فE\‘˘‰đÍ‹y‚Ń‘S‡Ź. ‘ć66‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď, ‹ž“s, 9ŒŽ, 2024.
17) ‹ŕŽqŒŤ‰î, ŽOŽ}Ÿ{‰Ô, Yulu Jiang, ‚‹´L–ž, Š|’JGş. A•¨•aŠQ‚ť‚¤‚Š•aŒ´ˆö‹Ű‚đ•W“I‚Ć‚ˇ‚é”_–ňƒV[ƒYŠJ”­Œ¤‹†FƒcƒƒZƒiƒ~ƒhC‚Ě”­ŒŠ‚ƍě—p‹@˜‰đÍ. ‘ć66‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď, ‹ž“s, 9ŒŽ, 2024.
16) Kakeya, H. Natural product-inspired chemical biology: Development of highly sensitive labeling reagents for amino acids and scarce natural products. International Congress on Natural Products Research 2024 (ICNPR 2024), Krakow, Poland, Jul. 2024.@@
15) úĺŕV˜aŠó, ‹ŕŽqŒŤ‰î, ’r“c‘ńŒd, Šâ“cƒ‰Ŕ, ‘ş’†ŒúĆ, ‰z–ěLá, ’ˇ”ö–ě‰f‰Ô, “n i, ź‘şTˆę, V—˘Ž–ç, ”ö’‡GN, Š|’JGş. •úü‹Ű‚Ě•Ą‡”|—{‚É‚ć‚éV‹KR‚Ş‚ńÜƒV[ƒY‚ĚŠJ”­Œ¤‹†. ‘ć34‰ńV–ň‘nť’k˜b‰ď, “Č–Ř, 7ŒŽ, 2024. [Œ¤‹†§—ăÜ]@@@
14) ’r“c‘ńŒd, ˆä–{łĆ, Š|’JGş. ‚Ş‚ńО×–E‚đ•W“I‚Ć‚ˇ‚郌ƒmƒŒƒ}ƒCƒVƒ“‚Ě“Ż’čEě—p‹@˜. ‘ć28‰ń“ú–{‚Ş‚ń•ŞŽq•W“IŽĄ—ĂŠw‰ď, “Œ‹ž, 6ŒŽ, 2024.@@
13) Furutani, Y., Kakeya, H., Matsuura, T. Development of novel small molecules that activate innate immunity and inhibit HBV replication. The 60th Annual Meeting of the Japan Society of Hepatology, Kumamoto, Jun, 2024.
12) ‹ŕŽqŒŤ‰î, ŽOŽ}Ÿ{‰Ô, Yulu Jiang, ‚‹´L–ž, Š|’JGş. •úü‹Ű‘ăŽÓŽY•¨ƒcƒƒZƒiƒ~ƒhC‚̍R‚ť‚¤‚Š•aŒ´ˆö‹ŰŠˆŤ‚Ć‚ť‚̑ϐŤ‰ť‚Ş‚ŕ‚˝‚炡ƒ†ƒj[ƒN‚Č•\ŒťŒ^‚ɂ‚˘‚Ä. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ď@‘ć18‰ń”N‰ď, “Œ‹ž, 5ŒŽ, 2024.
11) Kakeya, H. Separation and identification of the D/L-forms of amino acids and short-chain peptides using highly sensitive labeling reagents for research of cardiovascular disease. The 9th Annual Scientific Meeting of JCVA (Japan Cardiovascular Association), Shizuoka, May 2024.
10) ”öč ˝, ’†o—F”ü, ‰şŠÔŽuŽm, ěŁ‹M”Ž, ’ҁ@ˆ¤, ‘q‰iŒ’Žj, Š|’JGş, —F‰iČŽO, œAŁP‹v. ‚Š´“xƒ‰ƒxƒ‹‰ťÜL-FDVDA‚ĆPBrƒJƒ‰ƒ€‚đ—p‚˘‚˝H•i’†‚ĚƒCƒ~ƒ_ƒ][ƒ‹ƒWƒyƒvƒ`ƒh‚ƍ\ŹƒAƒ~ƒmŽ_Aƒ^ƒEƒŠƒ“‚ĚˆęÄ•ސÍ. ‘ć78‰ń“ú–{‰h—{EH—ĆŠw‰ď‘ĺ‰ď, •Ÿ‰Ş, 5ŒŽ, 2024.
9) ŠÝ–{[O, ŹŒŠŽR–ƒ‹I, ˜a“cŒ[“š, óŒ´“NŽq, ŽR‰Aˆę, ”öč—T, ÂŽRLŽ÷, Ÿ‰Y•ۍG, ĄňŒú, ‹´–{ł, ťě—zˆę, X–{’B–ç, ‹ŕˆä‰ëŽj, Š|’JGş, ’ˇ’Jě_“ń. –łÇóEŒyÇ‚̐VŒ^ƒRƒƒiƒEƒCƒ‹ƒXŠ´őÇŠłŽŇ‚É‚¨‚Ż‚éŒoŒű‚‹zŽűƒNƒ‹ƒNƒ~ƒ“iƒNƒ‹ƒNƒ‹[ƒWƒ…j‚Ě’†“™Ç‚ւ̐i“W—}§Œř‰Ę‚đŒŸŘ‚ˇ‚éƒvƒ‰ƒZƒ{‘ÎĆ“ńd–ÓŒŸ–łěˆ×‰ť”äŠrŽŽŒą. “ú–{–ňŠw‰ď‘ć144”N‰ďi‰Ą•lj, ‰Ą•l, 3ŒŽ, 2024.@@
8) Žü–h‘ĺŽ÷, ‘q‰iŒ’Žj, ‹g“cšˆť, ’r“c‘ńŒd, ŽÄčŽçO, Š|’JGş. V‹K‚Ş‚ńО×–EƒXƒtƒFƒAŒ`Ź‘jŠQÜƒXƒgƒŒƒvƒgƒXƒtƒFƒŠƒ“A‚Ě‘S‡ŹŒ¤‹†. “ú–{–ňŠw‰ď‘ć144”N‰ďi‰Ą•lj, ‰Ą•l, 3ŒŽ, 2024.
7) “ż“c“VŹ, ‘q‰iŒ’Žj, –ĽŽč–œ—R—˘, ’r“c‘ńŒd, ŕNłŒŞ, Š|’JGş. V‹KƒAƒmƒCƒLƒX—U“ąÜƒAƒ‚ƒLƒZƒ^ƒ~ƒhA‚ĚŠŽ‘S\‘˘Œˆ’č‹y‚Ń‘S‡ŹŒ¤‹†. “ú–{–ňŠw‰ď‘ć144”N‰ďi‰Ą•lj, ‰Ą•l, 3ŒŽ, 2024.
6) ŕ“c•Ž, ‘q‰iŒ’Žj, ’ç—˝‘ž˜Y, Š|’JGş. V‹KR^‹ŰÜƒAƒ€ƒtƒBƒI[ƒ‹‚Ě‘S‡ŹŒ¤‹†. “ú–{–ňŠw‰ď‘ć144”N‰ďi‰Ą•lj, ‰Ą•l, 3ŒŽ, 2024.
5) ’r“c‘ńŒd, ŽÄčŽçO, ŠŞ“cĘ‹G, ‘DŽR‰Ŕ‘ă, Žü–h‘ĺŽ÷, ‹g“cšˆť, ‘q‰iŒ’Žj, V“Ąˆę•q, ~Šřˆę•v, ˆä–{łĆ, Š|’JGş. V‹K‚Ş‚ńО×–EƒXƒtƒFƒAŒ`Ź‘jŠQÜƒXƒgƒŒƒvƒgƒXƒtƒFƒŠƒ“A‚Ě’P—فE\‘˘‰đÍ. “ú–{–ňŠw‰ď‘ć144”N‰ďi‰Ą•lj, ‰Ą•l, 3ŒŽ, 2024.
4) Š|’JGş. “V‘R•¨‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚đŠî”Ő‚Ć‚ľ‚˝•ŞŽq•W“IR‚Ş‚ńÜŠJ”­Œ¤‹†. ‚Ş‚ńŽĄ—ĂƒCƒmƒx[ƒVƒ‡ƒ“‚ÉŒü‚Ż‚Ä. ‹ž“s‘ĺŠw‚“™Œ¤‹†‰@E•¨ŽżE×–E“‡‹’“_@—ĘŽqƒiƒmˆă—ĂŒ¤‹†ƒZƒ“ƒ^[, ‹ž“s, 3ŒŽ, 2024.iľ‘ҍu‰‰j
3) Kakeya, H. Natural products-inspired chemical biology-Development of a novel asparagine synthetase inhibitor for cancer chemotherapy-, Asian Chemical Biology Initiative (ACBI) 2024 Istanbul Meeting, Istanbul, Turkey, Mar. 2024. iinvitedj@@
2) Matsuoka, T., Hattori, A., Oishi, S., Araki, M., Ma, B., Fujii, T., Arichi, N., Okuno, Y., Kakeya, H., Yamasaki, S., Ohno, H., Inuki, S. Establishment of an MR1-presentation reporter screening system to identify MAIT cell modulation. CD1-MR1 2024, Tasmania, Australia, Feb., 2024.
1) ”öč ˝, ‰şŠÔŽuŽm, ‘q‰iŒ’Žj, Š|’JGş, œAŁP‹v, . ‚Š´“xŒőŠw•ŞŠ„ƒ‰ƒxƒ‹‰ťÜL-FDVDA‚đ—p‚˘‚˝ś‘ĚŽŽ—żEH•i‚Š‚ç‚ĚƒAƒ~ƒm—Ž_‚̍‚Š´“x•ސ͖@‚ĚŠm—§. ‘ć15‰ńJapan@Bioanalysis Forum (JBF) ƒVƒ“ƒ|ƒWƒEƒ€, ‹ž“s, 3ŒŽ, 2024.

2023

37) Kakeya, H. Natural products-inspired chemical biology-Development of highly sensitive labeling reagents-, Asian Chemical Biology Initiative (ACBI) 2023 Kuala Lumpur Meeting, Kuala Lumpur, Malaysia, Dec. 2023. iinvitedj
36) Š|’JGş, “V‘R•¨‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[FV‹KƒAƒ~ƒmŽ_Eƒyƒvƒ`ƒh•ސ͖@‚ĚŠJ”­‚Ɖž—p. ‘ć13‰ńVƒAƒ~ƒmŽ_•ސ͌¤‹†‰ď, “Œ‹ž, 12ŒŽ, 2023. iľ‘ҍu‰‰j@@
35) œAŁP‹v, ”öč ˝, ’†o—F”ü, ‰şŠÔŽuŽm, ’r“c–ž‰Ä—˘, ‘q‰iŒ’Žj, Š|’JGş. ‚Š´“xŒőŠw•ŞŠ„ƒ‰ƒxƒ‹‰ťÜD-FDLDA‚đ—p‚˘‚˝”­yH•i’†‚ĚDL-ƒAƒ~ƒmŽ_•ސÍ. ‘ć13‰ńVƒAƒ~ƒmŽ_•ސ͌¤‹†‰ď, “Œ‹ž, 12ŒŽ, 2023.
34) ”öč ˝, ‰şŠÔŽuŽm, ‘q‰iŒ’Žj, Š|’JGş, œAŁP‹v. ‚Š´“xŒőŠw•ŞŠ„ƒ‰ƒxƒ‹‰ťÜL-FDVDA‚đ—p‚˘‚˝ƒAƒ~ƒm—Ž_‚̍\‘˘ˆŮŤ‘Ě‚ĆŒőŠwˆŮŤ‘Ě‚ĚˆęÄ•ސÍ. ˆęÄ•ސ͖@‚ĚŠm—§. ‘ć13‰ńVƒAƒ~ƒmŽ_•ސ͌¤‹†‰ď, “Œ‹ž, 12ŒŽ, 2023.
33) Sun, Y., Hashizume, D., Kakeya, H. Synthetic study of 2-(1H-imidazole-4-yl)-1,3,4-oxadiazole scaffolds for pharmaceuticals. The 40th Medicinal Chemistry Symposium. Nagoya, Nov., 2023.
32) Koyama, A., Kuranaga, T., Morimoto, R., Matsumoto, T., Kakeya, H. Acyl sulfonamide-mediated amidation and its application to the synthesis of middle molecular natural peptidic molecules. The 60th Japanese Peptide Symposium, Shiga, Nov. 2023.
31) Kuranaga, T., Morimoto, R., Pan, C., Ogawa, H., Kakeya, H. Design, synthesis, and application of highly sensitive labeling reagent for amino acids. The 60th Japanese Peptide Symposium, Shiga, Nov. 2023.
30) Ozaki, M., Shimotsuma, M., Kuranaga, T., Kakeya, H., Hirose, T. Identification of DL-amino acids containing threonine and isoleucine stereoisomers in peptides using an original chiral resolution labeling reagent. The 60th Japanese Peptide Symposium, Shiga, Nov. 2023.
29) Š|’JGş. “V‘R•¨ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚đŠî”Ő‚Ć‚ľ‚˝‘n”­ˆă–ň‰ČŠwŒ¤‹†. ‘ć9‰ń–ňŠw‚Ě–˘—ˆ‚đl‚Ś‚é‹ž“sƒVƒ“ƒ|ƒWƒEƒ€F‘n”­ˆă–ň‰ČŠwęUŠJŠw‹L”OƒVƒ“ƒ|ƒWƒEƒ€, ‹ž“s, 11ŒŽ, 2023. iľ‘ҍu‰‰j
28) Pan, Y., Suzuki, T., Sakai, K., Hirano, Y., Ikeda, H., Hattori, A., Dohmae, N., Nishio, K., Kakeya, H. Identification of an asparagine synthetase inhibitor bisabosqual A as an anticancer seed. The 3rd network salon, Medical Innovation Program, Kyoto University, Kyoto, Sep. 2023.
27) Kodama, K., Ikeda, H., Shibasaki, M., Kawami, M., Imoto, M., Kakeya, H. Screening and identification of anticancer lead compounds through a novel strategy targeting cancer stem cells. The 3rd network salon, Medical Innovation Program, Kyoto University, Kyoto, Sep. 2023.
26) Kakeya, H., Ozaki, M., Shimotsuma, M., Kuranaga, T., Hirose, T. Development of a new chiral resolution labeling reagent and aplication to separation of amyloid b fragment peptides with racemized and isomerized aspartic acid residues. The 3rd network salon, Medical Innovation Program, Kyoto University, Kyoto, Sep. 2023.
25) Koyama A., Kuranaga, T., Morimoto, R., Matsumoto, T., Kakeya, H. A novel peptide C-terminal modification and its application to the synthesis of middle molecular cyclic peptides. The 3rd network salon, Medical Innovation Program, Kyoto University, Kyoto, Sep. 2023.
24) Sun, Y., Hashizume, D., Kakeya, H. Studies on 2-(1H-imidazol-4-yl)-1,3,4-oxadiazole scaffolds for pharmacological molecules. The 3rd network salon, Medical Innovation Program, Kyoto University, Kyoto, Sep. 2023.
23) œAŁP‹v, ”öč ˝, ’†o—F”ü, ‰şŠÔŽuŽm, ‘q‰iŒ’Žj, Š|’JGş. ‚Š´“xŒőŠw•ŞŠ„ƒ‰ƒxƒ‹‰ťÜD-FDLDA‚đ—p‚˘‚˝H•i’†‚ĚDL-ƒAƒ~ƒmŽ_•ސÍ. “ú–{ƒAƒ~ƒmŽ_Šw‰ď‘ć17‰ńŠwp‘ĺ‰ď (JSAA2023), •Ÿ‰Ş, 9ŒŽ, 2023.
22) ”öč ˝, ‰şŠÔŽuŽm, ‘q‰iŒ’Žj, Š|’JGş, œAŁP‹v, . ‚Š´“xŒőŠw•ŞŠ„ƒ‰ƒxƒ‹‰ťÜL-FDVDA‚đ—p‚˘‚˝‘SƒAƒ~ƒm—Ž_ˆęÄ•ސ͖@‚ĚŠm—§. “ú–{ƒAƒ~ƒmŽ_Šw‰ď‘ć17‰ńŠwp‘ĺ‰ď (JSAA2023), •Ÿ‰Ş, 9ŒŽ, 2023.
21) ’†o—F”ü, ”öč ˝, ‰şŠÔŽuŽm, ‘q‰iŒ’Žj, Š|’JGş, œAŁP‹v. ŒőŠw•ŞŠ„ƒ‰ƒxƒ‹‰ťÜL-FDVDA‚đ—p‚˘‚˝ƒyƒvƒ`ƒh’†‚ĚThr‚ĆIle‚Ě—§‘ĚˆŮŤ‘Ě‚Ě“Ż’č. “ú–{ƒAƒ~ƒmŽ_Šw‰ď‘ć17‰ńŠwp‘ĺ‰ď (JSAA2023), •Ÿ‰Ş, 9ŒŽ, 2023.
20) ŹŽR ˆ¤, ‘q‰iŒ’Žj, X–{—Á‘ž, źŒł‘ńŠC, Š|’JGş. ƒGƒsƒƒŠ‰ť‚đ—}§‚ˇ‚éƒyƒvƒ`ƒhC––’[Cü–@‚Ć’†•ŞŽqŠÂóƒyƒvƒ`ƒh‡Ź‚ւ̉ž—p. ‘ć65‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď, “Œ‹ž, 9ŒŽ, 2023.@@@@@.@@
19) Ž™‹Ę ŠJ, ’r“c‘ńŒd, ŽÄčŽçO, ěŒŠ”ü—˘, ˆä–{łĆ, Š|’JGş. ‚Ş‚ńО×–E‚đ•W“I‚Ć‚ľ‚˝R‚Ş‚ńÜƒV[ƒY‚ĚŠJ”­Œ¤‹†. ‘ć33‰ńV–ň‘nť’k˜b‰ď. ‹ž“s, 9ŒŽ, 2023. [Œ¤‹†§—ăÜ]@@
18) ŹŽR ˆ¤, ‘q‰iŒ’Žj, X–{—Á‘ž, źŒł‘ńŠC, Š|’JGş. ’†•ŞŽqƒyƒvƒ`ƒh‘n–ň‚đŽuŒü‚ľ‚˝V‹Kƒyƒvƒ`ƒh‡Ź–@‚ĚŠJ”­. ‘ć33‰ńV–ň‘nť’k˜b‰ď, ‹ž“s, 9ŒŽ, 2023.@@@@@.@@
17) ź‰Ş‘ń˜N, •ž•” –ž, ‘ĺÎ^–ç, r–Ř–]Žk, —L’n–@l, Š|’JGş, ŽRč ť, ‘ĺ–ě_Í, ˆäŠŃW•ă. ×–E•\–Ę‚ĚMR1‘śÝ—ʂɊî‚Ă‚­ƒŠƒKƒ“ƒhƒXƒNƒŠ[ƒjƒ“ƒO–@‚ĚŠJ”­‚ĆMAIT×–E§Œä•ŞŽq‚Ě“Ż’č. ‘ć65‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď, “Œ‹ž, 9ŒŽ, 2023.@@@@@.@@
16) Yanaka, K., Hirano, Y., Qiun, X.Y., Suzuki, H., Kakeya, H., Matsuura, T., Furutani, Y. A small chemical compound iCDM-34 identified by an in silico screening suppresses HBV DNA through activation of aryl hydrocarbon receptor, 2023 Interbational HBV Meeting, Kobe, Sep. 2023.@@@.@@
15) Š|’JGş. ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚đ‹@ޞ‚Ć‚ľ‚˝•ŞŽqƒvƒƒtƒ@ƒCƒŠƒ“ƒO, 2023”N“xŽáŽčŽx‰‡‹ZpuK‰ď, •ś•”‰ČŠwČŠwp•ĎŠvŒ¤‹† ŠwpŒ¤‹†Žx‰‡Šî”ŐŒ`Ź ć’[ƒ‚ƒfƒ‹“Ž•¨Žx‰‡ƒvƒ‰ƒbƒgƒtƒH[ƒ€iADAMsj, –źŒĂ‰Ž, 9ŒŽ, 2023. iľ‘ҍu‰‰j
14) Š|’JGş. “V‘R•¨‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚ĚĹ‘OüFŽYŠw˜AŒg‚É‚ć‚éˆă–ň•i‚ĚŽŔ—p‰ť‚ÉŒü‚Ż‚Ä, Œ’“sƒCƒmƒx[ƒVƒ‡ƒ“ƒp[ƒNŒđ—ŹƒZƒ~ƒi[iŽĺĂF‡Š‹ž“sƒŠƒT[ƒ`ƒp[ƒNj, ‘ĺă, 7ŒŽ, 2023. iľ‘ҍu‰‰j
13) Š|’JGş. ƒVƒ“ƒ|ƒWƒEƒ€1Eu•W“I‚đŽË”˛‚݁Ii’ᕪŽqE’†•ŞŽqER‘́jv\“V‘R•¨‘n–ňFƒAƒXƒpƒ‰ƒMƒ“‡Źy‘f‚đŽË”˛‚­. ‘ć27‰ń“ú–{‚Ş‚ń•ŞŽq•W“IŽĄ—ĂŠw‰ďŠwpW‰ď, ˛‰ę, 6ŒŽ, 2023. iľ‘ҍu‰‰j
12) Pan, Y., Suzuki, T., Sakai, K., Hirano, Y., Ikeda, H., Hattori, A., Dohmae, N., Nishio, K., Kakeya, H. Identification of bisabosqual A as an asparagine synthetase (ASNS) inhibitor towards the development of molecular-targeted anticancer drug. The 17th Annual Meeting of Japanese Society for Chemical Biology, Osaka, May, 2023.
11) Kakeya, H. Development of an innovative anticancer drug TBP1901, an injectable prodrug of curcumin. 2023 NSFC*1-JSPS-CAS*2 Forum: Translational Medicine and Innovative Drug Research. Tianjin, China, Jun. 2023. (*1 Natural Science Foundation of China, *2 Chinese Academy of Science) [keynote lecture]
10) ź‰Ş‘ń˜N, •ž•” –ž, ‘ĺÎ^–ç, —L’n–@l, Š|’JGş, ŽRč ť, ‘ĺ–ě_Í, ˆäŠŃW•ă. MR1‚Ě×–E•\–Ę—Ę‚đŽw•W‚Ć‚ˇ‚郊ƒKƒ“ƒhƒXƒNƒŠ[ƒjƒ“ƒO–@‚ĚŠJ”­‚ĆMAIT×–Eƒ‚ƒWƒ…ƒŒ[ƒ^[‚Ě“Ż’č. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ď@‘ć17‰ń”N‰ď, ‘ĺă, 5ŒŽ, 2023.@@
9) Pan, Y., Suzuki, T., Sakai, K., Hirano, Y., Ikeda, H., Hattori, A., Dohmae, N., Nishio, K., Kakeya, H. Screening and identification of an asparagine synthetase (ASNS) inhibitor as a molecular-targeted anticancer drug. The 143rd Annual Meeting of Pharmaceutical Society of Japan. Hokkaido, Mar. 2023.@@@@@
8) ”öč ˝, ‰şŠÔŽuŽm, ‘q‰iŒ’Žj, Š|’JGş, œAŁP‹v. DL-ƒAƒ~ƒmŽ_ƒ‰ƒxƒ‹‰ťƒLƒbƒg‚đ—p‚˘‚˝ƒAƒ~ƒƒCƒhƒŔ’†‚ĚAspŽcŠî‚Ěƒ‰ƒZƒ~‰ťEˆŮŤ‰ť‚ĚŒŸo–@‚ĚŠJ”­\ŽžŠł‚ÉŠÖ—^‚ˇ‚é‹ĂWƒ^ƒ“ƒpƒNŽżEƒyƒvƒ`ƒh‚Ě‘Šúf’fEŽžŠłƒƒJƒjƒYƒ€‚Ě‰đ–ž‚ÉŒü‚݂ā\. ‘ć14‰ńJapan@Bioanalysis Forum (JBF) ƒVƒ“ƒ|ƒWƒEƒ€, “Œ‹ž, 3ŒŽ, 2023.
7) Ikeda, H., Shibasaki, M., Kodama, K., Kawami, M., Imoto, M., Kakeya, H. Screening for anticancer lead compounds through a new strategy for targeting cancer stem cells. Future Drug Discovery Empowered by Chemical Biology, Nara, Feb. 2023.
6) Sun, Y., Hashizume, D., Kakeya, H. Synthetic study on 2-(1H-imidazol-4-yl)-1,3,4-oxadiazole scaffolds for drug discovery. Future Drug Discovery Empowered by Chemical Biology, Nara, Feb. 2023.
5) Kuranaga, T., Tamura, M., Ikeda, H., Terada, S., Nakagawa, Y., Kakeya, H. Reactivity-guided identification and total synthesis of an unstable anticancer macrolide presaccharothriolide Z. Future Drug Discovery Empowered by Chemical Biology, Nara, Feb. 2023.
4) Kakeya, H., Abe, T., Horisawam Y., Kikuchi, O., Ozawa-Umeta, H., Kishimoto, A., Imaizumi, A., Hashimoto, T., Shirakawa, K., Takaori-Kondo, A., Yusa, K., Asakura, T., Kanai, M. Pharmacologic characterization of TBP1901, an innovative prodrug form of curcumin, and CRISPR-Cas9 screen for therapeutic targets of curcumin. Future Drug Discovery Empowered by Chemical Biology, Nara, Feb. 2023.
3) Koyama, A., Kuranaga, T., Morimoto, R., Kakeya, H. Acyl sulfamide-mediated amidation for biomimetic peptide synthesis. Future Drug Discovery Empowered by Chemical Biology, Nara, Feb. 2023.
2) Pan, Y., Suzuki, T., Sakai, K., Hirano, Y., Ikeda, H., Hattori, A., Dohmae, N., Nishio, K., Kakeya, H. Chemical biology research on an asparagine synthetase (ASNS) inhibitor as a molecular-targeted anticancer drug. Future Drug Discovery Empowered by Chemical Biology, Nara, Feb. 2023.
1) ˆŔ“c ő, ’|ŕVł–ž, ‘q‰iŒ’Žj, Š|’JGş. V‹K—U“ą‘̉ťŽŽ–ň‚đ—p‚˘‚˝D,L-ƒAƒ~ƒmŽ_‚̍‚Š´“x•ސ͖@ŠJ”­. ‘ć28‰ńLC&MSƒeƒNƒmƒvƒ‰ƒU, ƒIƒ“ƒ‰ƒCƒ“ŠJĂ, 1ŒŽ, 2023. [ƒxƒXƒgƒvƒŒƒ[ƒ“ƒe[ƒVƒ‡ƒ“ÜiƒxƒXƒgƒe[ƒ}Üj]

2022

15) ”öč ˝, ‰şŠÔŽuŽm, ‘q‰iŒ’Žj, Š|’JGş, œAŁP‹v. ŒőŠw•ŞŠ„ƒ‰ƒxƒ‹‰ťÜD-FDLDA‚đ—p‚˘‚˝ƒAƒ~ƒƒCƒhƒŔ’†‚ĚƒAƒXƒpƒ‰ƒMƒ“Ž_ŽcŠî‚Ěƒ‰ƒZƒ~‰ťEˆŮŤ‰ť‚Ě“Ż’č. VƒAƒ~ƒmŽ_•ސ͌¤‹†‰ď‘ć12‰ńŠwpu‰‰‰ď, “Œ‹ž, 12ŒŽ, 2022. [—DG”­•\Ü]
14) ˆŔ“c ő, ’|ŕVł–ž, ‘q‰iŒ’Žj, Š|’JGş. V‹K—U“ą‘̉ťŽŽ–ň‚đ—p‚˘‚˝ś‘ĚŽŽ—ż’†‹y‚Ń×–E”|—{ă´’†D,L-ƒAƒ~ƒmŽ_‚̍‚Š´“x•ސÍ. VƒAƒ~ƒmŽ_•ސ͌¤‹†‰ď‘ć12‰ńŠwpu‰‰‰ď, “Œ‹ž, 12ŒŽ, 2022.
13) Yasuda, Y., Takezawa, M., Kuranaga, T., Kakeya, H. Highly sensitiveanalysis of D-and L-amino acids in biological samples using new derivatization reagents. The 37th Annual Meeting of the Japanese Society for the study of Xenobiotics, Kanagawa, Nov. 2022.@
12) ź‰Ş‘ń˜N, •ž•” –ž, ‘ĺÎ^–ç, —L’n–@l, Š|’JGş, ŽRč ť, ‘ĺ–ě_Í, ˆäŠŃW•ă. ƒXƒvƒŠƒbƒgƒ‹ƒVƒtƒFƒ‰[ƒ[‚đ—˜—p‚ľ‚˝ƒXƒNƒŠ[ƒjƒ“ƒO–@‚É‚ć‚éV‹KMR1ƒŠƒKƒ“ƒh‚Ě“Ż’č‚Ć‚ť‚̍\‘˘ŠˆŤ‘ŠŠÖŒ¤‹†. ‘ć39‰ńƒƒfƒBƒVƒiƒ‹ƒPƒ~ƒXƒgƒŠ[ƒVƒ“ƒ|ƒWƒEƒ€, 11ŒŽ, 2022, ƒIƒ“ƒ‰ƒCƒ“ŠJĂ.@@@@@
11) Ozaki, M., Shimotsuma, M., Kuranaga, T., Kakeya, H., Hirose, T. Identification of DL-and DL-iso-form of aspartic acid residues in amyloid b peptide using a chiral resolution labeling reagent. The 59th Japanese Peptide Symposium, Miyagi, Oct. 2022.
10) Ikeda, H., Imoto, M., Kakeya, H. Identification of the polyether ionophore lenoremycin through a new screening strategy targeting cancer stem cells. The 81st Annual Meeting of the Japanese Cancer Association. Kanagawa, Sep. 2022. [selected as a late-breaking poster]@@@@@
9) Kura, Y., Develasco, M.A., Sakai, K., Fujita K., Bannno, E., Fujita, Y., Hashimoto, M., Nishimoto, M., Nozawa, M., Yoshimura, K., Kakeya, H., Umemura, H., Nishio, K. Chemopreventive potential of curcumin monoglucuronide in mouse Pten-null prostate cancer. The 81st Annual Meeting of the Japanese Cancer Association. Yokohama, Sep. 2022.@@@@@
8) ‘q‰iŒ’Žj, “c‘ş”ü”ż, ’r“c‘ńŒd, Ž›“c‰ ”V, ’†ě—Y‰î, Š|’JGş. ‰ťŠw‡Ź‚đ‹ěŽg‚ľ‚˝Šó­R‚Ş‚ńŠˆŤ“V‘R•¨ƒvƒŒƒTƒbƒJƒƒXƒŠƒIƒŠƒhZ‚Ě“Ż’č. ‘ć64‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď, Ă‰Ş, 9ŒŽ, 2022.@@@@@
7) Š|’JGş, ‘q‰iŒ’Žj, ’r“c‘ńŒd, •ž•” –ž, ź‘şTˆę, ˆä–{łĆ. ”÷ś•¨ŠÔ‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ě—‰đ‚Ć—L—pś•¨ŠˆŤƒŠƒKƒ“ƒh‚ĚŠJ”­. VŠwp—ĚˆćŒ¤‹†u‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ěƒtƒƒ“ƒeƒBƒAvŽć‚č‚Ü‚Ć‚ßƒVƒ“ƒ|ƒWƒEƒ€, ‹ž“s, 7ŒŽ, 2022.
6) Š|’JGş. “V‘R•¨‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚ĚĹ‘Oü. –k—˘‘ĺŠw‘ć100‰ńKMCFƒZƒ~ƒi[iKitasato Microbial Chemistry Frontierj, “Œ‹ž, 6ŒŽ, 2022. iľ‘ҍu‰‰j
5) Îě•ś—m, “ŕ“cç°, ‘吟—˜“Ţ, Ą–ěăÄ, —é–ŘŒ’—T, ‚“‡Ž‹P, “°‘O’ź, Š|’JGş, “c糌łŽO. ×–E“ŕ‚ł̔ńƒŠƒ{ƒ\[ƒ€ƒyƒvƒ`ƒh‡Źy‘f‚Ě‘I‘đ“Iƒ‰ƒxƒ‹‰ť‚¨‚ć‚Ń•Ş‰đ‹@\‚Ě”­ŒŠ. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ď@‘ć16‰ń”N‰ď, •xŽR, 5ŒŽ, 2022.@@
4) ˛X–Ř•‘á, ź‘şTˆę, źŽRW‹v, ”Ş‘ă“c—zŽq, Š|’JGş, ‹g“c–Ť. FKBP12‚É‚ć‚éƒZƒŠƒ“EƒXƒŒƒIƒjƒ“‘ăŽÓ§Œä‚̉ťŠwˆâ“`Šw“I‰đÍ. “ú–{”_Œ|‰ťŠw‰ď2022”N“x‘ĺ‰ď, ‹ž“siƒIƒ“ƒ‰ƒCƒ“j, 3ŒŽ, 2022.
3) Îě•ś—m, Ą–ěăÄ, “ŕ“cç°, —é–ŘŒ’—T, ‚“‡Ž‹P, “°‘O’ź, Š|’JGş, “c糌łŽO. ×–E“ŕ‚ł̔ńƒŠƒ{ƒ\[ƒ€ƒyƒvƒ`ƒh‡Źy‘f‚Ě‘I‘đ“IƒPƒ~ƒJƒ‹ƒ‰ƒxƒŠƒ“ƒO‚¨‚ć‚Ń•Ş‰đ‰ß’ö‚Ě”­ŒŠ. “ú–{–ňŠw‰ď‘ć142”N‰ď. –źŒĂ‰ŽiƒIƒ“ƒ‰ƒCƒ“j, 3ŒŽ, 2022.@@
2) Watari, S., Kaneko, K., Iwata, S., Nagao, N., Onaka, H., Shinzato, N., Kakeya, H. Syetematic screening of new microbial metabolites by combined-culture of actinomycetes. Japan-the Netherlands Microbiology Symposium 2022, Mar. 2022 (Kochi/on-line).@@@@@
1) Kakeya, H. Chemical communication research on microbes toward the development of novel antibiotics. Japan-the Netherlands Microbiology Symposium 2022, Mar. 2022 (Kochi/on-line). (Invited lecture)@@@@@

2021

18) Kakeya, H. Chemical communication research toward the development of novel antibiotics. (#182 Antibiotics Discovery), PACIFICHEM2021, Hawaii, USA, Dec. 2021. (Invited lecture)@@@@
17) Kakeya, H. Chemical communication research toward the development of new anticancer drugs. (#79 Chemical Communications through Natural and Synthetic Bioactive Compounds), PACIFICHEM2021, Hawaii, USA, Dec. 2021.@@
16) Omura, S., Khadka, S., Sato, F., Nakamura, Y., Nishio, K., Kakeya, H., Tsunoda, I. Curcumin mooglucuronide (CMG) treatment alters the gut microbiota, regulating an autoimmune model for multiple sclerosis. (#79 Chemical Communications through Natural and Synthetic Bioactive Compounds), PACIFICHEM2021, Hawaii, USA, Dec. 2021.@@
15) Ikeda, H., Muroi, M., Kondoh, Y., Ishikawa, S., Kakeya, H., Osada, H., Imoto, M. Miclxin, a novel MIC60 inhibitor, induces apoptosis via mitochondrial stress in beta-catenin mutant tumor cells. (#79 Chemical Communications through Natural and Synthetic Bioactive Compounds), PACIFICHEM2021, Hawaii, USA, Dec. 2021.@@
14) Matsumoto, T., Jiang, Y., Kuranaga, T., Lu, S., Wang, W., Onaka, H. Kakeya, H. Discovery of longicatenamides A-D produced by combined-culture of Streptomyces sp. KUSC_F05 and Tsukamurella pulmonis TP-B0596. (#79 Chemical Communications through Natural and Synthetic Bioactive Compounds), PACIFICHEM2021, Hawaii, USA, Dec. 2021.@@
13) Kuranaga, T., Minote, M., Morimoto, R., Pan, C., Ogawa, H., Kakeya, H. Highly sensitive amino acid labeling reagents inspired by a scarce natural product yaku'amide B. (#79 Chemical Communications through Natural and Synthetic Bioactive Compounds), PACIFICHEM2021, Hawaii, USA, Dec. 2021.@@
12) Minote, M., Kuranaga, T., Morimoto, R., Pan, C., Ogawa, H., Kakeya, H. Design, synthesis , and application of highly sensitive labeling reagents inspired by a scarce natural product. (#79 Chemical Communications through Natural and Synthetic Bioactive Compounds), PACIFICHEM2021, Hawaii, USA, Dec. 2021.@@
11) źŒł‘ńŠC, Yulu Jiang, ‘q‰iŒ’Žj Shun Lu, Weicheng Wang, ”ö’‡GN, Š|’JGş. •úü‹Ű—R—ˆƒƒ“ƒMƒJƒeƒiƒ~ƒhA-D‚ÉŠÖ‚ˇ‚錤‹†FˆŮ‘Ž”÷ś•¨‚Ě•Ą‡”|—{‚É‚ć‚鐜ŽYA\‘˘Œˆ’čAś•¨ŠˆŤA‹y‚Ń‘S‡Ź. ‘ć63‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď, ‘ĺăiƒnƒCƒuƒŠƒbƒhj, 9ŒŽ, 2021.@@@@@
10) Kura, Y., Velasco, M.D., Sakai, K., Fujita, Y., Hashimoto, M., Kakeya, H., Uemura, H., Nishio, K. Curcumin monoglucuronide modulates the tumor microenvironment of Pten-null prostate tumors and exhits antitumor activity The 80th Annunal Meeting of the Japan Cancer Asscociation. Sep. Yokohama, 2021.
9) Îě•ś—m, Ą–ě@ăÄ, “ŕ“cç°, —é–ŘŒ’—T, “°‘O@’ź, Š|’JGş, “c糌łŽO. ×–E“ŕ‚ł̔ńƒŠƒ{ƒ\[ƒ€ƒyƒvƒ`ƒh‡Źy‘f‚Ě‘I‘đ“IƒPƒ~ƒJƒ‹ƒ‰ƒxƒŠƒ“ƒO. ‘ć15‰ńƒoƒCƒIŠÖ˜A‰ťŠwƒVƒ“ƒ|ƒWƒEƒ€, 9ŒŽ, 2021.@@
8) ˛X–Ř•‘á, ź‘şTˆę, źŽRW‹v, ”Ş‘ă“c—zŽq, Š|’JGş, ‹g“c@–Ť. •Ş—ôy•ę‚É‚¨‚Ż‚éƒZƒŠƒ“‘ăŽÓ§Œä‹@\‚̉ťŠwˆâ“`Šw“I‰đÍ. y•ęˆâ“`ŠwƒtƒH[ƒ‰ƒ€‘ć54‰ńŒ¤‹†•ń‰ď, –źŒĂ‰Ž, 9ŒŽ, 2021.@
7) Š|’JGş, ‘q‰iŒ’Žj, ’r“c‘ńŒd, ź‘şTˆę, ˆä–{łĆ. ”÷ś•¨ŠÔ‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ě—‰đE§Œä‚Ć—L—pś•¨ŠˆŤƒŠƒKƒ“ƒh‚ĚŠJ”­. VŠwp—ĚˆćŒ¤‹†u‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ěƒtƒƒ“ƒeƒBƒAvE‘ć8‰ńŒöŠJƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“siƒIƒ“ƒ‰ƒCƒ“j 7ŒŽ, 2021.
6) ź‰Ş‘ń˜N, –{‰€çq, •ž•”@–ž, Š|’JGş, ŽRč@ť, ‘ĺÎ^–ç, ‘ĺ–ě_Í, ˆäŠŃW•ă. MAIT×–E‚ĚŠˆŤ‰ť‚đ’S‚¤MR1ƒŠƒKƒ“ƒh‚Ě’TőŒ¤‹†. VŠwp—ĚˆćŒ¤‹†u‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ěƒtƒƒ“ƒeƒBƒAvE‘ć8‰ńŒöŠJƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“siƒIƒ“ƒ‰ƒCƒ“j ,7ŒŽ, 2021.@@
5) ’r“c‘ńŒd, ěŒŠ”ü—˘, ˆä–{łĆ, Š|’JGş. ‚Ş‚ńО×–E‚đ•W“I‚Ć‚ľ‚˝R‚Ş‚ńÜƒV[ƒY‚Ě’TőŒ¤‹†. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ď@‘ć15‰ń”N‰ď. •Ÿ‰ŞiƒIƒ“ƒ‰ƒCƒ“j, 6ŒŽ, 2021.@@
4) X–{—Á‘ž, źŒł‘ńŠC, –ĽŽč–œ—R—˘, –ö‘ňŤs, ŽR“c—ł‘ž˜Y, ‘q‰iŒ’Žj, Š|’JGş. LC-MS‚đ—p‚˘‚˝’†ŤđŒ‰ş‚̍DŠ´“xƒAƒ~ƒmŽ_•ސÍ. ‘n–ň§˜b‰ď 2020 in ‹ž“s. ‹ž“siƒIƒ“ƒ‰ƒCƒ“j, 6ŒŽ, 2021.
3) ź‰Ş‘ń˜N, –{‰€çq, •ž•”@–ž, Š|’JGş, ŽRč@ť, ‘ĺÎ^–ç, ‘ĺ–ě_Í, ˆäŠŃW•ă. MAIT×–EŠˆŤ‰ťÜ5-OP-RU‚̍\‘˘ŠˆŤ‘ŠŠÖŒ¤‹†. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ď@‘ć15‰ď”N‰ď–ňŠw‰ď. •Ÿ‰ŞiƒIƒ“ƒ‰ƒCƒ“j, 6ŒŽ, 2021.@@
2) ’r“c‘ńŒd, ěŒŠ”ü—˘, ˆä–{łĆ, Š|’JGş. ‚Ş‚ńО×–E‚đ•W“I‚Ć‚ľ‚˝R‚Ş‚ńÜƒV[ƒY’TőŒn‚̍\’z. “ú–{–ňŠw‰ď‘ć141”N‰ď. ‹ž“s, 3ŒŽ, 2021.@@
1) Žđˆä–ƒ—˜“Ţ, ‚‹´L–ž, ŒĂ’J@—T, —é–ŘŒ’—T, “°‘O@’ź, Ź—ѐ´, •ž•”@–ž, Œ´“c@_, Š|’JGş. ƒsƒ‰ƒ][ƒ‹œŠi‚đ—L‚ˇ‚éV‹K’áŽ_‘f—U“ąˆöŽqHIF-1‘jŠQÜ‚ĚŠJ”­Œ¤‹†. “ú–{–ňŠw‰ď‘ć141”N‰ď. L“‡, 3ŒŽ, 2021.@@

2020

16) Š|’JGş. ŽŠ‘R‚ÉŠw‚Ԑś—‰ťŠwŒ¤‹†F•ŞŽqƒvƒ[ƒuŠJ”­‚Ć‘n–ň. ‹ž“s‘ĺŠwŠwŰ—Z‡‹łˆç„iƒZƒ“ƒ^[Eś—‰ťŠwŒ¤‹†ƒ†ƒjƒbƒg‘ć10‰ńŒöŠJƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 12ŒŽ, 2020. @@
15) Š|’JGş, ‘q‰iŒ’Žj. ‘n–ňEˆç–ň‚Ö‚Ě’§íFŽŠ‘R‚ÉŠw‚ÔƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†. ‹ž“s‘ĺŠwu‚Ś‚é‚Ť‚ႡvƒIƒ“ƒ‰ƒCƒ“2020. ‹ž“s, 10ŒŽ, 2020. @@
14) Pan, C., Kuranaga, T., Liu, C., Lu, S., Shinzato, N., Kakeya, H. Discovery of sulfur-containing cyclic lipopeptides thioamycolamides A-E, produced by the rare ctinomycete Amycolatopsis sp., The 62nd Symposium on the Chemistry of Natural Products, Nagoya, Sep. 2020.@@
13) –ĽŽč–œ—R—˘, Źě‚͂邊, X–{—Á‘ž, ŕN łŒŞ, ‘q‰iŒ’Žj, Š|’JGş. Šó­“V‘R•¨‚̍\‘˘‚đƒ‚ƒ`[ƒt‚Ć‚ľ‚˝‚Š´“xƒ‰ƒxƒ‹‰ťÜ‚ĚŠJ”­. “ú–{–ňŠw‰ď‘ć140”N‰ď. ‹ž“s, 3ŒŽ, 2020.iu‰‰ƒnƒCƒ‰ƒCƒgj
@@
12) “c‘ş”ü”ż, ’†ě—Y‰î, ‘q‰iŒ’Žj, Š|’JGş. “V‘Rƒvƒƒhƒ‰ƒbƒOŒ^R‚Ş‚ńÜƒŠ[ƒh‰ť‡•¨ƒTƒbƒJƒƒXƒŠƒIƒŠƒhB‚Ě‘S‡ŹŒ¤‹†. “ú–{–ňŠw‰ď‘ć140”N‰ď. ‹ž“s, 3ŒŽ, 2020.@@@
11) ’|’†@Œd, ź‘şTˆę, ‹ŕŽqŒŤ‰î, Shan Lu, Š|’JGş. “V‘R—L‹@‰ť‡•¨saccharothriolide B‚É’…‘z‚𓞂˝ƒvƒƒhƒ‰ƒbƒO‹Zp‚ĚŠJ”­Œ¤‹†. “ú–{–ňŠw‰ď‘ć140”N‰ď. ‹ž“s, 3ŒŽ, 2020.@@@
10) X–{—Á‘ž, ‘q‰iŒ’Žj, ˜e–{•qK, Š|’JGş. ŽŔ—p“Iinverseƒyƒvƒ`ƒh‡Ź–@‚ĚŠJ”­. “ú–{–ňŠw‰ď‘ć140”N‰ď. ‹ž“s, 3ŒŽ, 2020.@@
9) ‰““ĄŒ’‘ž, •ž•” –ž, —› á•X, Źě—SŽ÷, ŕN łŒŞ, Š|’JGş. ’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘fUSP47‚ĆCateninD1‚Ě‚Ş‚ńˆŤŤ‰ť‚É‚¨‚Ż‚é‹@”\˜AŠÖ. “ú–{–ňŠw‰ď‘ć140”N‰ď. ‹ž“s, 3ŒŽ, 2020.@@
8) Š|’JGş. ƒAƒJƒfƒ~ƒA”­‘n–ň‚đ–ÚŽw‚ľ‚˝‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†. TSMTP (Translational Science and Medicine Training Program) Symposium in Sapporo, ŽD–y, 2ŒŽ, 2020. iľ‘ҍu‰‰j@@@@
7) Kaneko, K., Nagao, N., Onaka, H., Shinzato, N., Kakeya, H. Detection of combined-culture specific constituents by the Molecular Networking and multivariate analyses. The 4th Kyoto Biomolecular Mass Spectrometry Society (KBMSS), Kyoto, Feb. 2020.
6) Š|’JGş, ŠÝ–{[O, ”~“c-ŹŕV“ľ, ‚‹´L–ž, ‹g“cšˆť, ‘q‰iŒ’Žj, ĄňŒú, ‹´–{ł, ‹ŕˆä‰ëŽj. …—nŤƒvƒƒhƒ‰ƒbƒOŒ^•ŞŽq•W“IR‚Ş‚ńÜCMG‚ĚŠJ”­Œ¤‹†. ‹ž“s‘ĺŠwƒƒfƒBƒJƒ‹ƒCƒmƒx[ƒVƒ‡ƒ“iMiPj‘ě‰z‘ĺŠw‰@ƒvƒƒOƒ‰ƒ€Eˆă–ňŒnŒ¤‹†Œđ—ŹƒTƒƒ“, ‹ž“s, 1ŒŽ, 2020.@@@
5) ‘q‰iŒ’Žj, Źě‚͂邊, –ĽŽč–œ—R—˘, X–{—Á‘ž, ŕNłŒŞ, Š|’JGş. ‹H­ŠC—m“V‘R•¨‚đ‹@”\ƒ‚ƒ`[ƒt‚É‚ľ‚˝‚Š´“xƒ‰ƒxƒ‹‰ťÜ. ‹ž“s‘ĺŠwƒƒfƒBƒJƒ‹ƒCƒmƒx[ƒVƒ‡ƒ“iMiPj‘ě‰z‘ĺŠw‰@ƒvƒƒOƒ‰ƒ€Eˆă–ňŒnŒ¤‹†Œđ—ŹƒTƒƒ“, ‹ž“s, 1ŒŽ, 2020.@@@@@@@
4) •ž•”–ž, ŕNłŒŞ, •Ÿ‰ŞŒ[‘ž, “ˆ“c´, ‰““ĄŒ’‘ž, Źě—SŽ÷, Š|’JGş. ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚đŠî”Ő‚Ć‚ľ‚˝’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘fUSP47‚̐ś—‹@”\‰đÍ. ‹ž“s‘ĺŠwƒƒfƒBƒJƒ‹ƒCƒmƒx[ƒVƒ‡ƒ“iMiPj‘ě‰z‘ĺŠw‰@ƒvƒƒOƒ‰ƒ€Eˆă–ňŒnŒ¤‹†Œđ—ŹƒTƒƒ“, ‹ž“s, 1ŒŽ, 2020.@@@@
3) ‘q‰iŒ’Žj, •ž•”–ž, Š|’JGş. ‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†. ‹ž“s‘ĺŠwƒƒfƒBƒJƒ‹ƒCƒmƒx[ƒVƒ‡ƒ“iMiPj‘ě‰z‘ĺŠw‰@ƒvƒƒOƒ‰ƒ€Eˆă–ňŒnŒ¤‹†Œđ—ŹƒTƒƒ“, ‹ž“s, 1ŒŽ, 2020.@@@@
2) Š|’JGş. —L—pś•¨ŠˆŤƒŠƒKƒ“ƒh‚ĚŠJ”­‚đŽuŒü‚ľ‚˝‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“Œ¤‹†. —L‹@‡Ź‚Ěƒjƒ…[ƒgƒŒƒ“ƒh2020i—L‹@‡Ź‰ťŠw‹Ś‰ďŠÖźŽx•”ŽĺĂj, ‘ĺă, 2ŒŽ, 2020. iľ‘ҍu‰‰j@@@@
1) Kakeya, H. Continuing Fascination with Discovery Science: Phenotypic Screening to Chemical Biology. Mona Symposium 2020: Natural Product Chemistry and Medicinal Chemistry. Kingston, Jamaica, Jan. 2020. (plenary lecture)

2019

32) Š|’JGş. ”÷ś•¨ŠÔ‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ě—‰đ‚Ć—L—pś•¨ŠˆŤƒŠƒKƒ“ƒh‚ĚŠJ”­. VŠwp—ĚˆćŒ¤‹†u‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ěƒtƒƒ“ƒeƒBƒAvE‘ć6‰ńŒöŠJƒVƒ“ƒ|ƒWƒEƒ€. ‰Ą•l, 12ŒŽ, 2019. iľ‘ҍu‰‰j@@@
31) Kakeya, H. Chemical comunication research toward the development of useful chemical probes. The 4th A3 Roundtable Meeting on Asia Chemical Probe Research, Sendai, Nov. 2019. (Plenary lecture)@@@@
30) Kakeya, H. Natural products-prompted chemical biology: Phenotypic screening and a new platform for target identification. The 6th Tishler-Omura Sympoium, Tokyo, Oct. 2019. (plenary lecture) [postponed due to the Typhoon no.19]@@@@
29) Li, X., Hattori, A., Takahashi, S., Goto, Y., Harada, H., Kakeya, H. Inhibition of UCHL1 blocks proliferation and metastasis in HIF01 dependent tumor malignancy. 31th EORTC-NCI-AACR Symposium: International Conference on Molecular Targets and Cancer Therapeutics. Boston, MA, USA, Oct. 2019.@@@@
28) Kakeya, H, Kishimoto, A., Umeta, H., Imaizumi, A., Kanai, M. Development of an injectable water-soluble anticancer drug CMG for oxaliplatin-resistant colorectal cancer with KRAS mutation. 31th EORTC-NCI-AACR Symposium: International Conference on Molecular Targets and Cancer Therapeutics. Boston, MA, USA, Oct. 2019.@
27) Furutani, Y., Sudoh, M., Kakeya, H., Kojima, S. A small chemical compound CDM-3008 modulates cccDNA and suppresses HBV through induction of interferon-stimulated genes. 2019 International HBV Meeting. Melbourne, Australia, Oct. 2019.@@@@@
26) Kuranaga, T., Kakeya, H. Highly sensitive labeling reagents inspired by a scarce marine natural product. 10th Korea-Japan Chemical Biology Symposium. Ishikawa, Oct. 2019.@@@@@
25) Kanai, M., Kishimoto, A., Umeta, H., Imaizumi, A., Kakeya, H. Symposia 20 "Frontier in Molecular Target Therapy of Cancer": Development of a water-soluble prodrug CMG which inhibits proteasome activity through DYRK2 dependent manner. The 78th Annual Meeting of the Japanese Cancer Association, Kyoto, Sep. 2019. (invited)@@@@@
24) Li, X., Hattori, A., Goto, Y., Harada, H., Kakeya, H. Involvment of UCHL1 in the HIF-1-dependent tumor cell malignancy in 3D cell culture model. The 78th Annual Meeting of the Japanese Cancer Association, Kyoto, Sep. 2019.@@@@@
23) Š|’JGş, ‘q‰iŒ’Žj. ŽŠ‘R‚ÉŠw‚Ô–ň‚Ă‚­‚č. ‹ž“s‘ĺŠwƒAƒJƒfƒ~ƒbƒNƒfƒC2019, ‹ž“s, 9ŒŽ, 2019.@@@@
22) ‚‹´L–ž, —с@G–ž, Poznaks, V. Š|’JGş. ’áŽ_‘f—U“ąˆöŽqHIF-1‘jŠQŠˆŤ‚đ—L‚ˇ‚éŠÂóƒfƒvƒVƒyƒvƒ`ƒhverucopeptin‚Ě‘S‡Ź. ‘ć61‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď, L“‡, 9ŒŽ, 2019.@@@@@
21) Kakeya, H. Frontier research on chemical communications unveils the mystery of life science. The 27th International Society of Heterocyclic Chemistry Congress. Kyoto, Sep. 2019. (invited)@@@@
20) “c‘ş”ü”ż, ’†ě—Y‰î, ‘q‰iŒ’Žj, Š|’JGş. R‚Ş‚ń•¨ŽżƒTƒbƒJƒƒXƒŠƒIƒŠƒhB‚ĚŽű‘Š“I‘S‡ŹŒ¤‹†. ‘ć39‰ń—L‹@‡ŹƒZƒ~ƒi[u–ž“ú‚Ě—L‹@‡Ź‚đ’S‚¤l‚Ě‚˝‚߂Ɂv, ‘ĺă, 8ŒŽ, 2019.@@@@@
19) Š|’JGş. ŽŠ‘R‚ÉŠw‚ÔƒTƒCƒGƒ“ƒXuŔF ‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ěƒtƒƒ“ƒeƒBƒAŒ¤‹†. ‹ž“s‘ĺŠwƒI[ƒvƒ“ƒLƒƒƒ“ƒpƒX. ‹ž“s, 8ŒŽ, 2019.@@@@
18) ŒĂ’J@—T, ŒËŒű^—Žq, ^ˆä‰xŽq, ”óŒűËŽq, Ź—ŃƒJƒIƒ‹, {“ĄłK, —é–ŘŽĄ˜a, Š|’JGş, Ź“ˆ‘ˆę. cccDNA‚đ—}§‚ˇ‚éƒCƒ“ƒ^[ƒtƒFƒƒ“—l’ᕪŽq‰ť‡•¨CDM-3008‚̍ě—p‹@\. ‘ć29‰ńRƒEƒBƒ‹ƒX—Ă–@Šw‰ďŠwpW‰ďE‘‰ď, _“ސě, 7ŒŽ, 2019.@@@@@
17) ‹ŕˆä‰ëŽj, ŠÝ–{[O, ”~“c@“ľ, Ąň@Œú, Š|’JGş. ƒIƒLƒTƒŠƒvƒ‰ƒ`ƒ“’ďRŤ‚ĚKRAS‘ĺ’°‚Ş‚ń‚ɑ΂ˇ‚éCMG’ŽËÜ‚đ—p‚˘‚˝V‹KŽĄ—Ă–@‚ĚŠJ”­. ‘ć17‰ń“ú–{—Տ°Žîᇊw‰ďŠwpW‰ď, ‹ž“s, 7ŒŽ, 2019.@@@@@
16) Š|’JGş. ”÷ś•¨ŠÔ‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ě—˜Šˆ—p‚É‚ć‚éV‹Kś•¨ŠˆŤƒŠƒKƒ“ƒh‚ĚŠJ”­Œ¤‹†. ‘ć19‰ń“ú–{’`”’Žż‰ČŠw‰ď”N‰ďE‘ć71‰ń“ú–{×–Eś•¨Šw‰ď‘ĺ‰ď ‡“Ż”NŽŸ‘ĺ‰ď. •şŒÉ, 6ŒŽ, 2019.@iľ‘ҍu‰‰j@@@@@@
15) Š|’JGş, ź‘şTˆę, ‘q‰iŒ’Žj, –ě’†Œł—T, ˆä–{łĆ. ”÷ś•¨ŠÔ‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ě—‰đE§Œä‚Ć—L—pś•¨ŠˆŤƒŠƒKƒ“ƒh‚ĚŠJ”­. VŠwp—ĚˆćŒ¤‹†u‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ěƒtƒƒ“ƒeƒBƒAvE‘ć5‰ńŒöŠJƒVƒ“ƒ|ƒWƒEƒ€, ‘ĺă, 6ŒŽ, 2019.@@@@@
14) ă–ěăđž, Š|’JGş, ă™ŽuŹ, ˆäŠŃW•ă, âV“Ą@—T, ˛“ĄŒ’Œá, ĺŒ´N•ś. [‘wŠwK–@‚ĆPCA‰đÍ‚đ‘g‚ݍ‡‚킚‚˝ƒPƒ~ƒJƒ‹ƒXƒy[ƒX‚̉Ž‹‰ť. VŠwp—ĚˆćŒ¤‹†u‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ěƒtƒƒ“ƒeƒBƒAvE‘ć5‰ńŒöŠJƒVƒ“ƒ|ƒWƒEƒ€, ‘ĺă, 6ŒŽ, 2019.@
13) Š|’JGş. uƒVƒ“ƒ|ƒWƒEƒ€E‚Ş‚ń‚ƏhŽĺ‚̉ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ě—‰đ‚Ɛ§Œäv. …—nŤƒvƒƒhƒ‰ƒbƒOŒ^•ŞŽq•W“IR‚Ş‚ńÜCMG‚ĚŠJ”­Œ¤‹†. ‘ć23‰ń“ú–{‚Ş‚ń•ŞŽq•W“IŽĄ—ĂŠw‰ďŠwpW‰ď. ‘ĺă, 6ŒŽ, 2019. iľ‘ҍu‰‰j@@@@@
12) “c‘ş”ü”ż, ’†ě—Y‰î, ‘q‰iŒ’Žj, Š|’JGş. R‚Ş‚ńŠˆŤ‚đ—L‚ˇ‚é”÷ś•¨‘ăŽÓŽY•¨ƒTƒbƒJƒƒXƒŠƒIƒŠƒhB‚Ě‘S‡ŹŒ¤‹†. ‘ć86‰ń“ú–{•ސ͉ťŠw‰ď—L‹@”÷—Ę•ŞÍŒ¤‹†§’k‰ďE‘ć110‰ńŒv‘ŞŽŠ“Ž§ŒäŠw‰ď—ÍŠw—ĘŒv‘Ş•”‰ď ‘ć36‰ń‡“ŻƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 6ŒŽ, 2019.@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
11) ‹ŕŽqŒŤ‰î, ’ˇ”ö–ě‰f‰Ô, •ž•”@–ž, Š|’JGş. ’áŽ_‘f—U“ąˆöŽqiHIFj‘jŠQ‰ť‡•¨verucopeptin‚̐ś‡Źˆâ“`ŽqƒNƒ‰ƒXƒ^[‚Ě“Ż’č‚ƐV‹K—މ‘̂̒Tő. ‘ć86‰ń“ú–{•ސ͉ťŠw‰ď—L‹@”÷—Ę•ŞÍŒ¤‹†§’k‰ďE‘ć110‰ńŒv‘ŞŽŠ“Ž§ŒäŠw‰ď—ÍŠw—ĘŒv‘Ş•”‰ď ‘ć36‰ń‡“ŻƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 6ŒŽ, 2019.@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
10) Š|’JGş. uƒVƒ“ƒ|ƒWƒEƒ€E‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ěƒtƒƒ“ƒeƒBƒAv. ”÷ś•¨ŠÔ‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ě—˜Šˆ—p‚É‚ć‚éV‹K—L—pś•¨ŠˆŤƒŠƒKƒ“ƒh‚ĚŠJ”­Œ¤‹†. ‘ć19‰ń“ú–{’`”’Žż‰ČŠw‰ď”N‰ďE‘ć71‰ń“ú–{×–Eś•¨Šw‰ď ‡“Ż”NŽŸ‘ĺ‰ď. •şŒÉ, 6ŒŽ, 2019. iľ‘ҍu‰‰j@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
9) ŒĂ’J@—T, ŒËŒű^—Žq, ^ˆä‰xŽq, ”óŒűËŽq, {“ĄłK, —é–ŘŽĄ˜a, Š|’JGş, Ź“ˆ‘ˆę. ƒCƒ“ƒ^[ƒtƒFƒƒ“—l‚ĚŠˆŤ‚đŽ‚Â’á•ŞŽq‰ť‡•¨CDM-3008‚̍RHBVŠˆŤ‚̉đÍ. ‘ć26‰ńŠĚ×–EŒ¤‹†‰ď. ‰Ą•l, 5ŒŽ, 2019.@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
8) Š|’JGş. uƒVƒ“ƒ|ƒWƒEƒ€E‚Ş‚ń”÷ŹŠÂ‹Ť‚Ě—‰đ‚Ć‚ť‚ĚŽ•ž‚ÉŒü‚Ż‚˝–ňŠw“IƒAƒvƒ[ƒ`‚Ƃ́HHIF-1ƒż‚Ě—‰đ‚Ɛ§Œä‚ÉŒü‚݂āv. ’áŽ_‘f‰ž“šƒVƒOƒiƒ‹‚đ•W“I‚Ć‚ľ‚˝‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. “ú–{–ňŠw‰ď‘ć139”N‰ď. ç—t, 3ŒŽ, 2019. iľ‘ҍu‰‰j@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
7) Š|’JGş. ’†’ˇŠúƒe[ƒ}ƒVƒ“ƒ|ƒWƒEƒ€uś–˝‰ČŠw‚É‚¨‚Ż‚é•ŞŽq‰ťŠw‚ĚƒvƒŒƒ[ƒ“ƒXv. ‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚ސD‚č‚Č‚ˇś–˝‰ČŠw. “ú–{‰ťŠw‰ď‘ć99t‹G”N‰ďi2019j. _ŒË, 3ŒŽ, 2019. iľ‘ҍu‰‰j
6) ó…r•˝, ”öč‘ž˜Y, ź‘şTˆę, Š|’JGş, ”ö’‡GN. •Ą‡”|—{‚É‚¨‚Ż‚éStreptomyces sp. HEK616‚É‚ć‚é5aTHQs‚̐śŽY‹@\, “ú–{”_Œ|‰ťŠw‰ď2019”N“x‘ĺ‰ď. “Œ‹ž, 3ŒŽ, 2019.
5) Kakeya, H. Development of cryptic antifungal 5aTHQs targting cell membrane signaling. Asian Chemical Biology Initiative (ACBI) 2019 Yangon Meeting. Yangon, Myanmer, Jan. 2019. (invited)@@@@@@@@@@@@@@@@@@@@
4) Š|’JGş. uƒVƒ“ƒ|ƒWƒEƒ€E“V‘R•¨‘n–ň`“ú–{‚Ě‹­‚Ý‚đś‚Š‚ľ‚˝V’Ş—Ź`v@“V‘R•¨‘n–ň‚Ě•œŒ ‚đŠú‚ľ‚āF”÷ś•¨ŠÔ‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ě—˜Šˆ—p. ‘ć402‰ńCBIŠw‰ďiî•ńŒvŽZ‰ťŠwś•¨Šw‰ďju‰‰‰ď. “Œ‹ž, 1ŒŽ, 2019. iľ‘ҍu‰‰j@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
3) Kakeya, H., Takahashi, N., Kishimoto, A., Imaizumi, A., Kanai, M. Development of an innovative water-soluble anticancer drug, curcumin mono-beta-D-glucuronide (CMG). The 1st International Symposium on Chemical Communication (ISCC2019). Tokyo, Jan. 2019.@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
2) Nonaka, M., Fukuda, M.N., Kakeya, H. Rapid screening of antibody-binding peptides by combination of T7 phage display and next-generation sequencing technologies. The 1st International Symposium on Chemical Communication (ISCC2019). Tokyo, Jan. 2019.@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
1) Jiang, Y., Lu, S., Hirai, G., Kato, T., Onaka, H., Kakeya, H. Towards the development of chemical communication molecules among microbes. The 1st International Symposium on Chemical Communication (ISCC2019). Tokyo, Jan. 2019.@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@

2018

33) Kakeya, H., Kishimoto, A., Imaizumi, A., Kanai, M. Development of a synthetic water-soluble curcumin mono-beta-D-glucuronide (CMG), as an innovative anticancer prodrug targeting KRAS-NF-kappaB signaling pathway. 30th EORTC-NCI-AACR Symposium: International Conference on Molecular Targets and Cancer Therapeutics. Dublin, Ireland, Nov. 2018.
32) Nonaka, M., Kakeya, H., Fukuda, M. Drug delivery to malignant brain tumor by a peptide specific to Annexin A1. 30th EORTC-NCI-AACR Symposium: International Conference on Molecular Targets and Cancer Therapeutics. Dublin, Ireland, Nov. 2018.
31) Š|’JGş. ˆă–ň•iƒV[ƒh•ŞŽq‚Ě‘˝—lŤ‘no‚Ć×–E“ŕ•W“I’TőE“Ż’č. ‹ž‘ĺƒeƒbƒNƒtƒH[ƒ‰ƒ€. “Œ‹ž, 10ŒŽ, 2018. iľ‘ҍu‰‰j
30) Jiang, Y. L., Lu, S., Hirai, G., Kato, T., Onaka, H., Kakeya, H. Enhancement of saccharothriolides production and discovery of new derivatives by combined culture of a rare actinomycete Saccharothrix sp. and Tsukamurella sp. The 22th Symposium on Development and Application of Naturally Occurring Drug Materials. Kumamoto, Oct. 2018.
29) ź‘şTˆę, ™ŽR—´‰î, ’‡’J’G, ”öč‘ž˜Y, ó…r•˝, ”ö’‡GN, Š|’JGş. ”÷ś•¨‚Ě•Ą‡”|—{‚Ĺ“ž‚ç‚ę‚é5aTHQ‚Ě–Œe˜aŤ‚Ɛś•¨ŠˆŤ. ‘ć60‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď. •Ÿ‰Ş, 9ŒŽ, 2018.
28) ŠâŸşDŽĄ, ˛“Ą—ş, ů–ě—T‰î, ŹźTŒá, –ěŒűłŽk, Š|’JGş, ’ˇ“c—T”V, А’źŽ÷. ƒAƒ|ƒg[ƒVƒX—U“ąŠˆŤ“V‘R•¨cytotrienin A‚̍‡ŹŒ¤‹†. ‘ć60‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď. •Ÿ‰Ş, 9ŒŽ, 2018.
27) Š|’JGş, –ě’†Œł—T, ‘q‰iŒ’Žj. “V‘R•¨‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. ‹ž“s‘ĺŠwƒAƒJƒfƒ~ƒbƒNƒfƒC2018, ‹ž“s, 9ŒŽ, 2018.
26) ‚‹´çŠG, Shan Lu, Yulu Jiang, “Œ Ž‹Ĺ, ź‘şTˆę, •ž•” –ž, Š|’JGş. ‘ć91‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď. ‹ž“s, 9ŒŽ, 2018.
25) źŒ´‘ń^, •ž•” –ž, Š|’JGş. Calpain7‚Ě×–E“ŕ‹ÇÝ‚̉đÍ. ‘ć91‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď. ‹ž“s, 9ŒŽ, 2018.
24) •Ÿ‰ŞŒ[‘ž, •ž•” –ž, Š|’JGş. y‘f”˝‰ž‘Ź“x˜_“I‰đÍ‚đ—p‚˘‚˝’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘fUSP47‚ĚC––’[—Ěˆć‚Ě‹@”\‰đÍ. ‘ć91‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď. ‹ž“s, 9ŒŽ, 2018.
23) Š|’JGş. “V‘R•¨‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[`•úü‹Ű‚É–Ł‚š‚ç‚ę‚ā`. 2018”N“xi‘ć33‰ńj“ú–{•úü‹ŰŠw‰ď‘ĺ‰ď. “Œ‹ž, 9ŒŽ, 2018. iľ‘ҍu‰‰j
22) ś“cŽŔš, ˆÉ“Ąˆ¤—, ź‘şTˆę, ‹g“c –Ť, Š|’JGş. ‘˝Šu•ÇŒ`Ź‚â×–EL’ˇ‚É‚¨‚Ż‚éƒXƒtƒBƒ“ƒSŽ‰Žż‚̏d—vŤ. y•ęˆâ“`ŠwƒtƒH[[ƒ‰ƒ€‘ć51‰ńŒ¤‹†•ń‰ď. •Ÿ‰Ş, 9ŒŽ, 2018. (ƒ|ƒXƒ^[Ü‚đŽóÜ)
21) Š|’JGş. ŽŠ‘R‚ÉŠw‚ÔƒTƒCƒGƒ“ƒXuŔF ‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“•ŞŽq‚Ě“ä‚É”—‚é. ‹ž“s‘ĺŠwƒI[ƒvƒ“ƒLƒƒƒ“ƒpƒX. ‹ž“s, 8ŒŽ, 2018.
20) Š|’JGş. ”_–ň‚Ě‘nťEŒ¤‹†ŠJ”­“ŽŒü‚ƐťÜ‰ť‹ZpƒZƒ~ƒi[FV‹K”_–ň‚ĚŠJ”­‚đŽuŒü‚ľ‚˝ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†. ƒV[ƒGƒ€ƒV[o”ĹƒZƒ~ƒi[. “Œ‹ž, 7ŒŽ, 2018.iľ‘ҍu‰‰j
19) Jiang, Y.L., Lu, S., Hirai, G., Kato, T., Onaka, H., Kakeya, H. Enhancement of saccharothriolide (STLs) production by combined-culture of Saccharothrix sp. and Tsukamurella sp. The 29th Meeting on Discovery and Development of New Drugs. Shizuoka, Jul. 2018.
18) “c‘ş—S–ç, Shan Lu, “ˆ“c´, Š|’JGş. ’áŽ_‘f—U“ąˆöŽqiHIFsjŠˆŤ‰ť•¨Žż‚Ě’P—فE\‘˘Œˆ’č‚ƍě—p‹@˜‰đÍ. ‘ć29‰ńV–ň‘nŹ’k˜b‰ď. Ă‰Ş, 7ŒŽ, 2018.
17) Š|’JGş. “V‘R•¨‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚Ě‘çŒí–Ą. ‘ć53‰ń“V‘R•¨‰ťŠw’k˜b‰ď. ‘ĺă, 7ŒŽ, 2018.iľ‘ҍu‰‰j
16) ’r“ŕ‘Pé, Cheng-Quin Pan, ś“cŽŔš, ź‘şTˆę, Š|’JGş. ś‘Ě–ŒƒVƒOƒiƒ‹‚ɍě—p‚ˇ‚é“V‘R•¨‚Ě’TőŒ¤‹†. ‘ć53‰ń“V‘R•¨‰ťŠw’k˜b‰ď. ‘ĺă, 7ŒŽ, 2018.
15) ˆÉ“Ąk˘, ‘q‰iŒ’Žj, Š|’JGş, ˜e–{•qK. ƒZƒIƒlƒ‰ƒ~ƒhF‚̍‡ŹŒ¤‹†. ‘ć53‰ń“V‘R•¨‰ťŠw’k˜b‰ď. ‘ĺă, 7ŒŽ, 2018.
14) Š|’JGş, ź‘şTˆę, ‘q‰iŒ’Žj, –ě’†Œł—T, ˆä–{łĆ. ”÷ś•¨ŠÔ‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ě—‰đ‚Ć—L—pś•¨ŠˆŤƒŠƒKƒ“ƒh‚ĚŠJ”­. VŠwp—ĚˆćŒ¤‹†u‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ěƒtƒƒ“ƒeƒBƒAvE‘ć3‰ńŒöŠJƒVƒ“ƒ|ƒWƒEƒ€. “Œ‹ž, 6ŒŽ, 2018.
13) Š|’JGş. u‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ěƒtƒƒ“ƒeƒBƒAv‚đ‹N“_‚É‚ľ‚˝‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. VŠwp—ĚˆćŒ¤‹†uŽ‰ŽżƒNƒIƒŠƒeƒB‚Ş‰đ‚Ť–ž‚Š‚ˇś–˝ŒťŰv‘ć4‰ń—Ěˆć‰ď‹c. •şŒÉ, 6ŒŽ, 2018. i“Á•ʍu‰‰j
12) ŒĂ’J@—T, Š|’JGş, Ź“ˆ‘ˆę. ƒ[ƒNƒVƒ‡ƒbƒvuBŒ^ŠĚ‰ŠV‹KŽĄ—Ă–ň‚Ě’Tő‚ĚŒťóvFƒhƒ‰ƒbƒOƒtƒŠ[‚ĚŽŔŒť‚đ–ÚŽw‚ľ‚˝cccDNA—}§ÜCDM-3008‚ĆƒGƒ“ƒeƒJƒrƒ‹‚Ƃ̕š—p‚É‚ć‚éHBVÄŠˆŤ‰ť‚Ě—}§. ‘ĺă, 6ŒŽ, 2018. i“Á•ʍu‰‰j
11) Lu, S., Nishimura, S., Ito, M., Kato, T., Kakeya, H. Discovery of pre-saccharothriolide X from the rare actinomycet Saccharothrix sp. The 13th Annual Meeting of Japanese Society for Chemical Biology, Tokyo, Jun. 2018.
10) Kakeya, H. Microbial metabolites targeting microenvironment: a cell membrane sigaling modulator and a hypoxia-response modulator. The 9th Japan-Korea chemical biology symposium, Incheon, Korea, May, 2018. (invited)
9) Ogawa, Y., Kakeya, H. Screening of sensitizers derived from microbial metabolites to induce apoptosis in pancreatic cancer cells. The 9th Japan-Korea chemical biology symposium, Incheon, Korea, May, 2018.
8) Nonaka, M., Kakeya, H., Fukuda, M. Identification of binding peptides against IgE from human myeloma U266 cells. The 9th Japan-Korea chemical biology symposium, Incheon, Korea, May, 2018.
7) Li, X.B., Goto, Y., Hattori, A., Harada, H., Kakeya, H. Study on the UCHL1-HIF-1 axis toward development of molecular targeted anticancer drugs. The 22th Annual Meeting of the Japanese Association for Molecular Target Therapy of Cancer (JAMTTC), Tokyo, May, 2018.
6) Kanai, M., Imaizumi, A., Kakeya, H. Development of a water-soluble curcumin monoglucronide (CMG) as a novel anticancer prodrug targeting KRAS-NF-kappa B signaling pathway. Global Academic Programs (GAP) conference, Stockholm, Sweden, May, 2018. (invited)
5) Š|’JGş. u’†’ˇŠúŠé‰ćEƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†‰Á‘Ź‚Ě‚˝‚߂̐ś•¨ŠˆŤ•ŞŽq‚Ě”­ŒŠí—ށv\”÷ś•¨ŠÔ‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ě“ä‚É’§‚ށ\. “ú–{‰ťŠw‰ď‘ć98t‹G”N‰ď. ç—t, 3ŒŽ, 2018. iľ‘ҍu‰‰j
4) ™čr•ś, ‚{N–ž, •ž•” –ž, Ź“ˆ‘ˆę, Š|’JGş. TGF-ƒŔƒVƒOƒiƒ‹“`’B‘jŠQÜKUSC-Y244‚ÍTGF-ƒŔ‚É‚ć‚éă”çŠÔ—t“]Ў‚đ—}§‚ˇ‚é. “ú–{–ňŠw‰ď‘ć138”N‰ď, ‹ŕ‘ň, 3ŒŽ, 2018.
3) Š|’JGş. uƒVƒ“ƒ|ƒWƒEƒ€F‚ą‚ꂊ‚ç‚Ě“V‘R•¨ƒTƒCƒGƒ“ƒXv\ƒPƒ~ƒJƒ‹ƒXƒy[ƒXŠg[í—ށF”÷ś•¨•Ą‡”|—{–@‹y‚ŃPDSS (Precurso-Directed in situ Synthesis)–@\, “ú–{”_Œ|‰ťŠw‰ď2018”N“x‘ĺ‰ď. –źŒĂ‰Ž, 3ŒŽ, 2018. iľ‘ҍu‰‰j
2) Š|’JGş. ”÷ś•¨ŠÔ‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ě—˜Šˆ—p‚É‚ć‚éƒPƒ~ƒJƒ‹ƒXƒy[ƒXŠg[í—Ş. VŠwp—ĚˆćŒ¤‹†u‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ěƒtƒƒ“ƒeƒBƒAvE‘ć2‰ńŒöŠJƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 2ŒŽ, 2018. iľ‘ҍu‰‰j
1) Lu, S., Nishimura, S., Ito, M., Kato, T., Kakeya, H. Expansion of chemical space in saccharothriolides: Precursor-directed in situ synthesis (PDSS) in a rare actinomycete Saccharothrix sp. Natural Product Discovery & Development in the Genomic Era (Natural Products 2018), Clearwater, FL, USA. Jan. 2018.

2017

26) Š|’JGş. ‘n”_–ňƒCƒmƒx[ƒVƒ‡ƒ“‚đ‘n”­‚ˇ‚éƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[•ű—Ş. ”_–ňƒfƒUƒCƒ“Œ¤‹†‰ďiŽĺĂF“ú–{”_–ňŠw‰ďE”_–ňƒfƒUƒCƒ“Œ¤‹†‰ďj. “Œ‹ž, 11ŒŽ, 2017. iľ‘ҍu‰‰j
25) Ąň Œú, ‚‹´L–ž, Œő‹ŕ‰pé, ‹ŕˆä‰ëŽj, ‹´–{ ł, –q–ě—IŽĄ, ’Ă“cF”Í, Š|’JGş. ‹@”\ŤH•i‘fŢ‚Ěˆă–ň•i‚Ö‚Ě“WŠJ‚đ–ÚŽw‚ľ‚˝‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. ‘ć7‰ńH•i–ňŠwƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 10ŒŽ, 2017. iľ‘ҍu‰‰j
24) ‚‹´L–ž, —Ń G–ž, Poznaks, V., Š|’JGş. ˆă–ň‰ťŠw“I“WŠJ‚đŽwŒü‚ľ‚˝verucopeptin‚Ě‘S‡ŹŒ¤‹†. ‘ć35‰ńƒƒfƒBƒVƒiƒ‹ƒPƒ~ƒXƒgƒŠ[ƒVƒ“ƒ|ƒWƒEƒ€. –źŒĂ‰Ž, 10ŒŽ, 2017.
23) Furutani, Y., Toguchi, M., kakeya, H., Kojima, S. Combinatorial treatment of CDM/iCDM and entecavir for efficient suppression of cccDNA. 2017 International HBV Meeting: The Molecular Biology of Hepatitis B viruses, Washington, DC, USA. Sep. 2017.
22) ź‘şTˆę, ‹g‘ş Ę, ™ŽR—´‰î, Š|’JGş. “V‘R—L‹@‰ť‡•¨‚̍\‘˘‰đÍ‚ĆNMRƒVƒOƒiƒ‹‚̏d•Ą. ‘ć18‰ńNMRŒ¤‹†‰ď. ˜a‰ĚŽR, 9ŒŽ, 2017. iľ‘ҍu‰‰j
21) ś“cŽŔš, ˆÉ“Ąˆ¤—, ź‘şTˆę, Š|’JGş. ƒXƒtƒBƒ“ƒSŽ‰Žż‚Ě‹@”\‰đ–ž‚đ–ÚŽw‚ľ‚˝‰ťŠwˆâ“`Šw“I‰đÍ.FƒGƒLƒmƒ}ƒCƒVƒ“—ނ̎擞‚Ć‚ť‚Ě•\ŒťŒ^. y•ęˆâ“`ŠwƒtƒH[ƒ‰ƒ€‘ć50‰ńŒ¤‹†•ń‰ď. “Œ‹ž, 9ŒŽ, 2017.
20) ź‘şTˆę, “ż‘qŤl, Š|’JGş, ź‰i–ÎŽ÷, ‘ĺ‹÷łŽq, śŁ‹`‹v, Carvalho, S., Cortes, J., Ribas, J. ƒXƒeƒ[ƒ‹‚đ•W“I‚É‚ˇ‚éR^‹Ű‰ť‡•¨ƒZƒIƒlƒ‰ƒ~ƒh‚É‚ć‚é×–E•ÇˆŮí. y•ęˆâ“`ŠwƒtƒH[ƒ‰ƒ€‘ć50‰ńŒ¤‹†•ń‰ď. “Œ‹ž, 9ŒŽ, 2017.
19) ‰ş‘ş‘sl, ”öč‘ž˜Y, ™ŽR—´‰î, ź‘şTˆę, ó…r•˝, Š|’JGş, ”ö’‡GN. •Ą‡”|—{‚É‚ć‚Á‚ĐśŽY‚ł‚ę‚éƒeƒgƒ‰ƒqƒhƒƒLƒmƒŠƒ“‰ť‡•¨‚̉đÍ. ‘ć32‰ń“ú–{•úü‹ŰŠw‰ď‘ĺ‰ď, ’ˇ–ě, 9ŒŽ, 2017.
18) Š|’JGş. ŽŠ‘R‚ÉŠw‚ÔƒTƒCƒGƒ“ƒXuŔF”÷ś•¨ŠÔ‰ťŠwƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚Ě“ä‚É”—‚é. ‹ž“s‘ĺŠwƒI[ƒvƒ“ƒLƒƒƒ“ƒpƒX. ‹ž“s, 8ŒŽ, 2017.
17) ‹ŕˆä‰ëŽj, ŹŕV “ľ, Ąň Œú, ‚‹´L–ž, Š|’JGş. ƒ[ƒNƒVƒ‡ƒbƒvuƒAƒJƒfƒ~ƒA”­R‚Ş‚ń–ňŠJ”­‚̐i“WvFƒvƒƒhƒ‰ƒbƒOŒ^ƒNƒ‹ƒNƒ~ƒ“‚đ—p‚˘‚˝V‹KR‚Ş‚ń–ň‚ĚŠJ”­. ‘ć15‰ń“ú–{—Տ°Žîᇊw‰ďŠwpW‰ď. •şŒÉ, 7ŒŽ, 2017.
16) Źě‚͂邊, —›@á•X, •ž•”@–ž, Œă“Ą—eŽq, XéęÍ‘ă, •˝‰ŞáÁа, Œ´“c@_, Š|’JGş. •ŞŽq•W“IR‚Ş‚ńÜŠJ”­‚đŽwŒü‚ľ‚˝’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘fUCHL1‘jŠQÜ‚Ě’TőŒ¤‹†. ‘ć28‰ńV–ň‘nŹ’k˜b‰ďuŽžŠł‚Ć‘n–ň‚ĚƒCƒmƒx[ƒVƒ‡ƒ“v. Ă‰Ş, 7ŒŽ, 2017.
15) ś“cŽŔš, ˆÉ“Ąˆ¤—, “Ą“cq•˝, ź‘şTˆę, Š|’JGş. ×–E–ŒŽ‰Žż‚đ•W“I‚Ć‚ˇ‚鉝‡•¨‚ĚƒXƒNƒŠ[ƒjƒ“ƒO‹y‚Ń‚ť‚ĚŠˆŤ•]‰ż. ‘ć28‰ńV–ň‘nŹ’k˜b‰ďuŽžŠł‚Ć‘n–ň‚ĚƒCƒmƒx[ƒVƒ‡ƒ“v. Ă‰Ş, 7ŒŽ, 2017.(—DG”­•\Üi§—ăÜj‚đŽóÜ)
14) Lu, S., Nishimura, S., Ito, M., Kato, T., Kakeya, H. Novel natural products, saccharothriolides, from rare actinomycete Saccharothrix sp. and precursor-directed in situ synthesis (PDSS) of thier analogs. The 10th Anniversary Symposium of Division of Bioinformatics and Chemical Genomics, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, July, 2017.
13) ‹ŕŽqŒŤ‰î, ’|’† Œd, ’ˇ”ö–ě‰f‰Ô, Îě•ś—m, ”g‘˝–ě˜aŽ÷, ŒÜ\—’‰ë”V, Š|’JGş. ƒPƒ~ƒJƒ‹ƒXƒy[ƒXŠg[‚đŽwŒü‚ľ‚˝ś‡ŹHŠw“IŒ¤‹†. ‹ž“s‘ĺŠw‘ĺŠw‰@–ňŠwŒ¤‹†‰Čˆă–ň‘nŹî•ń‰ČŠwęU10Žü”N‹L”OƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 7ŒŽ, 2017.
12) •Ÿ‰ŞŒ[‘ž, “ˆ“c´, •ž•” –ž, Š|’JGş. ’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘fUSP47‚Ěƒ|ƒŠƒ†ƒrƒLƒ`ƒ“˝Á‰ť‹@\‚̉𖞂ƑjŠQÜ’TőŒn‚̍\’z. ‹ž“s‘ĺŠw‘ĺŠw‰@–ňŠwŒ¤‹†‰Čˆă–ň‘nŹî•ń‰ČŠwęU10Žü”N‹L”OƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 7ŒŽ, 2017.
11) ‚‹´L–ž, —с@G–ž, Viktors Poznacks, Š|’JGş. ’áŽ_‘f—U“ąˆöŽqiHIFsj‘jŠQÜŠJ”­‚đŽwŒü‚ľ‚˝verucopeptin‚Ě‘S‡ŹŒ¤‹†. ‹ž“s‘ĺŠw‘ĺŠw‰@–ňŠwŒ¤‹†‰Čˆă–ň‘nŹî•ń‰ČŠwęU10Žü”N‹L”OƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 7ŒŽ, 2017.
10) Š|’JGş. ”÷ś•¨•Ą‡”|—{–@‚Ě—˜Šˆ—p‚É‚ć‚é‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. ‘ć12‰ń‰ťŠwś‘ÔŠwŒ¤‹†‰ď. ”ŸŠŮ, 6ŒŽ, 2017. iľ‘ҍu‰‰j
9) ŒĂ’J@—T, Š|’JGş, Ź“ˆ‘ˆę. ƒVƒ“ƒ|ƒWƒEƒ€uBŒ^ŠĚ‰ŠŒ¤‹†‚̐V“WŠJvFcccDNA—}§ÜCDM/iCDM‚ĆƒGƒ“ƒeƒJƒrƒ‹‚Ƃ̕š—pŒř‰Ę‚̉đÍ. ‘ć53‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď. L“‡, 6ŒŽ, 2017.
8) Lu, S., Nishimura, S., Ito, M., Kato, T., Kakeya, H. Generation of saccharothriolide analogs by precursor-directed in situ synthesis (PDSS) and their SAR study. The 12th Annual Meeting of Japanese Society for Chemical Biology, Sapporo, June, 2017.
7) ź‘şTˆę, ˆÉ“Ąˆ¤—, ‚‹´L–ž, Š|’JGş. ƒTƒ|ƒjƒ“‚ĆƒXƒeƒ[ƒ‹‚Ě•ŞŽqŠÔ‘ŠŒÝě—p‚É‚¨‚Ż‚é’Y‰ť…‘f•˝–ʂƐ…Ž_Šî‚̏d—vŤ. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ď ‘ć12‰ń”N‰ď, ŽD–y, 6ŒŽ, 2017.
6) Š|’JGş. ŽŠ‘R‚ÉŠw‚сAŒ´—‚đ•R‰đ‚ŤA‚­‚ˇ‚č‚đ‘n‚é. “ú–{ŠwpU‹ť‰ďiJSPSju“ú–{‚É‚¨‚Ż‚éƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚̐V“WŠJv‚ÉŠÖ‚ˇ‚éŽYŠw‹Ś—ÍŒ¤‹†ˆĎˆő‰ďiJSPS‘ć189ˆĎˆő‰ďjEH29”N“x‘ć1‰ń’č—á‰ď, “Œ‹ž, 5ŒŽ, 2017.iľ‘ҍu‰‰j
5) Li, X.B., Takahashi, S., Hattori, A., Goto, Y., Morinobu, A., Hiraoka, M., Harada, H., Kakeya, H. Chemical biology research on the UCHL1-HIFs axis toward development of molecular targeted anticancer drugs. SKO Symposium 2017 (Joint Symposium 2017 of Seoull Univ., Kyoto Univ., and Osaka Univ.), Osaka, May, 2017.
4) —›@á•X, •ž•”–ž, Œă“Ą—eŽq, XéęÍ‘ă, , •˝‰ŞáÁа, Œ´“c@_, Š|’JGş. ‘ĺŠw‰@śƒVƒ“ƒ|ƒWƒEƒ€u–ňŠw‚Ş‚ńŒ¤‹†‚Ě”­“W‚Ć–˘—ˆ‚đć“ą‚ˇ‚éŽáŽč‚Ş‚ńŒ¤‹†ŽŇ‚Ě’§ívFUCHL1-HIFŠˆŤ‰ťŒo˜H‚đ•W“I‚Ć‚ľ‚˝•ŞŽq•W“IR‚Ş‚ńÜŠJ”­Œ¤‹†. “ú–{–ňŠw‰ď‘ć137”N‰ď. ĺ‘ä, 3ŒŽ, 2017. iľ‘ҍu‰‰j
3) —с@‹ą•˝, ‚‹´L–ž, ’†ě—Y‰î, ŒËŒű^—Žq, ˛“Ą—T”ü, ŒĂ’J@—T, Ź“ˆ‘ˆę, Š|’JGş. V‹KBŒ^ŠĚ‰ŠŽĄ—Ă–ň‘nť‚ÉŒü‚Ż‚˝CDMs‚̍\‘˘ŠˆŤ‘ŠŠÖŒ¤‹†. “ú–{–ňŠw‰ď‘ć137”N‰ď. ĺ‘ä, 3ŒŽ, 2017.
2) Š|’JGş. uƒVƒ“ƒ|ƒWƒEƒ€F”_Œ|‰ťŠw‚Š‚ç”­M‚ˇ‚鎟˘‘ăŒ^“V‘R•¨‰ťŠwv\ƒAƒJƒfƒ~ƒA‘n–ň‚É‚¨‚Ż‚é•\ŒťŒ^ƒXƒNƒŠ[ƒjƒ“ƒO‚ĆŽŸ˘‘ă“V‘R•¨‰ťŠw\. “ú–{”_Œ|‰ťŠw‰ď2017”N“x‘ĺ‰ď. ‹ž“s, 3ŒŽ, 2017. iľ‘ҍu‰‰j
1) Š|’JGş. ‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†•ű—ށF•\ŒťŒ^ƒXƒNƒŠ[ƒjƒ“ƒO‚ĆƒV[ƒh•ŞŽqŠJ”­. ƒrƒbƒOƒf[ƒ^‹ě“ŽŒ^‘n–ňƒVƒXƒeƒ€Œ¤‹†‹’“_E‘ć3‰ńƒVƒ“ƒ|ƒWƒEƒ€. Œcœä‹`m‘ĺŠw. ‰Ą•l, 3ŒŽ, 2017. iľ‘ҍu‰‰j

2016

24) —›@á•X, Œă“Ą—eŽq, •ž•”–ž, •˝‰ŞáÁа, Œ´“c@_, Š|’JGş. V‹K•ŞŽq•W“IR‚Ş‚ńÜŠJ”­‚đŽwŒü‚ľ‚˝UCHL1-HIFŠˆŤ‰ťŒo˜H‘jŠQÜƒXƒNƒŠ[ƒjƒ“ƒOŒn‚̍\’z. ‘ć75‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď. ‰Ą•l, 10ŒŽ, 2016.
23) ź‘şTˆę, ™ŽR—´‰î, ’‡’J’G, ”öč‘ž˜Y, ó…r•˝, ”ö’‡GN, Š|’JGş. ”÷ś•¨‚Ě•Ą‡”|—{‚Ĺ“ž‚ç‚ę‚é5aTHQ‚Ćstreptoaminal‚̍\‘˘‚ƍ\‘˘. ‘ć21‰ń“V‘R–ň•¨‚ĚŠJ”­‚Ɖž—pƒVƒ“ƒ|ƒWƒEƒ€. ç—t, 10ŒŽ, 2016.iľ‘ҍu‰‰j
22) Kojima, S., Furutani, Y., Kakeya, H. Screening of novel cccDNA modulator compounds, iCDMs.The 2016 International HBV Meeting: The Molecular Biology of Hepatitis B Viruses. Seuol, Korea, Sep. 2016.
21) Îě•ś—m, Ą–ě@ăÄ, Š}ˆäş‘ž, —é–ŘŒ’—T, “°‘O@’ź, Š|’JGş. ”ńƒŠƒ{ƒ\[ƒ€Ťƒyƒvƒ`ƒh‡Źy‘f‚Ě‘I‘đ“Iƒ‰ƒxƒ‹‰ť‹Zp‚ĚŠJ”­‚Ɛv‘Ź‹@”\‰đÍƒVƒXƒeƒ€‚̍\’z. ‘ć58‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď. ĺ‘ä, 9ŒŽ, 2016.
20) ź–{‘אM, “ú”ä–ě˜a_, ˘‰i‰ëO, Š|’JGş, —Ń—Y“ń˜Y. ƒXƒvƒ‰ƒCƒVƒ“ƒO‘jŠQÜRQN-18690A (18-deoxyherboxidiene)‚Ě‘S‡Ź. ‘ć58‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď. ĺ‘ä, 9ŒŽ, 2016.
19) •Ÿ‰ŞŒ[‘ž, Â–؁@–L, •ž•”@–ž, Š|’JGş. ’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘fUSP47‚Ěƒ|ƒŠƒ†ƒrƒLƒ`ƒ“˝Á‰ť‚ÉŠÖ‚í‚镪Žq“ŕ—Ěˆć‚Ě“Ż’č. ‘ć89‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď. ĺ‘ä, 9ŒŽ, 2016.
18) ă—ɉî, Ź—Ń–œ—SŽq, •ž•”@–ž, Š|’JGş. ’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘f‘jŠQ‚É‚ć‚éHIF-1”­ŒťƒŒƒxƒ‹‚̐§Œä. ‘ć89‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď. ĺ‘ä, 9ŒŽ, 2016.
17) Îě•ś—mAŠ}ˆäş‘žAĄ–ě@ăāAŠ|’JGş. ”ńƒŠƒ{ƒ\[ƒ€Ťƒyƒvƒ`ƒh‡Źy‘f‚Ě–Ô—…“I‹@”\‰đÍ‹Zp‚ĚŠJ”­. ‘ć10‰ńƒoƒCƒIŠÖ˜A‰ťŠwƒVƒ“ƒ|ƒWƒEƒ€. Îě, 9ŒŽ, 2016.
16) Š|’JGş. uV‚ľ‚˘R^‹Ű–ňƒV[ƒhŠJ”­‚Ć“K‰žŠg‘ĺí—ށv\R^‹Ű–ňŠJ”­‚Ě‚˝‚ß‚ĚƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†•ű—ށFƒV[ƒh•ŞŽqŠJ”­‚ĆƒƒJƒjƒYƒ€‰đÍ. ‹Zpî•ń‹Ś‰ďƒZƒ~ƒi[. “Œ‹ž, 8ŒŽ, 2016.iľ‘ҍu‰‰j
15) Kakeya, H. Development of new anticancer drugs targeting TGF-ƒŔ and HIF signaling pathway. 2016 BIO International Convention. San Francisco, CA, USA, Jun. 2016.
14) Š|’JGş. ‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Fś‘Ě“ŕ”÷ŹŠÂ‹ŤƒVƒOƒiƒ‹‚̐§Œä. V‹K‘fŢ’TőŒ¤‹†‰ďE‘ć15‰ńƒZƒ~ƒi[. ‰Ą•l, 6ŒŽ, 2016. iľ‘ҍu‰‰j
13) ’‡’J’G, ™ŽR—´‰î, ź‘şTˆę, Š|’JGş. ś‘Ě–Œ‚Ć‘ŠŒÝě—p‚ˇ‚é5aTHQ—Ţ‚Ě\‘˘ŠˆŤ‘ŠŠÖŒ¤‹†‚ĆŒuŒőƒvƒ[ƒuŠJ”­. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ď ‘ć11‰ń”N‰ď. ‹ž“s, 6ŒŽ, 2016.
12) Ź“ˆ‘ˆę, Š|’JGş, ŒĂ’J —T, ‘Šč‰pŽ÷, ź‰Y˜a’m. ŽŸ˘‘㐜–˝Šî”Ő‹Zp‚đ—p‚˘‚˝BŒ^ŠĚ‰Š§ˆł‚Ě‚˝‚߂̑n–ňŒ¤‹†. ‘ć26‰ńRƒEƒBƒ‹ƒX—Ă–@Šw‰ď‘‰ď. ˆ¤’m, 5ŒŽ, 2016.
11) Ź“ˆ‘ˆę, ŒĂ’J —T, Š|’JGş. ƒVƒ“ƒ|ƒWƒEƒ€EBŒ^ŠĚ‰ŠŒ¤‹†‚ĚUp-To-DateFƒCƒ“ƒ^[ƒtƒFƒƒ“—lŠˆŤ‚đŽ‚Â’á•ŞŽq‰ť‡•¨CDM‚É‚ć‚écccDNA—}§ě—p‚̉đÍ. ‘ć52‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď. ç—t, 5ŒŽ, 2016.
10) Š|’JGş. TGF-ƒŔ‚¨‚ć‚Ń’áŽ_‘f‰ž“šƒVƒOƒiƒ‹‚đ•W“I‚Ć‚ľ‚˝V‹K‚Ş‚ńŽĄ—Ă–ň‚ĚŠJ”­Œ¤‹†. ‘ć15‰ń‘ŰƒoƒCƒIƒeƒNƒmƒƒW[“WŽŚ‰ďiBIOtech 2016j. “Œ‹ž, 5ŒŽ, 2016.
9) Kakeya, H. Microbial metabolites-prompted chemical biology: Phenotypic screening and a new platform for target identification. The Fifth Symposium of RIKEN-Max Planck Joint Research Center for System Chemical Biology. Berlin, Germany, Apr. 2016. iľ‘ҍu‰‰j
8) ‚‹´L–ž, —с@G–ž, Š|’JGş. ’áŽ_‘f—U“ąˆöŽqiHIFj‘jŠQŠˆŤ‚đ—L‚ˇ‚éŠÂóƒfƒvƒVƒyƒvƒ`ƒhverucopeptin‚Ě‘S‡ŹŒ¤‹†. “ú–{–ňŠw‰ď‘ć136”N‰ď. ‰Ą•l, 3ŒŽ, 2016.
7) ™ŽR—´‰î, ź‘şTˆę, ”öč‘ž˜Y, ó…r•˝, ”ö’‡GN, Š|’JGş. ‘ĺŠw‰@śƒVƒ“ƒ|ƒWƒEƒ€FŽ‰ŽżŒ‹‡Ť“V‘R•¨‚ĚŠˆ—p\•úü‹Ű•Ą‡”|—{‰t‚ć‚čŒŠo‚ľ‚˝V‹KƒAƒ‹ƒJƒƒCƒhŒQ‚ÉŠÖ‚ˇ‚錤‹†. “ú–{–ňŠw‰ď‘ć136”N‰ď. ‰Ą•l, 3ŒŽ, 2016. iľ‘ҍu‰‰j
6) Cornelio, K., Matsumori, N., Murata, M., Nishimura, S., Kakeya, H., Yoshida, M., Matsunaga, S. Examination of apossible mechanism for the membrane translocation of the marine sponge-derived bioactive metabolite TNM-A. “ú–{‰ťŠw‰ď96t‹G”N‰ďi2016j, ‹ž“s, 3ŒŽ, 2016.
5) ‰ş‘ş“ml, ”öč‘ž˜Y, ™ŽR—´‰î, ź‘şTˆę, ó…r•˝, Š|’JGş, ”ö’‡GN. •Ą‡”|—{“ÁˆŮ“I‚ɐśŽY‚ł‚ę‚éƒeƒgƒ‰ƒqƒhƒƒLƒmƒŠƒ“ś‡Źˆâ“`Žq‚̉đÍ. “ú–{”_Œ|‰ťŠw‰ď2016”N“x‘ĺ‰ď. ŽD–y, 3ŒŽ, 2016.
4) Nishimura, S., Ito, A., Kakeya, H. Strict recognition of membrane lipids by a sea cucumber saponin, holotoxin B. Gordon Research Conference-Marine Natural Products-, Ventra, CA, USA, Mar., 2016.
3) ‹g‘ş@Ę, ź‘şTˆę, ‘ĺ’ˍšD, •ž•”@–ž, Š|’JGş. E’áŽ_‘f—U“ąˆöŽq(HIF)‘jŠQŠˆŤ‚đ—L‚ˇ‚éverucopeptin‚̍\‘˘‰đÍ‚ƍě—p‹@˜‰đÍ, VŠwp—ĚˆćŒ¤‹†u“V‘R•¨ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[F•ŞŽq•W“I‚ĆŠˆŤ§Œäv’n‹ćƒ~ƒjƒVƒ“ƒ|ƒWƒEƒ€i‹ž“sj, ‹ž“s, 2ŒŽ, 2016.
2) Kakeya, H. Academic drug discovery research: Phenotypic screening and target identification. University of Bordeaux-Kyoto University Mini-Symposium on Biomolecular Science. Kyoto, Jan. 2016. iľ‘ҍu‰‰j
1) Nishimura, S., Moriyama, A., Katagiri, N., Takahashi, N., Kakeya, H. In vivo linking of membrane lipids and membrane proteins using amphiphilic lipid probes. The 8th Takeda Science Foundation Symposium on PharmaSciences: Biomolecule-Based Medicinal Science: Featuring Mid-Size Drugs. Osaka, Jan. 2016.

2015

31) Kakeya, H. Natural products-based academic drug discovery. International symposium on natural products chemistry and chemical biology 2015. Hawaii, USA, Dec., 2015. iľ‘ҍu‰‰j
30) Kakeya, H. Natural products-prompted chemical biology; Phenotypic screening and target identification. The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015. iľ‘ҍu‰‰j
29) Lu, S., Nishimura, S., Hirai, G., Ito, M., Kawahara, T., Izumikawa, M., Sodeoka, M., Shin-ya, K., Tsuchida, T., Kakeya, H. Saccharothliolides A-C, novel phenyl-substituted 10-membered macrolides from a rare actinomycete Saccharothrix sp., identified by HPLC-MS profiling of microbial metabolites. The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015.
28) Takahashi, N., Hayashi, H., Kakeya, H. Synthetic study on the antitumor cyclodepcipeptide metabolite, verucopeptin. The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015.
27) Sugiyama, R., Nishimura, S., Ozaki, T., Asamizu, S., Onaka, H., Kakeya, H. 5-Alkyl-1,2,3,4-tetrahydroquinolines (5aTHQs), new membrane-interacting lipophilic metabolites, produced by combined-culture of Streptomyces nigrescens and Tsukamurella pulmonis. The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015.
26) Nishimura, S., Sugiyama, R., Fujita, K., Ito, S., Sakanishi, K., Iwabuchi, Y., Kanoh, N., Matsumori, N., Kakeya, H. Structure and function of heronamides, polyene macrolactams from marine-derived actinomycetes . The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015.
25) Ishikawa, F., Miyamoto, K., Konno, S., Kasai, S., Kakeya, H. Accurate detection and manipulation of adenylation domain functions in nonribosomal peptide synthetases by an enzyme-linked immunosorbent assay system using active site-directed probes for adenylation domains. The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015.
24) Konno, S., Ishikawa, F., Suzuki, T., Dohmae, N., Kakeya, H. Profiling of nonribosomal peptide synthetase activities using active site-directed proteomic probes for adenylation domains. The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015.
23) Nishimura, S., Kakeya, H. Sterol-targeting antibiotics and the balance of membrane trafficking. The International Chemical Congress of Pacific Basin Societies 2015 (PACIFICHEM 2015). Hawaii, USA, Dec., 2015.
22) Yoshimura, A., Nishimura, S., Otsuka, S., Hattori, A., Kakeya, H. Studies on the microbial metabolite verucopeptin, an inhibitor of HIF-signaling pathway. SKO Symposium 2015 (Joint Symposium 2015 of Seuol Univ., Kyoto Univ., and Osaka Univ.), Seoul, Nov., 2015.
21) Š}ˆäş‘ž, Îě•ś—m, Š|’JGş. ”ńƒŠƒ{ƒ\[ƒ€Ťƒyƒvƒ`ƒh‡Źy‘f‚Ě–|–óŒăCü‚đ•W“I‚Ć‚ľ‚˝‰ťŠwƒvƒ[ƒu‚ĚŠJ”­. ‘ć65‰ń“ú–{–ňŠw‰ď‹ß‹EŽx•”‘‰ďE‘ĺ‰ď. 10ŒŽ, ‘ĺă, 2015.
20) Îě•ś—m, Ą–ěăÄ, Š}ˆäş‘ž, —é–ŘŒ’—T, “°‘O’ź, Š|’JGş. ‡ŹŹ•ŞŽq‰ť‡•¨ŒQ‚É‚ć‚éƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚Ě‘I‘đ“I•WŽŻ‰ť‚¨‚ć‚Ńƒvƒƒtƒ@ƒCƒŠƒ“ƒO‚Ö‚Ě“WŠJ. ‘ć9‰ńƒoƒCƒIŠÖ˜A‰ťŠwƒVƒ“ƒ|ƒWƒEƒ€. 9ŒŽ, ŒF–{, 2015.iu‰‰Ü‚đŽóÜj
19) А’źŽ÷, ˆÉ“ŒrĆ, Ž›“ˆ—D‘ž, âźq•˝, ŠâŸşDŽĄ, “Ą“cq•˝, ™ŽR—´‰î, ź‘şTˆę, Š|’JGş. Heronamides A-C ‚Ě‘S‡Ź‚ƍ\‘˘‰ü’ůA‚¨‚ć‚э\‘˘ŠˆŤ‘ŠŠÖ. ‘ć57‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď. ‰Ą•l, 9ŒŽ, 2015.
18) Lu, S., Nishimura, S., Hirai, G., Ito, M., Kawahara, T., Izumikawa, M., Sodeoka, M., Shin-ya, K., Tsuchida, T., Kakeya, H. Studies on Saccharothriolides A-C, Novel Phenyl-substituted 10-Membered Macrolidesfrom a Rare Actinomycete Saccharothrix sp. 57th Symposium on the chemistry of natural products. Yokohama, Sep. 2015.
17) Žl•ű“c—I•ă, “Ą“cq•˝, űPŒËŠG—˘, ź‘şTˆę, •˝‰Ş^а, Œ´“c_, Š|’JGş. IDH3ƒż\HIF-1Œo˜H‚đ§Œä‚ˇ‚鐜•¨ŠˆŤ•¨Žż‚Ě’TőŒ¤‹†. ‘ć26‰ńV–ň‘nť’k˜b‰ď. Ă‰Ş, 9ŒŽ, 2015. (—DG”­•\Üi§—ăÜj‚đŽóÜ)
16) Š|’JGş. ‰ż’l‘n‘˘Œ^‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[, ‘ć7‰ń–ňŠw‚Ě–˘—ˆ‚đl‚Ś‚é‹ž“sƒVƒ“ƒ|ƒWƒEƒ€u–ňEHEˆă˜AŒg‚É‚ć‚鉿’l‘n‘˘Œ^‘n–ňŒ¤‹†‚Ěƒtƒƒ“ƒeƒBƒAv, ‹ž“s, 8ŒŽ, 2015.
15) Š|’JGş. ‹ž“s‘ĺŠwƒI[ƒvƒ“ƒLƒƒƒ“ƒpƒXE–ňŠw•”E–Í‹[Žö‹Ć. ‘n–ňEˆç–ň‚Ö‚Ě’§íFŽŠ‘R‚ÉŠw‚ÔƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†. ‹ž“s, 8ŒŽ, 2015.
14) Š|’JGş. ƒVƒ“ƒ|ƒWƒEƒ€u‘n–ň‚̏Ť—ˆv. ‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[FƒV[ƒh•ŞŽqŠJ”­‚Ć•ŞŽqƒvƒƒtƒ@ƒCƒŠƒ“ƒO. ‘ć63‰ń“ú–{‰ťŠw—Ă–@Šw‰ď‘‰ď. “Œ‹ž, 6ŒŽ, 2015. iľ‘ҍu‰‰j
13) Ą–ěăÄ, Îě•ś—m, —é–ŘŒ’—T, “°‘O ’ź, Š|’JGş. ƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚ɑ΂ˇ‚銈Ť•”ˆĘŽwŒüŒ^ƒvƒ[ƒu‚đ—p‚˘‚˝”ńƒŠƒ{ƒ\[ƒ€Ťƒyƒvƒ`ƒh‡Źy‘fŠˆŤ‚Ěƒvƒƒtƒ@ƒCƒŠƒ“ƒO. ‘ć15‰ń“ú–{’`”’Žż‰ČŠw‰ď”N‰ď, “ż“‡, 6ŒŽ, 2015.
12) Nishimura, S., Sugiyama, R., Fujita, K., Kakeya, H. Abnormal cell wall deposition by heronamides, small molecules targeting phospholipids possessing saturated hydrocarbon chain. Pombe 2105 (8th International Fission Yeast Meeting), Kobe, Japan, June, 2015.
11) Š}ˆäş‘ž, Îě•ś—m, Š|’JGş. ”ńƒŠƒ{ƒ\[ƒ€Ťƒyƒvƒ`ƒh‡Źy‘f‚Ě’S‘Ěƒ^ƒ“ƒpƒNŽż‚đ•W“I‚Ć‚ľ‚˝’ᕪŽqƒvƒ[ƒu‚ĚŠJ”­. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ďE‘ć10‰ń”N‰ď, ĺ‘ä, 6ŒŽ, 2015.
10) Ą–ěăÄ, Îě•ś—m, —é–ŘŒ’—T, “°‘O’ź, Š|’JGş. ƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚ɑ΂ˇ‚銈Ť•”ˆĘŽwŒüŒ^ƒvƒ[ƒu‚đ—˜—p‚ľ‚˝”ńƒŠƒ{ƒ\[ƒ€Ťƒyƒvƒ`ƒh‡Źy‘fŠˆŤ‚Ěƒvƒƒtƒ@ƒCƒŠƒ“ƒO. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ďE‘ć10‰ń”N‰ď, ĺ‘ä, 6ŒŽ, 2015.[—DGƒ|ƒXƒ^[Ü‚đŽóÜ]
9) Š|’JGş. ś‘Ě“ŕ”÷ŹŠÂ‹ŤƒVƒOƒiƒ‹‚đ•W“I‚Ć‚ľ‚˝‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. ‘n–ň–ň—ƒtƒH[ƒ‰ƒ€E‘ć58‰ń’k˜b‰ď. “Œ‹ž, 5ŒŽ, 2015. iľ‘ҍu‰‰j
8) Š|’JGş. ’†’ˇŠúƒe[ƒ}ƒVƒ“ƒ|ƒWƒEƒ€i“ú–{‰ťŠw‰ďEƒCƒuƒjƒ“ƒOƒZƒbƒVƒ‡ƒ“juś‡Źƒ}ƒVƒiƒŠ[‚Ć“V‘R•¨ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[‚Ě—Z‡‚É‚ć‚éV“WŠJv. ć“ą“I“V‘R•¨ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[F•\ŒťŒ^ƒXƒNƒŠ[ƒjƒ“ƒO‚Ć•W“I’TőE“Ż’č. “ú–{‰ťŠw‰ď‘ć95t‹G”N‰ď. ç—t, 3ŒŽ, 2015. iľ‘ҍu‰‰j
7) Kakeya, H. Technologies bridging metabolome and clock -Chemical biology for drug discovery; seed molecules development and target identification-. International Symposium on RNA and Clock: Epigenetic Landscape in Biological Rhythms. Hyogo, Mar. 2015. iľ‘ҍu‰‰j
6) “Ą“cq•˝, ™ŽR—´‰î, ź‘şTˆę, Š|’JGş. Heronamide A‚¨‚ć‚ŃB‚̐śŹ‹@\‚ÉŠÖ‚ˇ‚錤‹†. “ú–{–ňŠw‰ď‘ć135”N‰ďi_ŒËj. _ŒË, 3ŒŽ, 2015.
5) Ą–ěăāAÎě•ś—mA—é–ŘŒ’—TA“°‘O’źAŠ|’JGş. ƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚ɑ΂ˇ‚銈Ť•”ˆĘŽwŒüŒ^ƒvƒ[ƒu‚ĚŠJ”­. “ú–{–ňŠw‰ď‘ć135”N‰ďi_ŒËj. _ŒË, 3ŒŽ, 2015. [—DG”­•\Ü‚đŽóÜ]
4) Š}ˆäş‘ž, Îě•ś—m, Š|’JGş, ”ńƒŠƒ{ƒ\[ƒ€Ťƒyƒvƒ`ƒh‡Źy‘f‚Ě‚Řƒvƒ`ƒWƒ‹’S‘Ěƒ^ƒ“ƒpƒNŽż‚đ•W“I‚Ć‚ľ‚˝ƒvƒ[ƒu‚ĚŠJ”­Œ¤‹†. “ú–{–ňŠw‰ď‘ć135”N‰ďi_ŒËj. _ŒË, 3ŒŽ, 2015.
3) Îě•ś—m, Ą–ěăÄ, Š|’JGş. ŠˆŤ•”ˆĘŽwŒüŒ^ƒvƒ[ƒu‚̓AƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚đ‚‘I‘đ“I‚É•WŽŻ‚ˇ‚é. ‘ć17‰ńś–˝‰ťŠwŒ¤‹†‰ď, ‚’m, 1ŒŽ, 2015.
2) Sugiyama, R., Nishimura, S., Ozaki, T., Onaka, H., Kakeya, H. 5-Alkyl-1,2,3,4-tetrahydroquinolines, membrane-interacting lipophilic metabolites, found in a unique combined culture of Streptomyces sp. and Tsukamurella pulmonis. Natural Products 2015; Natural product discovery & development in the post genomic era [Organized by Society for Industrial Microbiology and Biotechnology (SIMB)], San Diego, CA, USA, Jan. 2015.
1) Kakeya, H., Yoshimura, A., Sugiyama, R., Kishimoto, S., Nishimura, S., Hattori, A., Ishikawa, F., Yomoda, Y., Lu, S., Katagiri, N., Shimada, S., Seto, E., Hayashi, H., Takahashi, N., Harada, H. Chemical Biology for modulators targeting cancer microenvironment and cell membrane signaling. Natural Products 2015; Natural product discovery & development in the post genomic era [Organized by Society for Industrial Microbiology and Biotechnology (SIMB)] , San Diego, CA, USA, Jan. 2015.

2014


32) Š|’JGş. ƒVƒ“ƒ|ƒWƒEƒ€Eƒ‚ƒmƒgƒŠ‚̐V“WŠJF ‘n–ňƒV[ƒYŠJ”­‚đŽwŒü‚ľ‚˝“V‘R•¨ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[ -•\ŒťŒ^ƒXƒNƒŠ[ƒjƒ“ƒO‚Ć•W“I’TőE“Ż’č-. ‘ć20‰ń“V‘R–ň•¨‚ĚŠJ”­‚Ɖž—pƒVƒ“ƒ|ƒWƒEƒ€. “Œ‹ž, 11ŒŽ, 2014.iľ‘ҍu‰‰j
31) Îě•ś—m, Ą–ěăÄ, Š|’JGş. ƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚ɑ΂ˇ‚éƒe[ƒ‰[ƒƒCƒhƒPƒ~ƒJƒ‹ƒ‰ƒxƒŠƒ“ƒO–@‚ĚŠJ”­. ‘ć20‰ń“V‘R–ň•¨‚ĚŠJ”­‚Ɖž—pƒVƒ“ƒ|ƒWƒEƒ€. “Œ‹ž, 11ŒŽ, 2014.
30) Nishimura, S., Sugiyama, R., Matsumori, N., Kakeya, H. Marine natural products targeting cell membrane. 3rd Annual Conference of the International Chemical Biology Society (ICBS2014), San Francisco, CA, USA, Nov. 2014.
29) ŠÝ–{^ŽĄ, ź‘şTˆę, •ž•”–ž, ”g‘˝–ě˜aŽ÷, ŒÜ\—’‰ë”V, Š|’JGş. ƒAƒVƒ‹ƒOƒAƒjƒWƒ“\‘˘‚đ—L‚ˇ‚éV‹KƒVƒfƒƒtƒHƒAchlorocatechelin—ނ̒P—فE\‘˘Œˆ’čA‘S‡ŹA‚¨‚ć‚ѐś•¨ŠˆŤ. ‘ć56‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď. ‚’m, 10ŒŽ, 2014.
28) Ą–ěăÄ, Îě•ś—m, Š|’JGş. ŠˆŤ•”ˆĘŽwŒüŒ^ƒvƒ[ƒu‚đ—p‚˘‚˝ƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚Ě‘I‘đ“I•WŽŻ‰ť. ‘ć8‰ńƒoƒCƒIŠÖ˜A‰ťŠwƒVƒ“ƒ|ƒWƒEƒ€. 9ŒŽ, ‰ŞŽR, 2014.
27) Îě •ś—m, ‹{–{ Œ’Œá, Ą–ě ăÄ, Š}ˆä ş‘ž, Š|’J Gş. i‰ť•ŞŽqHŠw‚đŽwŒü‚ľ‚˝ƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚ɑ΂ˇ‚éELISA–@‚ĚŠJ”­. ‘ć8‰ńƒoƒCƒIŠÖ˜A‰ťŠwƒVƒ“ƒ|ƒWƒEƒ€. 9ŒŽ, ‰ŞŽR, 2014.
26) “ż‘qŤl, ź‘şTˆę, ‰z’qƒŽq, ‹g“c–Ť, Š|’JGş. –Œ—A‘—‚É‚ć‚é×–E–ŒƒXƒeƒ[ƒ‹ƒŠƒbƒ`ƒhƒƒCƒ“‚Ě‹ÇÝ§Œä‹@\‚̉đ–ž. y•ęˆâ“`Šw‘ć47‰ńŒ¤‹†•ń‰ď. “Œ‹ž, 9ŒŽ, 2014.
25) Kakeya, H. Chemical biology for drug discovery and target identification. IUPAC2014 & 248th ACS (American Chemical Society) National Meeting, San Francisco, CA, USA, Aug. 2014. (ľ‘ҍu‰‰)
24) Â–Ř–L, –p‹Ń‰Ô, Ź—Ń–œ—SŽq, •ž•”–ž, Š|’JGş.@’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘fUSP47‚ĚŠˆŤ”­Œť‚É‚¨‚Ż‚éC––’[—Ěˆć‚Ě–đŠ„. ‘ć19‰ń“ú–{•a‘ÔƒvƒƒeƒA[ƒ[Šw‰ďŠwpW‰ď. ‘ĺă, 8ŒŽ, 2014.
23) Š|’JGş. ‹ž“s‘ĺŠwƒI[ƒvƒ“ƒLƒƒƒ“ƒpƒXE–ňŠw•”E–Í‹[Žö‹Ć. ‘n–ňEˆç–ň‚É’§‚ŢƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. ‹ž“s, 8ŒŽ, 2014.
22) XŽR˛”Ž, ź‘şTˆę, Š|’JGş. ś‘Ě–Œ‚đ•W“I‚Ć‚ˇ‚é“V‘R•¨‚̍ě—p‹@˜‰đÍ‚đŽwŒü‚ľ‚˝LiDEL–@‚ĚŠJ”­. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ďE‘ć9‰ń”N‰ď. ‘ĺă, 6ŒŽ, 2014.[—DGƒ|ƒXƒ^[Ü‚đŽóÜ]
21) ”öč‘ž˜Y, ™ŽR—´‰î, ź‘şTˆę, ó…r•˝, Š|’JGş, ”ö’‡GN. •Ą‡”|—{‚đ—˜—p‚ľ‚˝V‹Kƒeƒgƒ‰ƒqƒhƒƒLƒmƒŠƒ“—ނ̒P—قÂť‚̐ś‡Ź‚ÉŠÖ‚ˇ‚錤‹†. 2014”N“xi‘ć29‰ńj“ú–{•úü‹ŰŠw‰ď. ˆďé, 6ŒŽ, 2014.
20) Konno, S., Ishikawa, S., Kakeya, H. Chemical labeling of adenylation domains in nonribosomal peptide synthetase. Gordon Research Conferences: Bioorganic Chemistry-Global Challenges in the 21st Century-. Andover, NH, USA, June, 2014.
19) Ishikawa, F., Konno, S., Kakeya, H Highly selective detection method for nonribosomal peptide synthetase using cocktails of active-site probes for adenylation domains. Gordon Research Conferences: Bioorganic Chemistry-Global Challenges in the 21st Century-. Andover, NH, USA, June, 2014.
18) Š|’JGş. ‘n–ňƒV[ƒYŠJ”­‚đŽwŒü‚ľ‚˝“V‘R•¨ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. “V‘R•¨ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[ -•ŞŽq•W“I‚ĆŠˆŤ§Œä-E‘ć6‰ńŒöŠJƒVƒ“ƒ|ƒWƒEƒ€. ˆ¤’m, 5ŒŽ, 2014.iľ‘ҍu‰‰j
17) ŠÝ–{^ŽĄ, ź‘şTˆę, •ž•”–ž, ”g‘˝–ě˜aŽ÷, ŒÜ\—’‰ë”V, Š|’JGş. V‹KƒVƒfƒƒtƒHƒAchlorocatechelin—ނ̒P—فE\‘˘Œˆ’č‚Ć“SŒ‹‡”\•]‰ż. •ś‰ČČu‰ťŠw—Ă–@Šî”ŐŽx‰‡Šˆ“ށv ‘ć3‰ńƒVƒ“ƒ|ƒWƒEƒ€uƒAƒJƒfƒ~ƒA‚Š‚ç‚̍R‚Ş‚ńÜ‘n–ň‚ÉŒü‚݂āv. ‰Ť“ę, 5ŒŽ, 2014
16) “ˆ“c´, ‹g‘şĘ, ˆŔ“c‡M, ‚‹´L–ž, ź‘şTˆę, •ž•”–ž, Š|’JGş. ‚Ş‚ń•ŞŽq•W“I‘n–ň‚đŽwŒü‚ľ‚˝’áŽ_‘f—U“ąˆöŽq(HIF)‘jŠQÜ‚Ě’TőEŠJ”­Œ¤‹†. •ś‰ČČu‰ťŠw—Ă–@Šî”ŐŽx‰‡Šˆ“ށv ‘ć3‰ńƒVƒ“ƒ|ƒWƒEƒ€uƒAƒJƒfƒ~ƒA‚Š‚ç‚̍R‚Ş‚ńÜ‘n–ň‚ÉŒü‚݂āv. ‰Ť“ę, 5ŒŽ, 2014.
15) Š|’JGş. ƒVƒ“ƒ|ƒWƒEƒ€E“V‘R•¨ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[(2)FƒPƒ€EƒoƒCƒIƒPƒ~ƒXƒgƒŠ[F”÷ś•¨‹@”\‚đŠˆ—p‚ľ‚˝‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†. “ú–{–ňŠw‰ď134”N‰ď. ŒF–{, 3ŒŽ, 2014.iľ‘ҍu‰‰j
14) ŠÝ–{^ŽĄ, ź‘şTˆę, •ž•”–ž, ”g‘˝–ě˜aŽ÷, ŒÜ\—’‰ë”V, Š|’JGş. Streptomyces‘Ž•úü‹Ű‚ć‚čŒŠo‚ľ‚˝‰–‘fŒ´ŽqŠÜ—LV‹KƒVƒfƒƒtƒHƒA‚Ě’P—فE\‘˘Œˆ’č. “ú–{–ňŠw‰ď134”N‰ď. ŒF–{, 3ŒŽ, 2014. [—DG”­•\Ü‚đŽóÜ], [”N‰ď”­•\ƒnƒCƒ‰ƒCƒg‚ÉĚ‘đ]
13) ™ŽR—´‰î, ź‘şTˆę, ”öč‘ž˜Y, ”ö’‡GN, Š|’JGş. ƒeƒgƒ‰ƒqƒhƒƒLƒmƒŠƒ“œŠi‚đ—L‚ˇ‚éV‹K•úü‹Ű‘ăŽÓ•¨‚̍\‘˘‘˝—lŤ‚Ɛś•¨ŠˆŤ. “ú–{–ňŠw‰ď134”N‰ď. ŒF–{, 3ŒŽ, 2014. [—DG”­•\Ü‚đŽóÜ]
12) ‹g‘şĘ, ź‘şTˆę, ‘ĺ’ˎѐD, •ž•”–ž, Š|’JGş. ’áŽ_‘f—U“ąˆöŽq(HIF)ŠˆŤ‰ťŒo˜H‚đ‘jŠQ‚ˇ‚éverucopeptin‚̍ě—p‹@˜‰đÍ. “ú–{–ňŠw‰ď134”N‰ď. ŒF–{, 3ŒŽ, 2014.
11) ˆŔ“c‡M, “ę“c—L”ü, rě•–ž, “ˆ“c´, •ž•”–ž, ź‘şTˆę, ‘ĺÎ^–ç, “ĄˆäMF, Š|’JGş. V‹K’áŽ_‘f—U“ąˆöŽqHIF‘jŠQÜ‚Ě’Tő‚ƍ\‘˘ŠˆŤ‘ŠŠÖŒ¤‹†. “ú–{–ňŠw‰ď134”N‰ď. ŒF–{, 3ŒŽ, 2014.
10) ‚‹´L–ž, Š|’JGş. RŽîᇐŤŠÂóƒfƒvƒVƒyƒvƒ`ƒhverucopeptin‚Ě‘S‡ŹŒ¤‹†. “ú–{–ňŠw‰ď134”N‰ď. ŒF–{, 3ŒŽ, 2014.
9) Ą–ěăÄ, Îě•ś—m, Š|’JGş. Œőe˜aŤƒvƒ[ƒu‚đ—˜—p‚ľ‚˝ƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚ɑ΂ˇ‚郊ƒKƒ“ƒhˆË‘ś“I•WŽŻ‰ť. “ú–{–ňŠw‰ď134”N‰ď. ŒF–{, 3ŒŽ, 2014
8) Žë–ě–ž•F, ź‘şTˆę, ‰Á“Ą•˝, Š|’JGş. Chaetoglobosin D‚ÍROSŽYś‚É‚ć‚č×–E‚ĚƒZƒŠƒ“Ž‘‰ť‚đ‘jŠQ‚ˇ‚é. “ú–{–ňŠw‰ď134”N‰ď. ŒF–{, 3ŒŽ, 2014.
7) Ź—Ń–œ—SŽq, •ž•”–ž, Â–Ř–L, Š|’JGş. ’EUrm1‰ťŠˆŤ‚ĚŒŸo‚¨‚ć‚Ń•ŞŽq“Ż’č. “ú–{–ňŠw‰ď134”N‰ď. ŒF–{, 3ŒŽ, 2014.
6) Â–؁@–L, –p@‹Ń‰Ô, Ź—с@–œ—SŽq, •ž•”@–ž, Š|’J@Gş. ’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘f(USP)47‚Ě•ŞŽq“ŕƒhƒƒCƒ“‚Ě‹@”\‰đÍ. “ú–{–ňŠw‰ď134”N‰ď. ŒF–{, 3ŒŽ, 2014.
5) ‰Ş‘şMŽq, ťě—zˆę, “â‘׎j, •˝–쑁ŠG, •Ŕ–؉ër, “n糗Yˆę, “yˆäC, ‰Ą’níL, ‚‹´Ži, źˆä’l, ŕ_“c—FŽq, ĄňŒú, ‹´–{ł, Š|’JGş, ˜a“cŒ[“š, “‡’ÏÍ, ’ˇ’Jě_“ń, X–{’B–ç. –łěˆ×Š„•tƒNƒƒXƒI[ƒo[2d–ÓŒŸŽŽŒą‚É‚ć‚Á‚ÄTheracurmin‚Í‘ź‚ĚƒNƒ‹ƒNƒ~ƒ“ťÜ‚ć‚č‚ŕ—D‚ę‚˝‹zŽűŒř—Ś‚ĚŒüă‚Ş‚Ý‚ç‚ę‚˝. “ú–{–ňŠw‰ď134”N‰ď. ŒF–{, 3ŒŽ, 2014.
4) Sugiyama, R., Nishimura, S., Matsumori, N., Tsunematsu, Y., Hattori, A., Kakeya, H. Mode of action of heronamides, polyene macrolactams from a marine-derived Streptomyces sp. Gordon Research Conferences: Marine natural products- from discovery to human health-. Ventura, CA, USA, Mar. 2014.
3) Š|’JGş. ‘n–ňEˆç–ň‚É’§‚ŢƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[F–ňŠw‚Ö‚Ě—Ui‚˘‚´‚ȁj‚˘. —Œ–kƒqƒ|ƒNƒ‰ƒeƒX‹äŠy•”, ‹ž“s•{—§—Œ–k‚“™ŠwZ. 3ŒŽ, 2014.iľ‘ҍu‰‰j
2) Yoshimura, A., Nishimura, S., Otsuka, S., Hattori, A. Kakeya, H. Mode of action of vercopeptin, an inhibitor of HIF-signaling pathway isolated from an actinomycete. The 12th International Student Seminar (12th ISS), Kyoto Univeristy. Kyoto, Feb. 2014.
1) Š|’JGş. •˝Ź25”N“x‹ž“s–ň‰Č‘ĺŠw‘ć2‰ń‘n–ň‰ČŠwƒtƒƒ“ƒeƒBƒAƒVƒ“ƒ|ƒWƒEƒ€. ‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[F•\ŒťŒ^ƒXƒNƒŠ[ƒjƒ“ƒO‚Ć•W“I“Ż’č. ‹ž“s, 2ŒŽ, 2014.iľ‘ҍu‰‰j

2013


21) Žë–ě–ž•F, ź‘şTˆę, ‰Á“Ą •˝, Š|’JGş. ƒZƒŠƒ“‘ăŽÓ‚̓AƒNƒ`ƒ“‘jŠQÜ‚Ö‚ĚŠ´ŽóŤ‚đă¸‚ł‚š‚é. ‘ć5‰ńH•i–ňŠwƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 11ŒŽ, 2013.
20) ź‘şTˆę, “ż‘qŤl, ‰z’qƒŽq, ‹g“c–Ť, Š|’JGş. ƒXƒeƒ[ƒ‹ƒŠƒbƒ`×–E–ŒƒhƒƒCƒ“‚ĚŒ`Ź‹@\‚̉đÍ. ‘ć5‰ńH•i–ňŠwƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 11ŒŽ, 2013. [—DG”­•\Ü‚đŽóÜ]
19) ‹{–{Œ’Œá, Îě•ś—m, —с@–L, Š|’JGş. Ž…ó‹ŰNeosartorya‘Ž—R—ˆƒvƒŒƒjƒ‹Šî“]ˆÚy‘f‚ÉŠÖ‚ˇ‚錤‹†. ‘ć5‰ńH•i–ňŠwƒVƒ“ƒ|ƒWƒEƒ€. 11ŒŽ, ‹ž“s, 2013.
18) Š}ˆäş‘ž, Žđˆä—C‹X, Pź—Y‘ž, •ž•”–ž, ź‘şTˆę, Š|’JGş. TGF-ƒŔƒVƒOƒiƒ‹‘jŠQŠˆŤ‚đ—L‚ˇ‚é“V‘R•¨ƒgƒŠƒvƒgƒyƒvƒ`ƒ“A‚Ě•W“I•ŞŽq’TőŒ¤‹†. ‘ć5‰ńH•i–ňŠwƒVƒ“ƒ|ƒWƒEƒ€. ‹ž“s, 11ŒŽ, 2013.@[—DG”­•\Ü‚đŽóÜ]
17) Kakeya, H. Natural Products-Initiated Chemical Biology; Screening, Discovery, and Target Identification. 13th International Conference on the Chemistry and other bioactive compounds (ICCA-13), Yamanashi, Sep. 2013. (Invited Lecture)
16) ™ŽR—´‰î, ź‘şTˆę, źXM–ž, Pź—Y‘ž, •ž•”–ž, ‘ş“c“š—Y, Š|’JGş. ŠC—m—R—ˆ•úü‹Ű‚ސśŽY‚ˇ‚éheronamide—ނ̒P—قÐś•¨ŠˆŤ. ‘ć55‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď. ‹ž“s, 9ŒŽ, 2013.
15) Ą–ěăÄ, Îě•ś—m, Š|’JGş. ƒAƒfƒjƒŒ[ƒVƒ‡ƒ“ƒhƒƒCƒ“‚đ•W“I‚Ć‚ľ‚˝Œőe˜aŤƒvƒ[ƒu‚ĚŠJ”­. ‘ć7‰ńƒoƒCƒIŠÖ˜A‰ťŠwƒVƒ“ƒ|ƒWƒEƒ€.  ˆ¤’m, 9ŒŽ, 2013.
14) ™–{‘׍N, Îě•ś—m, ‹{–{Œ’Œá, ŒI“c‰ëŽj, Ą–ěăÄ, Š|’JGş. Andrimid‚̐ś‡Źy‘f‚Ě‹@”\‰đÍ. ‘ć7‰ńƒoƒCƒIŠÖ˜A‰ťŠwƒVƒ“ƒ|ƒWƒEƒ€. ˆ¤’m, 9ŒŽ, 2013.
13) Nishimura, S., Tokukura, M., Ochi, J., Yoshida, M., Kakeya, H. Sterol-rich membrane domains and the balance of membrane traffic. Pombe 2013 (7th International fission yeast meeting), June, London, UK, 2013.
12) ‹{–{Œ’Œá, Îě•ś—m, —с@–L, Š|’JGş. Ž…ó‹ŰNeosartorya sp. —R—ˆƒvƒŒƒjƒ‹Šî“]ˆÚy‘f‚Ě‹@”\‰đÍ. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ďE‘ć8‰ń”N‰ď. “Œ‹ž, 6ŒŽ, 2013.
11) Îě•ś—m, Š|’JGş. AdenylationƒhƒƒCƒ“‚đ•W“I‚Ć‚ľ‚˝‚e˜aŤƒvƒ[ƒu‚ĚŠJ”­. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ďE‘ć8‰ń”N‰ď. “Œ‹ž, 6ŒŽ, 2013.
10) Îě•ś—m, Š|’JGş. LC-MS/MS‚đ—p‚˘‚˝’ᕪŽqƒvƒ[ƒu‚ɑ΂ˇ‚é•W“Iƒ^ƒ“ƒpƒNŽż‚Ě“Ż’č. ‘ć13‰ń“ú–{’`”’Žż‰ČŠw‰ď. ’šŽć, 6ŒŽ, 2013.
9) ˆÉ“Ąş”Ž, Š|’JGş, ‹g“c–Ť. ’ESUMO‰ťy‘fSENP1‘jŠQÜ‚Ě’Tő. ‘ć17‰ń“ú–{‚Ş‚ń•ŞŽq•W“IŽĄ—ĂŠw‰ďEŠwpW‰ď. ‹ž“s, 6ŒŽ, 2013.
8) ‹g‘ş@Ę, ź‘şTˆę, •ž•”–ž, Š|’JGş. ’áŽ_‘f—U“ąˆöŽq(HIF)ŠˆŤ‰ťŒo˜H‚đ‘jŠQ‚ˇ‚é•úü‹Ű—R—ˆverucopeptin‚̐â‘Η§‘Ě”z’u‚ĚŒˆ’č. ‘ć17‰ń“ú–{‚Ş‚ń•ŞŽq•W“IŽĄ—ĂŠw‰ďEŠwpW‰ď. ‹ž“s, 6ŒŽ, 2013.
7) Žë–ě–ž•F, ź‘şTˆę, Š|’JGş. ƒAƒ~ƒmŽ_‘ăŽÓ‚đ•Ď’˛‚ˇ‚é“V‘R‰ť‡•¨‚Ě’TőŒ¤‹†. ‘ć17‰ń“ú–{‚Ş‚ń•ŞŽq•W“IŽĄ—ĂŠw‰ďEŠwpW‰ď. ‹ž“s, 6ŒŽ, 2013.
6) ‹{–{Œ’Œá, Îě•ś—m, —с@–L, Š|’JGş. •ŞŽq‹@”\•ĎŠˇ‚đŽwŒü‚ľ‚˝Ž…ó‹ŰNeosartorya sp. —R—ˆƒvƒŒƒjƒ‹Šî“]ˆÚy‘f‚Ě‹@”\‰đÍ. “ú–{–ňŠw‰ď‘ć133”N‰ď. _“ސě, 3ŒŽ, 2013.
5) Îě•ś—m, Š|’JGş. —L—pś‡Źy‘f‚Ě“Ż’čE‹@”\‰đÍ‚đŽwŒü‚ľ‚˝‰ťŠwƒc[ƒ‹‚ĚŠJ”­\AdenylationƒhƒƒCƒ“‚đ•W“I‚Ć‚ľ‚˝‚e˜aŤƒvƒ[ƒu‚ĚŠJ”­\. “ú–{–ňŠw‰ď‘ć133”N‰ď. _“ސě, 3ŒŽ, 2013.
4) ™ŽR—´‰î, ź‘şTˆę, Pź—Y‘ž, •ž•”–ž, Š|’JGş. V‹Kƒ|ƒŠƒGƒ“ƒ}ƒNƒƒ‰ƒNƒ^ƒ€–‚Ě’P—فE\‘˘Œˆ’č‚Ć‚ť‚̐ś•¨ŠˆŤ. “ú–{–ňŠw‰ď‘ć133”N‰ď. _“ސě, 3ŒŽ, 2013.
3) ‹g‘ş@Ę, ź‘şTˆę, ŠÝ–{^ŽĄ, •ž•”–ž, Š|’JGş. 1,3-dimethyl˝ó\‘˘‚Ě—§‘Ě”z’uŒˆ’č–@‚ĚŒŸŘFtumescenamide C‚Ćverucopeptin‚đ—á‚É. “ú–{–ňŠw‰ď‘ć133”N‰ď. _“ސě, 3ŒŽ, 2013.
2) –p‹Ń‰Ô, •ž•”–ž, Â–Ř–L, Ź—Ń–œ—SŽq, X‹g‰pŽq, Š|’JGş. ’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘f(USP)47‚ĚŠˆŤ”­Œť‹@\‚̉đÍ. “ú–{–ňŠw‰ď‘ć133”N‰ď. _“ސě, 3ŒŽ, 2013.
1) X–{’B–ç, ťě—zˆę, “â‘׎j, •˝–쑁ŠG, •Ŕ–؉ër, “n糗Yˆę, “yˆäC, —é–ؐ´”ü, ŽR“ŕ‚݂䂍, ‰Ą’níL, ‘ĺ’ËŠě•F, ŕ_“c—FŽq, ĄňŒú, –ě’†—SŽi, •s”j‹Ş, Ž›–{‹M‘Ľ, Š|’JGş, ˜a“cŒ[“š, ’ˇ’Jě_“ń. 4ťÜ–łěˆ×Š„•tƒNƒƒXƒI[ƒo[2d–ÓŒŸŽŽŒą‚É‚ć‚čAƒZƒ‰ƒNƒ‹ƒ~ƒ“”z‡ˆů—ż‚̍‚‚˘‹zŽűŒř—Ś‚ŞŽŔŘ‚ł‚ę‚˝. “ú–{–ňŠw‰ď‘ć133”N‰ď. _“ސě, 3ŒŽ, 2013.

2012


20) –p‹Ń‰Ô, •ž•”–ž, Â–Ř–L, Ź—Ń–œ—SŽq, X‹g‰pŽq, Š|’JGş. ’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘f(USP)47‚ĚŠˆŤ”­Œť‚É‚¨‚Ż‚é•ŞŽq“ŕƒ†ƒrƒLƒ`ƒ“—lƒhƒƒCƒ“‚Ě–đŠ„. ‘ć85‰ń“ú–{ś‰ťŠw‰ď. 12ŒŽ, •Ÿ‰Ş, 2012.
19) •ž•”–ž, źě–˘—ˆŽq, –p‹Ń‰Ô, Ź—Ń–œ—SŽq, X‹g‰pŽq, Š|’JGş. ’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘fUCH-L3‚ÍŽ_‰ťƒXƒgƒŒƒX‚Ě•W“Iƒ^ƒ“ƒpƒNŽż‚Ĺ‚ ‚é. ‘ć85‰ń“ú–{ś‰ťŠw‰ď. 12ŒŽ, •Ÿ‰Ş, 2012.
18) Š|’JGş. ľ‘ҍu‰‰F“V‘R•¨‰ťŠw‚đŠî”Ő‚Ć‚ľ‚˝‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[. ŽáŽčŒ¤‹†ŽŇ‚Ě‚˝‚߂̗L‹@‰ťŠwŽD–yƒZƒ~ƒi[. 11ŒŽ, –kŠC“š, 2012.
17) Žđˆä—C‹X, ź‘şTˆę, •ž•”–ž, ‘ž“c‘ń–¤, “y‹‰ë•v, ‰Ş‘ş‹Ď, Š|’JGş. 3ƒŔ-Hydroxysteroid dehydrogenase (3ƒŔ-HSD) ‘jŠQÜ‚ĚŠJ”­Œ¤‹†. ‘ć30‰ńƒƒfƒBƒVƒiƒ‹ƒPƒ~ƒXƒgƒŠ[ƒVƒ“ƒ|ƒWƒEƒ€. 11ŒŽ, “Œ‹ž, 2012.
16) Kanou, A., Nishimura, S., Kakeya, H. Chemical genetics for dissecting the crosstalk between cell metabolism and cell morphology. The 1st International Symposium on Chemical Biology of Natural Products: Target ID and Regulation of Bioactivity. Kyoto, Oct., 2012.
15) ‹g‘şĘ, ‘ĺ’ˎѐD, ź‘şTˆę, •ž•”–ž, Š|’JGş. ’áŽ_‘f—U“ąˆöŽq(HIF)ŠˆŤ‰ťŒo˜H‚đ‘jŠQ‚ˇ‚éverucopeptin‚ÉŠÖ‚ˇ‚錤‹†. ‘ć19‰ń“V‘R–ň•¨‚ĚŠJ”­‚Ɖž—pƒVƒ“ƒ|ƒWƒEƒ€. 10ŒŽ, ‘ĺă, 2012.
14) ’JŒű–ƒ—˘Ž}, Žđˆä—C‹X, ź‘şTˆę, •ž•”–ž, Š|’JGş. GBF1‘jŠQŠˆŤ‚đ—L‚ˇ‚égolgicide A ‚̍\‘˘ŠˆŤ‘ŠŠÖŒ¤‹†. ‘ć62‰ń“ú–{–ňŠw‰ď‹ß‹EŽx•”‘‰ďE‘ĺ‰ď, 10ŒŽ, •şŒÉ, 2012.[—DGƒ|ƒXƒ^[”­•\Ü‚đŽóÜ]
13) ‹g‘şĘ, ‘ĺ’ˎѐD, ź‘şTˆę, •ž•”–ž, ’ˇ“c—T”V, Š|’JGş. ’áŽ_‘f—U“ąˆöŽq(HIF)ŠˆŤ‰ťŒo˜H‚đ‘jŠQ‚ˇ‚éverucopeptin‚̉ťŠw“I‰đÍŒ¤‹†. ‘ć54‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď. 10ŒŽ, “Œ‹ž, 2012.
12) ŒÓ‹Ĺœ—, •ž•”–ž, Š|’JGş. ’áŽ_‘f—U“ąˆöŽq(HIF)‘jŠQÜ’Tő‚Ě‚˝‚ß‚ĚƒnƒCƒRƒ“ƒeƒ“ƒcEƒXƒNƒŠ[ƒjƒ“ƒOŒn‚̍\’z. ‘ć16‰ń“ú–{‚Ş‚ń•ŞŽq•W“IŽĄ—ĂŠw‰ďEŠwpW‰ď. •Ÿ‰Ş, 6ŒŽ, 2012.
11) ™ŽR—´‰î, ź‘şTˆę, X—[ŠóŽq, ”ö’‡GN, Š|’JGş. •úü‹Ű‚Ě•Ą‡”|—{‚É‚ć‚Á‚Ä“ž‚ç‚ę‚éV‹Kƒeƒgƒ‰ƒqƒhƒƒLƒmƒŠƒ“—U“ą‘̂Ɋւˇ‚錤‹†. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ď ‘ć7‰ń”N‰ď. 6ŒŽ, ‹ž“s, 2012.
10) •ž•”–ž, źě–˘—ˆŽq, –p‹Ń‰Ô, Ź—Ń–œ—SŽq, X‹g‰pŽq, Š|’JGş. Activity-based Profilling‚É‚ć‚éŽ_‰ťƒXƒgƒŒƒXŠ´ŽóŤ’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘f‚Ě“Ż’č. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ď ‘ć7‰ń”N‰ď. 6ŒŽ, ‹ž“s, 2012.
9) Hu, X.-T., Hattori, A., Tokiwa, R., Kakeya, H. A high content screening system to develop novel HIF-1 inhibitors disrupting its heterodimeric formation. Organization for Oncology and Translational Research (OOTR) 8th Annual Meeting, Kyoto, Japan, Apr. 2012.[—DGƒ|ƒXƒ^[”­•\Ü‚đŽóÜ]
8) Piao, J.-H., Tashiro, A., Nishikawa, M., Moriyoshi, E., Hattori, A., Kakeya, H. Enzymatic properties of recombinant human ubiquitin specific protease 47. Organization for Oncology and Translational Research (OOTR) 8th Annual Meeting, Kyoto, Japan, Apr. 2012.
7) Š}ˆäş‘ž, Žđˆä—C‹X, Pź—Y‘ž, •ž•”–ž, ‘ĺÎ^–ç, “ĄˆäMF, ź‘şTˆę, Š|’JGş. V‹KTGF-ƒŔƒVƒOƒiƒ‹“`’B‘jŠQÜtryptopeptin A‚¨‚ć‚Ń•ŞŽqƒvƒ[ƒu‚̍‡ŹŒ¤‹†. “ú–{–ňŠw‰ď‘ć132”N‰ď. ŽD–y, 3ŒŽ, 2012.
6) ™ŽR—´‰î, ź‘şTˆę, X—[ŠóŽq, ”ö’‡GN, Š|’JGş. •úü‹Ű‚ސśŽY‚ˇ‚éV‹Kƒeƒgƒ‰ƒqƒhƒƒLƒmƒŠƒ“—U“ą‘̂̒P—فE\‘˘‰đÍ. “ú–{–ňŠw‰ď‘ć132”N‰ď. ŽD–y, 3ŒŽ, 2012.
5) ŒÓ‹Ĺœ—, •ž•”–ž, í”Ő—ç, Š|’JGş. “ń•ŞŽqŒuŒő‘Š•âƒVƒXƒeƒ€‚đ—˜—p‚ľ‚˝’áŽ_‘f—U“ąˆöŽq(HIF)‘jŠQÜŠˆŤ•]‰żŒn‚̍\’z. “ú–{–ňŠw‰ď‘ć132”N‰ď. ŽD–y, 3ŒŽ, 2012.
4) źě–˘—ˆŽq, Ź—Ń–œ—SŽq, –p‹Ń‰Ô, X‹g‰pŽq, •ž•”–ž, Š|’JGş. ’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘fUCH-L3‚ÍŽ_‰ťƒXƒgƒŒƒX‰ş‚Ĺ•sŠˆŤ‰ť‚ł‚ę‚é. “ú–{–ňŠw‰ď‘ć132”N‰ď. ŽD–y, 3ŒŽ, 2012.
3) –p‹Ń‰Ô, “c‘ăˆŸˆß, źě–˘—ˆŽq, X‹g‰pŽq, •ž•”–ž, Š|’JGş. ƒqƒgUSP47‚Ě’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘fŠˆŤ‚̉đÍ. “ú–{–ňŠw‰ď‘ć132”N‰ď. ŽD–y, 3ŒŽ, 2012
2) ź‘şTˆę, Š|’JGş. ƒVƒ“ƒ|ƒWƒEƒ€u“V‘R•¨‰ťŠw‚̐V‚ľ‚˘’Ş—ŹvFś‘Ě–Œ‚đ‰đÍ‚ˇ‚鉝Šwˆâ“`Šw. “ú–{–ňŠw‰ď‘ć132”N‰ď. ŽD–y, 3ŒŽ, 2012. iľ‘ҍu‰‰j
1) Š|’JGş. ƒVƒ“ƒ|ƒWƒEƒ€uH•i‹@”\Šw‚Ć–ň—ŠwFÚ“_‚Ć‘Šˆá“_‚Š‚çŠw‚ÔŽŸ‚ĚƒAƒvƒ[ƒ`Fh‚ŕ‚̂ƂčhEh‚ŕ‚̂­‚čh‚đŠî”Ő‚Ć‚ľ‚˝ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†. “ú–{”_Œ|‰ťŠw‰ď2011”N“x‘ĺ‰ď. ‹ž“s, 3ŒŽ, 2012. iľ‘ҍu‰‰j

2011


15) Š|’JGş. ‘n–ňƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[FŽŠ‘R‚ÉŠw‚ԁh–ňh‚Ă‚­‚č. ‰ČŠwE‹ZpƒtƒFƒXƒ^ in ‹ž“s. ‹ž“s, 12ŒŽ, 2011.
14) Morimoto, T., Wada, H., Sunagawa, Y., Fujita, M., Kakeya, H., Sasaki, H., Imaizumi, A., Hashimoto, T., Akao, M., Osakada, G., Kambara, H., Doi, O., Shiomi, H., Kimura, T., Shimatsu, A., Hasegawa, K., Effects of highly absorptive curcumin on systolic and diastolic function in hypertensive patients with left ventricular hypertrophy. Heart failure: Pharmacologic Therapy in Advanced Preclinical and Clinical Trials. American Association Scientific Sessions 2011. Orland, FL, USA, Nov. 2011.
13) Hattori, A., Tashiro, A., Piao, J.-H., Moriyoshi, E., Kakeya, H. Characterization of enzymatic properties of recombinant human specific protease 47. 7th General Meeting of the International Proteolysis Society. San Diedo, CA, USA, Oct. 2011.
12) ŠÝ–{^ŽĄ, Pź—Y‘ž, ź‘şTˆę, •ž•”–ž, Š|’JGş. •úü‹Ű‚ŞŽYś‚ˇ‚éV‹KŠÂóƒŠƒ|ƒfƒvƒVƒyƒvƒ`ƒhpentadepsin A‚ÉŠÖ‚ˇ‚錤‹†. ‘ć53‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď. ‘ĺă. 9ŒŽ, 2011.
11) Espiritu, R.A., Matsumori, N., Murata, M., Nishimura, S., Kakeya, H., Matsunaga, S., Yoshida, M. Interaction of the marine sponge cyclic peptide theonellamide A with lipid bilayers investigated by membrane-permeabilizing activities and solid state 2H NMR. 14th Asian Chemical Congress 2011. Bangkok, Thailand, Sep. 2011.
10) ‰z’qƒŽq, ź‘şTˆę, Š|’JGş. •Ş—ôy•ę‚É‚¨‚Ż‚é×–E–ŒƒXƒeƒ[ƒ‹‚Ě‹ÇÝ§Œä‚̉đÍ. y•ęˆâ“`ŠwƒtƒH[ƒ‰ƒ€E‘ć44‰ńŒ¤‹†•ń‰ď. •Ÿ‰Ş, 9ŒŽ, 2011.
9) ‘ĺ–ě—TŽi, •ž•”–ž, ă“cł“š, ‰eŽRi, ‹g‹M’Bа, Š|’JGş. ƒqƒgC7orf24‚Ěˆâ“`Žq”­Œť‚́A“]ŽĘŠJŽn“_‹ß–T‚Ě3ƒ–Š‚ĚCCAAT”z—ń‚ɐ§Œä‚ł‚ę‚é. ‘ć84‰ń“ú–{ś‰ťŠw‰ď. ‹ž“s, 9ŒŽ, 2011.
8) •ž•”–ž, –p‹Ń‰Ô, “c‘ăˆŸˆß, X‹g‰pŽq, Š|’JGş. ƒOƒ‰ƒ“ƒUƒCƒ€B‚đƒŒƒ|[ƒ^[‚É—p‚˘‚˝’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘fŠˆŤ‘Ş’č–@‚̍\’z. ‘ć84‰ń“ú–{ś‰ťŠw‰ď. ‹ž“s, 9ŒŽ, 2011.
7) ‰i–{—CŽ÷, •ž•”–ž, Š|’JGş, ’|–{‰ŔŽi, ‚{´˝, ŠÜ…đŒ‚Ĺ‚Ě˜A‘ą”˝‰ž‚đ—˜—p‚ľ‚˝pHˆË‘śŤV‹KDNAƒAƒ‹ƒLƒ‹‰ťÜ‚ĚÝŒv. ‘ć9‰ńŽŸ˘‘ă‚đ’S‚¤—L‹@‰ťŠwƒVƒ“ƒ|ƒWƒEƒ€. “Œ‹ž, 5ŒŽ, 2011.
6) ŠÝ–{^ŽĄ, Pź—Y‘ž, ź‘şTˆę, •ž•”–ž, Š|’JGş. ”÷ś•¨ƒƒ^ƒ{ƒ[ƒ€‰đÍ‚É‚ć‚čŒŠo‚ľ‚˝V‹KŠÂóƒŠƒ|ƒfƒvƒVƒyƒvƒ`ƒh. “ú–{–ňŠw‰ď‘ć131”N‰ď. Ă‰Ş, 3ŒŽ, 2011.
5) ’†“‡˝, •ž•”–ž, Pź—Y‘ž, ź‘şTˆę, ŻŽi–ž, —Ń—Y“ń˜Y, ’ˇ“c—T”V, Š|’JGş. ŒŒŠÇVś‘jŠQÜazaspirene‚̍ě—p‹@˜‰đÍ‚Ć•W“Iƒ^ƒ“ƒpƒNŽż’Tő. “ú–{–ňŠw‰ď‘ć131”N‰ď. Ă‰Ş, 3ŒŽ, 2011.
4) •ž•”–ž, “c‘ăˆŸˆß, X‹g‰pŽq, –p‹Ń‰Ô, Š|’JGş. ’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘fŠˆŤ‚̐V‚ľ‚˘‘Ş’č–@‚ĚŠm—§. “ú–{–ňŠw‰ď‘ć131”N‰ď. Ă‰Ş, 3ŒŽ, 2011.
3) Pź—Y‘ž, •ž•”–ž, ‘ĺÎ^–ç, “ĄˆäMF, ź‘şTˆę, Š|’JGş. •úü‹Ű‚̐śŽY‚ˇ‚éV‹KR‚Ş‚ńÜƒŠ[ƒh‰ť‡•¨tryptopeptin‚̉ťŠw\‘˘Œˆ’č. “ú–{–ňŠw‰ď‘ć131”N‰ď. Ă‰Ş, 3ŒŽ, 2011.
2) Š|’JGş. “Á•ĘƒVƒ“ƒ|ƒWƒEƒ€“V‘R•¨‰ťŠw‚ĆƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[uV‹Kś•¨ŠˆŤ“V‘R—L‹@•ŞŽq‚ĚŠJ‘ń‚ĆƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†v. “ú–{–ňŠw‰ď‘ć131”N‰ď. Ă‰Ş, 3ŒŽ, 2011.iľ‘ҍu‰‰j
1) Š|’JGş. ’áŽ_‘f—U“ąˆöŽq(HIF)‚Ě‹@”\§Œä•¨Žż‚Ě’TőE•]‰ż. ‚Ş‚ńŽx‰‡Šˆ“ށu‰ťŠw—Ă–@Šî”ŐŽx‰‡Šˆ“ށv-ƒAƒJƒfƒ~ƒA‚Š‚ç‚̍R‚Ş‚ńÜ‘n–ň‚ÖŒü‚Ż‚Ä-. ‹ž“s, 3ŒŽ, 2011.

2010


12) Tsunematsu, Y., Oishi, S., Fujii, N., Nishimura, S., Hattori, A., Kakeya, H. Tryptopeptin A, a novel TGF-beta signaling inhibitor from Streptomyces sp. International Chemical Congress of Pacific Basin Societies 2010 (PACIFICHEM 2010). Hawaii, USA, Dec., 2010.
11) Nishimura, S., Matsunaga, S., Kakeya, H., Yoshida, M. Mode of action of theonellamides, antifungal bicyclic peptides from a marine sponge. International Chemical Congress of Pacific Basin Societies 2010 (PACIFICHEM 2010). Hawaii, USA, Dec., 2010.
10) “c‘ăˆŸˆß, •ž•”–ž, –p‹Ń‰Ô, ŽR“cˆ¤, ‘ĺÎ^–ç, “ĄˆäMF, Š|’JGş. ƒqƒg’Eƒ†ƒrƒLƒ`ƒ“‰ťy‘fUSP47‚̍y‘fŠw“IŤó‰đÍ. 83‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ďE‘ć33‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ď‡“Ż‘ĺ‰ď: Biochemistry and Molecular Biology 2010 (BMB2010). 12ŒŽ, _ŒË, 2010.
9) ‘ĺ–ě—TŽi, •ž•”–ž, ă“cł“š, ‰eŽRi, ‹g‹M’Bа, Š|’JGş. C7orf24/GGCT‚Ě“]ŽĘ‚ÍNF-Y‚É‚ć‚čŠˆŤ‰ť‚ł‚ę‚é. ‘ć83‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ďE‘ć33‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ď‡“Ż‘ĺ‰ď: Biochemistry and Molecular Biology 2010 (BMB2010). 12ŒŽ, _ŒË, 2010.
8) ź‘şTˆę, ‰z’qƒŽq, —L“c—SŽq, źŽRW‹v, ź‰i–ÎŽ÷, ‹g“c–Ť, Š|’JGş. ŠCŽYR^‹Ű•¨Žżtheonellamide‚̍ě—p‹@˜‰đ–ž. ‘ć60‰ń“ú–{–ňŠw‰ď‹ß‹EŽx•”‘‰ďE‘ĺ‰ď. 10ŒŽ, ‘ĺă, 2010.
7) Pź—Y‘ž, ‘ĺÎ^–ç, “ĄˆäMF, ź‘şTˆę, •ž•”–ž, Š|’JGş. •úü‹Ű‚ސśŽY‚ˇ‚éV‹KTGF-ƒŔƒVƒOƒiƒ‹“`’B‘jŠQÜ‚Ě’P—فE\‘˘‰đÍ‚ƍ‡Ź. ‘ć‚T‚Q‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď. 9ŒŽ, Ă‰Ş, 2010. [§—ăÜ‚đŽóÜ]
6) —с@–L, ’†‘ş‘ń˜N, ‘哇Œ’Žu˜N, •ž•”ł•˝, ’ˇ“c—T”V, Š|’JGş. V‹KŒŒŠÇVś‘jŠQ•¨Žż‚̐ś‡Źˆâ“`ŽqŒQ‚ĚƒNƒ[ƒjƒ“ƒO. 2010”N“xi‘ć25‰ńj“ú–{•úü‹ŰŠw‰ď‘ĺ‰ď. 9ŒŽ, “Œ‹ž, 2010.
5) ‘ĺ’΂ł‚‚Ť, ‚{N–ž, ‚”¨‚Đ‚łŽ}, ´…Žj˜Y, ’ˇ“c—T”V, •ž•”–ž, Š|’JGş. V‹K’áŽ_‘f—U“ąˆöŽq(HIF)‘jŠQÜ‚Ě‘nťŒ¤‹†. ‘ć1‚S‰ń“ú–{‚Ş‚ń•ŞŽq•W“IŽĄ—ĂŠw‰ďEŠwpW‰ď. 7ŒŽ, “Œ‹ž, 2010.
4) ‚{N–ž, ‚”¨‚Đ‚łŽ}, •ž•”–ž, Š|’JGş. V‹Kscaffold‚đ—L‚ˇ‚éTGF-ƒŔƒVƒOƒiƒ‹“`’BŽŐ’f–ň‚Ě‘nťŒ¤‹†. ‘ć1‚S‰ń“ú–{‚Ş‚ń•ŞŽq•W“IŽĄ—ĂŠw‰ďEŠwpW‰ď. 7ŒŽ, “Œ‹ž, 2010.
3) ź‘şTˆę, ‰z’qƒŽq, —L“c—SŽq, źŽRW‹v, ź‰i–ÎŽ÷, ‹g“c–Ť, Š|’JGş. ƒXƒeƒ[ƒ‹‚đ•W“I‚Ć‚ˇ‚étheonellamide‚̍ě—p‹@˜‰đÍ. “ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Šw‰ď ‘ć5‰ń”N‰ď. 5ŒŽ, _“ސě, 2010.
2) Ohno, Y., Hattori, A., Ueda, M., Kageyama, S., Yoshiki, T., Kakeya, H. Involvement of NF-Y in transcriptional regulation if the human C7orf24/GGCT gene. Organisation for Oncology and Translational Research (OOTR) 6th Annual Conference. Kyoto, Japan, Feb., 2010. [—DGƒ|ƒXƒ^[”­•\Ü‚đŽóÜ]
1) ‚{N–ž, •ž•”–ž, Š|’JGş.@V‹KŠĚŽžŠłŽĄ—Ă–ň‚ĚŠJ”­Œ¤‹†FhHit to Probeh‚̐헪‚ĆŽŔŘ. uTGF-ƒŔŠˆŤ‰ť”˝‰ž‚đ•W“I‚Ć‚ľ‚˝ŠĚŽžŠł‚̐V‹Kf’f–@, ŽĄ—ÁE—\–h–@‚ĚŠJ”­vŒ¤‹†”ǃVƒ“ƒ|ƒWƒEƒ€. 2ŒŽ, ‘ĺă, 2010.

2009


7) ‰Á“Ą’źŽ÷, ‚–ŘŠC, Š|’JGş, ’ˇ“c—T”V. Aspergillus fumigatus‚É‚¨‚Ż‚épseurotinś‡Źˆâ“`ŽqƒNƒ‰ƒXƒ^[‚̉đÍ. ‘ć9‰ńŽ…ó‹Ű•ŞŽqś•¨ŠwƒRƒ“ƒtƒ@ƒŒƒ“ƒX. “Œ‹ž, 11ŒŽ, 2009.
6) Nishimura, S., Matsuyama, A.., Yoshida, M., Matsunaga, S., Kakeya, H. Regulation of sterol localization revealed by chemical genetics using theonellamide. The 5th International Fission Meeting. Tokyo, Oct. 2009.
5) Š|’JGş. ƒVƒ“ƒ|ƒWƒEƒ€uƒQƒmƒ€–ň—Šw‚Ć‘n–ňvFƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†‚đŠî”Ő‚Ć‚ľ‚˝ƒAƒJƒfƒ~ƒA‚É‚¨‚Ż‚é‘n–ňŒ¤‹†. ‘ć68‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď. ‰Ą•l, 10ŒŽ, 2009iľ‘ҍu‰‰j.
4) ź‘şTˆę, źŽRW‹v, ź‰i–ÎŽ÷, Š|’JGş, ‹g“c–Ť. ƒXƒeƒ[ƒ‹‚đ•W“I‚Ć‚ˇ‚étheonellamide—Ţ‚Ş—U“ą‚ˇ‚镪—ôy•ę‚ĚŒ`‘ÔˆŮí. y•ęˆâ“`ŠwƒtƒH[ƒ‰ƒ€‘ć42‰ńŒ¤‹†•ń‰ď. ’}”g, 7ŒŽ, 2009.
3) ‘ĺ–ě—TŽi, •ž•”–ž, Š|’JGş. V‹KŠŕŠÖ˜AˆöŽqƒqƒgC7orf24‚Ě“]ŽĘ§Œä‹@\‚̉đÍ. ‘ć13‰ń“ú–{Šŕ•ŞŽq•W“IŽĄ—ĂŠw‰ď. “ż“‡, 6ŒŽ, 2009.
2) •ž•”–ž, Pź—Y‘ž, ‘ĺ’ˎѐD, ‚{N–ž, ź‘şTˆę, –î‘q“O, ‘ĺÎ^–ç, “ĄˆäMF, ´…Žj˜Y, ’ˇ“c—T”V, Š|’JGş. HIF-1‹@”\§Œä‰ť‡•¨‚Ě•]‰żŒn\’z‚Ć’TőŒ¤‹†. “ú–{–ňŠw‰ď‘ć129”N‰ď. ‹ž“s, 3ŒŽ, 2009.
1) Kakeya, H. Natural products-initiated chemical biology. Organic Chemistry Seminar in University of Louis Pasteur. Strasbourg, France, Apr. 2009 (Invited Lecture).

2008


5) Š|’JGş. ”÷ś•¨Ž‘Œš‚đŠî”Ő‚Ć‚ľ‚˝ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†. ‘ć17‰ń“V‘R–ň•¨‚ĚŠJ”­‚Ɖž—pƒVƒ“ƒ|ƒWƒEƒ€. ƒVƒ“ƒ|ƒWƒEƒ€1\u”÷ś•¨öÝ”\—Í‚ĚÄ”FŽŻ-‘n–ň‚ĆŠî‘bŒ¤‹†‚ւ̉ž—pv. ”Ž‘˝, 11ŒŽ, 2008.iľ‘ҍu‰‰j
4) –î‘q“OAŠ|’JGşAˆÉ“Ą”üç•äA–{‘˝‹`ş. ’ž‚̍‹CŹ•ސśŹ‚ÉŠÖ—^‚ˇ‚éƒeƒ‹ƒyƒ“‡Źy‘fˆâ“`Žq‚̉đÍŒ¤‹†. ‘ć55‰ń“ú–{ś–ňŠw‰ď”N‰ď. ’ˇč, 9ŒŽ, 2008.
3) —Ń—Y“ń˜YAŻŽi–žAÎě—ElAŽRŒűˆę˜YA“c‘ş—F—TAĄˆä_‹MAźƒ–’J—m•ăA‚•”ŒŤˆęAŠ|’JGşA’ˇ“c—T”V. ƒAƒ“ƒTƒ}ƒCƒVƒ“ŒnRŽîᇓV‘R•¨AƒTƒCƒgƒgƒŠƒGƒjƒ“A‚Ě‘S‡Ź. ‘ć50‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď. ”Ž‘˝, 9ŒŽ, 2008.
2) Š|’JGş. "‚ŕ‚̂Ƃč"‚đŠî”Ő‚Ć‚ľ‚˝ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†. ‘ć128‰ń“ú–{–ňŠw‰ďƒVƒ“ƒ|ƒWƒEƒ€ “V‘R•¨ƒpƒ[Fw‚ŕ‚̂ƂčC‡ŹC‹@”\‰đ–žx`‘ĺŠw”­“V‘R•¨–ňŠwŒ¤‹†`. ‰Ą•l, 3ŒŽ, 2008.iľ‘ҍu‰‰j
1) Š|’JGş. ‘n–ňƒV[ƒYŠJ”­‚đŽwŒü‚ľ‚˝V‹K“V‘R—L‹@‰ť‡•¨‚ĚŠJ‘ńE‘nť‚ĆƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†. \S‘ŸEŒŒŠÇ•aŽĄ—Ă‚Ěƒ‹ƒlƒbƒTƒ“ƒX\—Տ°SŒŒŠÇÄśŒ¤‹†‰ď. ‹ž“s, 1ŒŽ, 2008.iľ‘ҍu‰‰j

2007


@@@@@
6) Š|’JGş. —L—p“V‘R—L‹@‰ť‡•¨‚ĚŠJ‘ń‚ĆƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†. —L‹@‡Ź‰ťŠw‹Ś‰ďuK‰ďi•˝Ź19”N“xŒăŠúiHjj. “Œ‹ž, 11ŒŽ, 2007.iľ‘ҍu‰‰j
5) _ŽR—m, Š|’JGş, ‰PˆäŒ’˜Y, ŸNˆäG–ž, ’ˇ“c—T”V. Epoxyquinol B inhibits the NF- B signaltransduction pathway through the TAK1 activity. ‘ć66‰ń“ú–{ŠŕŠw‰ď. ‰Ą•l, 10ŒŽ, 2007.
4) źŕVł–F, ŽRŒűˆę˜Y, ŻŽi–ž, Š|’JGş, Ź–쐣—˜Œb, ’ˇ“c—T”V. Panepophenatnrin‚Ě•sÄ‘S‡Ź‹y‚Ń‚ť‚̍\‘˘ŠˆŤ‘ŠŠÖŒ¤‹†. ‘ć49‰ń“V‘R—L‹@‰ť‡•¨“˘˜_‰ď. ŽD–y, 9ŒŽ, 2007.
3) ‰Á“Ą’źŽ÷A‚–ŘŠCAóŒŠsOAŠ|’JGşA’ˇ“c—T”V. Aspergillus fumigatus‚̐śŽY‚ˇ‚é×–EŽüŠú‘jŠQÜƒgƒŠƒvƒƒXƒ^ƒ`ƒ“‚̐ś‡Źˆâ“`ŽqƒNƒ‰ƒXƒ^[‚Ě“Ż’č. ‘ć2‰ń“ú–{ƒPƒ~ƒJƒ‹ƒoƒCƒIƒƒW[Œ¤‹†‰ď. ‹ž“s, 5ŒŽ, 2007.
2) Kakeya, H., Kamiyama, H., Osada, H. Chemical biology of epoxyquinol B, an anti-angiogenic small molecule. RIKEN International Symposium on Chemcial Biology 2007 (RIKEN ISCB 2007). Kanagawa, Japan, Jan., 2007.
1) Hayashi, Y., Matsuzawa, M., Yamaguchi, J., Shoji, M., Kakeya, H., Onose, R., Osada, H. Total synthesis and structure activity relationship of (+)-panepophenanthrin, a ubiquitin-activating enzyme inhibitor. The Takeda Science Foundation Symposium on Pharma Sciences: On the Frontiers of Chemical Biology. Tokyo, Japan, Dec., 2007.